Patent Grant
10269558
The present disclosure generally relates to methods and systems for manufacturing electronic devices. More particularly, the disclosure relates to methods for providing a structure by depositing a layer on a substrate in a reactor.
As the trend has pushed structures in semiconductor devices to smaller and smaller sizes, different patterning techniques have arisen to produce these structures. These techniques include spacer defined double or quadruple patterning, (immersion) lithography (193i), extreme ultraviolet lithography (EUV), and directed self-assembly (DSA) lithography. Lithography may be combined with spacer defined double or quadruple patterning.
In these techniques it may be advantageous to transfer the pattern of the polymer resist to a hardmask. A hardmask is a material used in semiconductor processing as an etch mask with a good etching resistance and etching selectivity to produce small structures. The hardmask may be made from a silicon dioxide layer.
Spacers may also be used in semiconductor manufacturing to protect against subsequent processing steps and may be made from silicon dioxide.
Further silicon dioxide can be used to fill gaps in the structures of semiconductor devices.
It is therefore advantageous to produce a silicon dioxide layer.
In accordance with at least one embodiment of the invention there is provided a method of providing a structure by depositing a layer on a substrate in a reactor, the method comprising:
The reactant gas may comprise substantially no nitrogen. By using a reactant gas which is substantially nitrogen free a silicon dioxide layer may be deposited. The layer may have an improved etch rate. With substantially no nitrogen a nitrogen concentration of less than 5000 ppm, preferably less than 1000 ppm and most preferably less than 100 ppm nitrogen may be meant.
According to a further embodiment there is provided a method of providing a structure by depositing a layer on a substrate, the method comprising:
For purposes of summarizing the invention and the advantages achieved over the prior art, certain objects and advantages of the invention have been described herein above. Of course, it is to be understood that not necessarily all such objects or advantages may be achieved in accordance with any particular embodiment of the invention. Thus, for example, those skilled in the art will recognize that the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught or suggested herein without necessarily achieving other objects or advantages as may be taught or suggested herein.
All of these embodiments are intended to be within the scope of the invention herein disclosed. These and other embodiments will become readily apparent to those skilled in the art from the following detailed description of certain embodiments having reference to the attached figures, the invention not being limited to any particular embodiment(s) disclosed.
These and other features, aspects, and advantages of the invention disclosed herein are described below with reference to the drawings of certain embodiments, which are intended to illustrate and not to limit the invention.
It will be appreciated that elements in the figures are illustrated for simplicity and clarity and have not necessarily been drawn to scale to help improve understanding of illustrated embodiments of the present disclosure.
Although certain embodiments and examples are disclosed below, it will be understood by those in the art that the invention extends beyond the specifically disclosed embodiments and/or uses of the invention and obvious modifications and equivalents thereof. Thus, it is intended that the scope of the invention disclosed should not be limited by the particular disclosed embodiments described below.
The particular implementations shown and described are illustrative of the invention and its best mode and are not intended to otherwise limit the scope of the aspects and implementations in any way. Indeed, for the sake of brevity, conventional manufacturing, connection, preparation, and other functional aspects of the system may not be described in detail.
Silicon dioxide films have a wide variety of applications, as will be apparent to the skilled artisan, such as in planar logic, DRAM, and NAND Flash devices. More specifically, conformal silicon dioxide thin films that display uniform etch behavior have a wide variety of applications, both in the semiconductor industry and also outside of the semiconductor industry. According to some embodiments of the present disclosure, various silicon dioxide films and precursors and methods for depositing those films by atomic layer deposition (ALD) are provided. Importantly, in some embodiments the silicon dioxide films have a relatively uniform etch rate for both the vertical and the horizontal portions, when deposited onto 3-dimensional structures. Such three-dimensional structures may include, for example and without limitation, FinFETS or other types of multiple gate FETs.
Thin film layers comprising silicon oxide can be deposited by plasma-enhanced atomic layer deposition (PEALD) or chemical vapor deposition (PECVD) type processes or by thermal ALD processes. In some embodiments a silicon oxide thin film is deposited over a three dimensional structure, such as a fin in the formation of a finFET device, and/or in the application of spacer defined double patterning (SDDP) and/or spacer defined quadruple patterning (SDQP). In some embodiments a silicon oxide thin film is deposited over a flat layer as a hard mask and subsequent layer are positioned on top for lithographic processing.
The formula of the silicon dioxide is generally referred to herein as SiO2 for convenience and simplicity. However, the skilled artisan will understand that the Si:O ratio in the silicon dioxide layer and excluding hydrogen or other impurities, can be represented as SiOx, where x varies from about 0.5 to about 2.0, as long as some Si—O bonds are formed. In some cases, x may vary from about 0.9 to about 1.7, from about 1.0 to about 1.5, or from about 1.2 to about 1.4. In some embodiments unstable silicon monoxide is formed which may decompose in Si and SiO2.
ALD-type processes are based on controlled, generally self-limiting surface reactions. Gas phase reactions are typically avoided by contacting the substrate alternately and sequentially with the reactants. Vapor phase reactants are separated from each other in the reaction chamber, for example, by removing excess reactants and/or reactant byproducts between reactant pulses. The reactants may be removed from proximity with the substrate surface with the aid of a purge gas and/or vacuum. In some embodiments excess reactants and/or reactant byproducts are removed from the reaction space by purging, for example with an inert gas.
The methods presented herein provide for deposition of SiO2 thin films on substrate surfaces. Geometrically challenging applications are also possible due to the nature of ALD-type processes. According to some embodiments, ALD-type processes are used to form SiO2 thin films on substrates such as integrated circuit workpieces, and in some embodiments on three-dimensional structures on the substrates. In some embodiments, ALD type processes comprise alternate and sequential contact of the substrate with a silicon halide precursor and an oxygen precursor. In some embodiments, a silicon precursor contacts the substrate such silicon species adsorb onto the surface of the substrate. In some embodiments, the silicon species may be same as the silicon precursor, or may be modified in the adsorbing step, such as by losing one or more ligands.
According to certain embodiments, a silicon dioxide thin film may be formed on a substrate by an ALD-type process comprising multiple silicon dioxide deposition cycles, each silicon dioxide deposition cycle comprising:
In some embodiments, plasma enhanced ALD (PEALD) processes are used to deposit silicon dioxide films. Briefly, a substrate or workpiece is placed in a reaction chamber and subjected to alternately repeated surface reactions. In some embodiments, thin silicon dioxide films are formed by repetition of a self-limiting ALD cycle. Preferably, for forming silicon dioxide films, each ALD cycle comprises at least two distinct phases. The provision and removal of a reactant from the reaction space may be considered a phase. In a first phase, a first reactant comprising silicon is provided and forms no more than about one monolayer on the substrate surface. This reactant is also referred to herein as “the silicon precursor,” “silicon-containing precursor,” or “silicon reactant” and may be, for example, a silicon halide such as H2SiI2.
In a second phase, a (second) reactant comprising a reactive species is provided and may convert adsorbed silicon species to silicon dioxide. In some embodiments the reactant gas comprises an oxygen precursor. In some embodiments, the reactive species comprises an excited species. In some embodiments the reactant comprises a species from an oxygen containing plasma. In some embodiments, the reactant comprises oxygen radicals, oxygen atoms and/or oxygen plasma. In some embodiments, the reactant may comprise O-containing plasma or a plasma comprising O. In some embodiments, the reactant may comprise a plasma comprising O-containing species. In some embodiments the reactant may comprise oxygen atoms and/or O* radicals. The reactant gas may comprise other species that are not oxygen precursors. In some embodiments, the reactant may comprise a plasma of argon, radicals of argon, or atomic argon in one form or another. In some embodiments, the reactant may comprise a species from a noble gas, such as He, Ne, Ar, Kr, or Xe, preferably Ar or He, for example as radicals, in plasma form, or in elemental form. These reactive species from noble gases do not necessarily contribute material to the deposited film, but can in some circumstances contribute to film growth as well as help in the formation and ignition of plasma. In some embodiments a gas that is used to form a plasma may flow constantly throughout the deposition process but only be activated intermittently. In some embodiments, the reactant does not comprise a species from a noble gas, such as Ar. Thus, in some embodiments the adsorbed silicon halide precursor is not contacted with a reactive species generated by a plasma from Ar.
Additional phases may be added and phases may be removed as desired to adjust the composition of the final film.
One or more of the reactants may be provided with the aid of a carrier gas, such as for example Ar or He. In some embodiments the silicon halide precursor and the reactant are provided with the aid of a carrier gas.
In some embodiments, two of the phases may overlap, or be combined. For example, the silicon halide precursor and the reactant may be provided simultaneously in pulses that partially or completely overlap. In addition, although referred to as the first and second phases, and the first and second reactants, the order of the phases may be varied, and an ALD cycle may begin with any one of the phases. That is, unless specified otherwise, the precursors and reactants can be provided in any order, and the process may begin with any of the precursors or reactant.
As discussed in more detail below, in some embodiments for depositing a silicon dioxide film, one or more deposition cycles begin with provision of the silicon halide precursor, followed by the reactant. In other embodiments deposition may begin with provision of the reactant, followed by the silicon halide precursor.
In some embodiments the substrate on which deposition is desired, such as a semiconductor workpiece, is loaded into a reactor. The reactor may be part of a cluster tool in which a variety of different processes in the formation of an integrated circuit are carried out. In some embodiments a flow-type reactor is utilized. In some embodiments a shower head type of reactor is utilized. In some embodiments, a space divided reactor is utilized. In some embodiments a high-volume manufacturing-capable single wafer ALD reactor is used. In other embodiments a batch reactor comprising multiple substrates is used. For embodiments in which batch ALD reactors are used, the number of substrates is preferably in the range of 10 to 200, more preferably in the range of 50 to 150, and most preferably in the range of 100 to 130.
Exemplary single wafer reactors, designed specifically to enhance ALD processes, are commercially available from ASM America, Inc. (Phoenix, Ariz.) under the tradenames Pulsar® 2000 and Pulsar® 3000 and ASM Japan K.K (Tokyo, Japan) under the tradename Eagle® XP, XP8 and Dragon®. Exemplary batch ALD reactors, designed specifically to enhance ALD processes, are commercially available from and ASM Europe B.V (Almere, Netherlands) under the tradenames A400™ and A412™.
In some embodiments, if necessary, the exposed surfaces of the workpiece can be pretreated to provide reactive sites to react with the first phase of the ALD process. In some embodiments a separate pretreatment step is not required. In some embodiments the substrate is pretreated to provide a desired surface termination. In some embodiments the substrate is pretreated with plasma.
Excess reactant and reaction byproducts, if any, are removed from the vicinity of the substrate, and in particular from the substrate surface, between reactant pulses. In some embodiments the reaction chamber is purged between reactant pulses, such as by purging with an inert gas. The flow rate and time of each reactant, is tunable, as is the removal step, allowing for control of the quality and various properties of the films.
As mentioned above, in some embodiments a reaction gas is provided to the reaction chamber continuously during each deposition cycle, or during the entire ALD process, and reactive species are provided by generating a plasma in the reaction gas, either in the reaction chamber or upstream of the reaction chamber. In some embodiments the reaction gas comprises oxygen. In some embodiments the reaction gas is oxygen. In other embodiments the reactant gas may comprise helium, or argon. In some embodiments the reactant gas is helium or argon. The reactant gas such as oxygen, argon, helium or argon may have a flow of 0.1 to 10, preferably 2 to 8, more preferably 3 to 6 and most preferably around 5 slm. The gas may also serve as a purge gas for the precursor and/or reactant (or reactive species).
In some embodiments, nitrogen, argon, or helium may serve as a purge gas for a first precursor and a source of excited species for converting the silicon halide precursor to the silicon dioxide film.
The cycle is repeated until a film of the desired thickness and composition is obtained. In some embodiments the deposition parameters, such as the flow rate, flow time, purge time, and/or reactants themselves, may be varied in one or more deposition cycles during the ALD process in order to obtain a film with the desired characteristics. In some embodiments, argon and/or argon plasma are not provided in a deposition cycle, or in the deposition process.
The term “pulse” may be understood to comprise feeding reactant into the reaction chamber for a predetermined amount of time. The term “pulse” does not restrict the length or duration of the pulse and a pulse can be any length of time.
In some embodiments, the silicon reactant is provided first. After an initial surface termination, if necessary or desired, a first silicon reactant pulse is supplied to the workpiece. In accordance with some embodiments, the first reactant pulse comprises a carrier gas flow and a volatile silicon species, for example a silicon halide such as H2SiI2, that is reactive with the workpiece surfaces of interest. Accordingly, the silicon reactant adsorbs upon these workpiece surfaces. The first reactant pulse self-saturates the workpiece surfaces such that any excess constituents of the first reactant pulse do not further react with the molecular layer formed by this process. The carrier gas may have a flow of 0.5 to 8, preferably 1 to 5, more preferably 2 to 3 and most preferably around 2.8 slm.
The first silicon reactant pulse is preferably supplied in gaseous form. The silicon precursor gas is considered “volatile” for purposes of the present description if the species exhibits sufficient vapor pressure under the process conditions to transport the species to the workpiece in sufficient concentration to saturate exposed surfaces.
In some embodiments the silicon reactant pulse is from about 0.05 seconds to about 5.0 seconds, about 0.1 seconds to about 3 seconds or about 0.2 seconds to about 1.0 seconds. The optimum pulsing time can be readily determined by the skilled artisan based on the particular circumstances.
In some embodiments the silicon reactant consumption rate is selected to provide a desired dose of precursor to the reaction space. Reactant consumption refers to the amount of reactant consumed from the reactant source, such as a reactant source bottle, and can be determined by weighing the reactant source before and after a certain number of deposition cycles and dividing the mass difference by the number of cycles. In some embodiments the silicon reactant consumption is more than about 0.1 mg/cycle. In some embodiments the silicon reactant consumption is about 0.1 mg/cycle to about 50 mg/cycle, about 0.5 mg/cycle to about 30 mg/cycle or about 2 mg/cycle to about 20 mg/cycle. In some embodiments the minimum preferred silicon reactant consumption may be at least partly defined by the reactor dimensions, such as the heated surface area of the reactor. In some embodiments in a showerhead reactor designed for 300 mm silicon wafers, silicon reactant consumption is more than about 0.5 mg/cycle, or more than about 2.0 mg/cycle. In some embodiments the silicon reactant consumption is more than about 5 mg/cycle in a showerhead reactor designed for 300 mm silicon wafers. In some embodiments the silicon reactant consumption is more than about 1 mg/cycle, preferably more than 5 mg/cycle at reaction temperatures below about 550° C. in a showerhead reactor designed for 300 mm silicon wafers.
After sufficient time for a molecular layer to adsorb on the substrate surface, excess first silicon reactant is then removed from the reaction space. In some embodiments the excess first reactant is purged by stopping the flow of the first chemistry while continuing to flow a carrier gas or purge gas for a sufficient time to diffuse or purge excess reactants and reactant by-products, if any, from the reaction space. In some embodiments the excess first precursor is purged with the aid of inert gas, such as argon, that is flowing throughout the ALD cycle.
In some embodiments, the first reactant is purged for about 0.1 seconds to about 10 seconds, about 0.3 seconds to about 5 seconds or about 0.3 seconds to about 1 second. Provision and removal of the silicon reactant can be considered the first or silicon phase of the ALD cycle.
In the second phase, a reactant comprising a reactive species, such as oxygen plasma is provided to the workpiece. Argon, Ar, is flowed continuously to the reaction chamber during each ALD cycle in some embodiments. Argon plasma may be formed by generating a plasma in argon in the reaction chamber or upstream of the reaction chamber, for example by flowing the argon through a remote plasma generator.
In some embodiments, plasma is generated upon flowing oxygen and argon gases. In some embodiments the Ar and O2 are provided to the reaction chamber before the plasma is ignited or oxygen and Ar ions or radicals are formed. In some embodiments the Ar and O2 are provided to the reaction chamber continuously and oxygen and Ar containing plasma, ions or radicals is created or supplied when needed.
Typically, the reactant, for example comprising oxygen plasma, is provided for about 0.1 seconds to about 10 seconds. In some embodiments the reactant, such as oxygen plasma, is provided for about 0.1 seconds to about 10 seconds, 0.5 seconds to about 5 seconds or 0.5 seconds to about 2.0 seconds. However, depending on the reactor type, substrate type and its surface area, the reactant pulsing time may be even higher than about 10 seconds. In some embodiments, pulsing times can be on the order of minutes. The optimum pulsing time can be readily determined by the skilled artisan based on the particular circumstances.
In some embodiments the reactant is provided in two or more distinct pulses, without introducing another reactant in between any of the two or more pulses. For example, in some embodiments an oxygen plasma is provided in two or more, preferably in two, sequential pulses, without introducing a Si-precursor in between the sequential pulses. In some embodiments during provision of oxygen plasma two or more sequential plasma pulses are generated by providing a plasma discharge for a first period of time, extinguishing the plasma discharge for a second period of time, for example from about 0.1 seconds to about 10 seconds, from about 0.5 seconds to about 5 seconds or about 1.0 seconds to about 4.0 seconds, and exciting it again for a third period of time before introduction of another precursor or a removal step, such as before the Si-precursor or a purge step. Additional pulses of plasma can be introduced in the same way. In some embodiments a plasma is ignited for an equivalent period of time in each of the pulses.
Oxygen plasma may be generated by applying RF power of from about 10 W to about 2000 W, preferably from about 50 W to about 1000 W, more preferably from about 100 W to about 600 W in some embodiments. In some embodiments the RF power density may be from about 0.02 W/cm2 to about 2.0 W/cm2, preferably from about 0.05 W/cm2 to about 1.5 W/cm2. The RF power may be applied to oxygen that flows during the oxygen plasma pulse time, that flows continuously through the reaction chamber, and/or that flows through a remote plasma generator. Thus in some embodiments the plasma is generated in situ, while in other embodiments the plasma is generated remotely. In some embodiments a showerhead reactor is utilized and plasma is generated between a substrate holder (on top of which the substrate is located) and a showerhead plate. In some embodiments the gap between the substrate holder and showerhead plate is from about 0.1 cm to about 20 cm, from about 0.5 cm to about 5 cm, or from about 0.8 cm to about 3.0 cm.
After a time period sufficient to completely saturate and react the previously adsorbed molecular layer with the oxygen plasma pulse, any excess reactant and reaction byproducts are removed from the reaction space. As with the removal of the first reactant, this step may comprise stopping the generation of reactive species and continuing to flow the inert gas, such as helium or argon for a time period sufficient for excess reactive species and volatile reaction by-products to diffuse out of and be purged from the reaction space. In other embodiments a separate purge gas may be used. The purge may, in some embodiments, be from about 0.1 seconds to about 10 seconds, about 0.1 seconds to about 4 seconds or about 0.1 seconds to about 0.5 seconds. Together, the oxygen plasma provision and removal represent a second, reactive species phase in a silicon dioxide atomic layer deposition cycle.
The two phases together represent one ALD cycle, which is repeated to form silicon dioxide thin films of a desired thickness. While the ALD cycle is generally referred to herein as beginning with the silicon phase, it is contemplated that in other embodiments the cycle may begin with the reactive species phase. One of skill in the art will recognize that the first precursor phase generally reacts with the termination left by the last phase in the previous cycle. Thus, while no reactant may be previously adsorbed on the substrate surface or present in the reaction space if the reactive species phase is the first phase in the first ALD cycle, in subsequent cycles the reactive species phase will effectively follow the silicon phase. In some embodiments one or more different ALD cycles are provided in the deposition process.
According to some embodiments of the present disclosure, PEALD reactions may be performed at temperatures ranging from about 25° C. to about 700° C., preferably from about 50° C. to about 600° C., more preferably from about 100° C. to about 450° C., and most preferably from about 200° C. to about 400° C. In some embodiments, the optimum reactor temperature may be limited by the maximum allowed thermal budget. Therefore, in some embodiments the reaction temperature is from about 300° C. to about 400° C. In some applications, the maximum temperature is around about 400° C., and, therefore the PEALD process is run at that reaction temperature.
According to some embodiments of the present disclosure, the pressure of the reaction chamber during processing is maintained between 0.08 to 40 Torr, preferably 0.8 to 30 Torr and more preferably between 2 to 20 Torr, and most preferably around 8 Torr.
PECVD Process
Plasma-enhanced chemical vapor deposition (PECVD) is a process used to deposit thin films from a gas state (vapor) to a solid state on a substrate. Chemical reactions are involved in the process, which occur after creation of a plasma of the reactive gases. The plasma is continuously applied to the space between which is filled with the reactive gases. In some embodiments, a radio frequency (RF) plasma source is employed to create the plasma, though any type of plasma source capable of generating a direct plasma may be employed, including microwave and DC sources. Further, in some embodiments, a remotely-generated plasma may be employed to supply reactive species. In further embodiments (pulse PECVD) only one of the reactants, either the Silicon precursor or the reactive species is provided continuously to the chamber while the other reactant is pulsed intermittently
Si Precursors
A number of suitable silicon halide precursors can be used in the presently disclosed PEALD processes. At least some of the suitable precursors may have the following general formula:
H2n+2−y−zSinXyAz (1)
wherein, n=1-10, y=1 or more (and up to 2n+2−z), z=0 or more (and up to 2n+2−y), X is I or Br, and A is a halogen other than X, preferably n=1-5 and more preferably n=1-3 and most preferably 1-2.
According to some embodiments, silicon halide precursors may comprise one or more cyclic compounds. Such precursors may have the following general formula:
H2n+2−y−zSinXyAz (2)
wherein the formula (2) compound is cyclic compound, n=3-10, y=1 or more (and up to 2n−z), z=0 or more (and up to 2n−y), X is I or Br, and A is a halogen other than X, preferably n=3-6.
According to some embodiments, silicon halide precursors may comprise one or more iodosilanes. Such precursors may have the following general formula:
H2n+2−y−zSinIyAz (3)
wherein, n=1-10, y=1 or more (and up to 2n+2−z), z=0 or more (and up to 2n+2−y), and A is a halogen other than I, preferably n=1-5 and more preferably n=1-3 and most preferably 1-2.
According to some embodiments, some silicon halide precursors may comprise one or more cyclic iodosilanes. Such precursors may have the following general formula:
H2n+2−y−zSinIyAz (4)
wherein the formula (4) compound is a cyclic compound, n=3-10, y=1 or more (and up to 2n−z), z=0 or more (and up to 2n−y), and A is a halogen other than I, preferably n=3-6.
According to some embodiments, some silicon halide precursors may comprise one or more bromosilanes. Such precursors may have the following general formula:
H2n+2−y−zSinBryAz (5)
wherein, n=1-10, y=1 or more (and up to 2n+2−z), z=0 or more (and up to 2n+2−y), and A is a halogen other than Br, preferably n=1-5 and more preferably n=1-3 and most preferably 1-2.
According to some embodiments, some silicon halide precursors may comprise one or more cyclic bromosilanes. Such precursors may have the following general formula:
H2n+2−y−zSinBryAz (6)
wherein the formula (6) compound is a cyclic compound, n=3-10, y=1 or more (and up to 2n−z), z=0 or more (and up to 2n−y), and A is a halogen other than Br, preferably n=3-6.
According to some embodiments, preferred silicon precursors comprise one or more iodosilanes. Such precursors may have the following general formula:
H2n+2−y−zSinIy (7)
wherein, n=1-5, y=1 or more (up to 2n+2), preferably n=1-3 and more preferably n=1-2.
According to some embodiments, preferred silicon halide precursors comprise one or more bromosilanes. Such precursors may have the following general formula:
H2n+2−y−zSinIy (8)
wherein, n=1-5, y=1 or more (up to 2n+2), preferably n=1-3 and more preferably n=1-2.
According to some embodiments of a PEALD process, suitable silicon halide precursors can include at least compounds having any one of the general formulas (1) through (8). In general formulas (1) through (8), halides/halogens can include F, Cl, Br and I. In some embodiments, a silicon halide precursor comprises SiI4, HSiI3, H2SiI2, H3SiI, Si2I6, HSi2I5, H2Si2I4, H3Si2I3, H4Si2I2, H5Si2I, or Si3I8. In some embodiments, a silicon halide precursor comprises one of HSiI3, H2SiI2, H3SiI, H2Si2I4, H4Si2I2, and H5Si2I. In some embodiments the silicon halide precursor comprises two, three, four, five or six of HSiI3, H2SiI2, H3SiI, H2Si2I4, H4Si2I2, and H5Si2I, including any combinations thereof.
In certain embodiments, the Si halide precursor is H2SiI2. In some embodiments, Si halide precursors of formulas (9)-(28), below, can be used in PEALD processes.
O-Precursors
As discussed above, the reactant according to the present disclosure may comprise an oxygen precursor. In some embodiments the reactant in a PEALD process may comprise a reactive species. Suitable plasma compositions include oxygen plasma, radicals of oxygen, or atomic oxygen in one form or another. In some embodiments, the reactive species may comprise O-containing plasma or a plasma comprising O. In some embodiments, the reactive species may comprise a plasma comprising O-containing species. In some embodiments the reactive species may comprise oxygen atoms and/or O* radicals. In some embodiments, argon plasma, radicals of argon, or atomic argon in one form or another are also provided. And in some embodiments, a plasma may also contain noble gases, such as He, Ne, Ar, Kr and Xe, preferably Ar or He, in plasma form, as radicals, or in atomic form. In some embodiments, the reactant does not comprise any species from a noble gas, such as Ar. Thus, in some embodiments plasma is not generated in a gas comprising a noble gas.
In some embodiments the reactant may be formed, at least in part, from O2 and H2, where the O2 and H2 are provided at a flow ratio (O2/H2) from about 20:1 to about 1:20, preferably from about 10:1 to about 1:10, more preferably from about 5:1 to about 1:5 more preferably from about 1:2 to about 4:1, and most preferably 1:1.
The reactant may be formed in some embodiments remotely via plasma discharge (“remote plasma”) away from the substrate or reaction space. In some embodiments, the reactant may be formed in the vicinity of the substrate or directly above substrate (“direct plasma).
Oxygen may flow continuously throughout the silicon dioxide deposition cycle, with oxygen plasma formed at the appropriate times to convert adsorbed silicon compound into silicon dioxide.
As mentioned above, in some embodiments the substrate may be contacted simultaneously with the silicon compound and the reactive oxygen species to form the layer in a plasma enhanced chemical vapor deposition (PECVD) process.
According to some embodiments, the silicon dioxide layer is deposited using a plasma enhanced chemical vapor deposition (PEALD) process on a substrate having three-dimensional features, such as in a FinFET application. The features may have an aspect ratios of more than 2, preferably an aspect ratios of more than 3, more preferably an aspect ratios of more than 6 and most preferably an aspect ratios of more than 11. The process may comprise the steps as described above in conjunction with
Si Precursors
A number of suitable silicon halide precursors may be used in the presently disclosed processes. In some embodiments these precursors may be used in plasma ALD or plasma CVD processes thereby a layer with a desired quality (at least one of the desired WER, WERR, pattern loading effect or/and step coverage features described below) is deposited.
According to some embodiments, some silicon precursors comprise iodine or bromine and the film deposited by using that precursor has at least one desired property, for example at least one of the desired WER, WERR, pattern loading effect or/and step coverage features described below.
At least some of the suitable precursors may have the following general formula:
H2n+2−y−z−wSinXyAzRw (9)
wherein, n=1-10, y=1 or more (and up to 2n+2−z−w), z=0 or more (and up to 2n+2−y−w), w=0 or more (and up to 2n+2−y−z), X is I or Br, A is a halogen other than X, R is an organic ligand and can be independently selected from the group consisting of alkoxides, alkylsilyls, alkyl, substituted alkyl, alkylamines and unsaturated hydrocarbon; preferably n=1-5 and more preferably n=1-3 and most preferably 1-2. Preferably R is a C1-C3 alkyl ligand, such as methyl, ethyl, n-propyl or isopropyl.
According to some embodiments, some silicon halide precursors comprise one or more cyclic compounds. Such precursors may have the following general formula:
H2n+2−y−z−wSinIyAzRw (10)
wherein, n=3-10, y=1 or more (and up to 2n−z−w), z=0 or more (and up to 2n−y−w), w=0 or more (and up to 2n−y−z), X is I or Br, A is a halogen other than X, R is an organic ligand and can be independently selected from the group consisting of alkoxides, alkylsilyls, alkyl, substituted alkyl, alkylamines and unsaturated hydrocarbon; preferably n=3-6. Preferably R is a C1-C3 alkyl ligand, such as methyl, ethyl, n-propyl or isopropyl.
According to some embodiments, some silicon halide precursors comprise one or more iodosilanes. Such precursors may have the following general formula:
H2n-y-z-wSinIyAzRw (11)
wherein, n=1-10, y=1 or more (and up to 2n+2−z−w), z=0 or more (and up to 2n+2−y−w), w=0 or more (and up to 2n+2−y−z), A is a halogen other than I, R is an organic ligand and can be independently selected from the group consisting of alkoxides, alkylsilyls, alkyl, substituted alkyl, alkylamines and unsaturated hydrocarbon; preferably n=1-5 and more preferably n=1-3 and most preferably 1-2. Preferably R is a C1-C3 alkyl ligand, such as methyl, ethyl, n-propyl or isopropyl.
According to some embodiments, some silicon halide precursors comprise one or more cyclic iodosilanes. Such precursors may have the following general formula:
H2n+2−y−z−wSinIyAzRw (12)
wherein, n=3-10, y=1 or more (and up to 2n−z−w), z=0 or more (and up to 2n−y−w), w=0 or more (and up to 2n−y−z), A is a halogen other than I, R is an organic ligand and can be independently selected from the group consisting of alkoxides, alkylsilyls, alkyl, substituted alkyl, alkylamines and unsaturated hydrocarbon; preferably n=3-6. Preferably R is a C1-C3 alkyl ligand, such as methyl, ethyl, n-propyl or isopropyl.
According to some embodiments, some silicon halide precursors comprise one or more bromosilanes. Such precursors may have the following general formula:
H2n+2−y−z−wSinBryAzRw (13)
wherein, n=1-10, y=1 or more (and up to 2n+2−z−w), z=0 or more (and up to 2n+2−y−w), w=0 or more (and up to 2n+2−y−z), A is a halogen other than Br, R is an organic ligand and can be independently selected from the group consisting of alkoxides, alkylsilyls, alkyl, substituted alkyl, alkylamines and unsaturated hydrocarbon; preferably n=1-5 and more preferably n=1-3 and most preferably 1-2. Preferably R is a C1-C3 alkyl ligand, such as methyl, ethyl, n-propyl or isopropyl.
According to some embodiments, some silicon halide precursors comprise one or more cyclic bromosilanes. Such precursors may have the following general formula:
H2n-y-z-wSinBryAzRw (14)
wherein, n=3-10, y=1 or more (and up to 2n−z−w), z=0 or more (and up to 2n−y−w), w=0 or more (and up to 2n−y−z), A is a halogen other than Br, R is an organic ligand and can be independently selected from the group consisting of alkoxides, alkylsilyls, alkyl, substituted alkyl, alkylamines and unsaturated hydrocarbon; preferably n=3-6. Preferably R is a C1-C3 alkyl ligand such as methyl, ethyl, n-propyl or isopropyl.
According to some embodiments, some silicon halide precursors comprise one or more iodosilanes or bromosilanes in which the iodine or bromine is not bonded to the silicon in the compound. Accordingly some suitable compounds may have iodine/bromine substituted alkyl groups. Such precursors may have the following general formula:
H2n+2−y−z−wSinXyAzRIIw (15)
wherein, n=1-10, y=0 or more (and up to 2n+2−z−w), z=0 or more (and up to 2n+2−y−w), w=1 or more (and up to 2n+2−y−z), X is I or Br, A is a halogen other than X, RII is an organic ligand containing I or Br and can be independently selected from the group consisting of I or Br substituted alkoxides, alkylsilyls, alkyls, alkylamines and unsaturated hydrocarbons; preferably n=1-5 and more preferably n=1-3 and most preferably 1-2. Preferably RII is an iodine substituted C1-C3 alkyl ligand.
According to some embodiments, some silicon halide precursors comprise one or more cyclic iodosilanes or bromosilanes. Accordingly some suitable cyclic compounds may have iodine/bromine substituted alkyl groups. Such precursors may have the following general formula:
H2n-y-z-wSinXyAzRIIw (16)
wherein, n=3-10, y=0 or more (and up to 2n+2−z−w), z=0 or more (and up to 2n+2−y−w), w=1 or more (and up to 2n+2−y−z), X is I or Br, A is a halogen other than X, RII is an organic ligand containing I or Br and can be independently selected from the group consisting of I or Br substituted alkoxides, alkylsilyls, alkyls, alkylamines and unsaturated hydrocarbons; preferably n=3-6. Preferably R is an iodine substituted C1-C3 alkyl ligand.
According to some embodiments, some suitable silicon halide precursors may have at least one of the following general formulas:
H2n+2−y−z−wSinXyAz(NR1R2)w (17)
wherein, n=1-10, y=1 or more (and up to 2n+2−z−w), z=0 or more (and up to 2n+2−y−w), w=1 or more (and up to 2n+2−y−z), X is I or Br, A is a halogen other than X, N is nitrogen, and R1 and R2 can be independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, silyl, alkylsilyl and unsaturated hydrocarbon; preferably n=1-5 and more preferably n=1-3 and most preferably 1-2. Preferably R1 and R2 are hydrogen or C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl and n-butyl. More preferably R1 and R2 are hydrogen or C1-C3 alkyl groups, such as methyl, ethyl, n-propyl or isopropyl. Each of the (NR1R2)w ligands can be independently selected from each other.
(H3-y-z-wXyAz(NR1R2)wSi)3—N (18)
wherein, y=1 or more (and up to 3−z−w), z=0 or more (and up to 3−y−w), w=1 or more (and up to 3−y−z), X is I or Br, A is a halogen other than X, N is nitrogen and R1 and R2 can be independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, silyl, alkylsilyl, and unsaturated hydrocarbon. Preferably R1 and R2 are hydrogen or C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl and n-butyl. More preferably R1 and R2 are hydrogen or C1-C3 alkyl groups, such as methyl, ethyl, n-propyl or isopropyl. Each of the (NR1R2), ligands can be independently selected from each other. Each of the three H3-y-z-wXyAz(NR1R2)w Si ligands can be independently selected from each other.
In some embodiments, some suitable silicon halide precursors may have at least one of the following more specific formulas:
H2n+2−y−wSinIy(NR1R2)w (19)
wherein, n=1-10, y=1 or more (and up to 2n+2−w), w=1 or more (and up to 2n+2−y), N is nitrogen, and R1 and R2 can be independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, silyl, alkylsilyl, and unsaturated hydrocarbon; preferably n=1-5 and more preferably n=1-3 and most preferably 1-2. Preferably R1 and R2 are hydrogen or C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl and n-butyl. More preferably R1 and R2 are hydrogen or C1-C3 alkyl groups, such as methyl, ethyl, n-propyl or isopropyl. Each of the (NR1R2)w ligands can be independently selected from each other.
(H3-y-wIy(NR1R2)wSi)3—N (20)
wherein, y=1 or more (and up to 3−w), w=1 or more (and up to 3−y), N is nitrogen and R1 and R2 can be independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, silyl, alkylsilyl, and unsaturated hydrocarbon. Preferably R1 and R2 are hydrogen or C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl and n-butyl. More preferably R1 and R2 are hydrogen or C1-C3 alkyl groups, such as methyl, ethyl, n-propyl or isopropyl. Each of the three H3-y-wIy(NR1R2)wSi ligands can be independently selected from each other.
According to some embodiments, some suitable silicon halide precursors may have at least one of the following general formulas:
H2n+2−y−z−wSinXyAz(NR1R2)w (21)
wherein, n=1-10, y=1 or more (and up to 2n+2-z-w), z=0 or more (and up to 2n+2−y−w), w=1 or more (and up to 2n+2−y−z), X is I or Br, A is a halogen other than X, N is nitrogen, R1 can be independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, silyl, alkylsilyl, and unsaturated hydrocarbon, and R2 can be independently selected from the group consisting of alkyl, substituted alkyl, silyl, alkylsilyl and unsaturated hydrocarbon; preferably n=1-5 and more preferably n=1-3 and most preferably 1-2. Preferably R1 is hydrogen or C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl, and n-butyl. More preferably R1 is hydrogen or C1-C3 alkyl groups, such as methyl, ethyl, n-propyl, or isopropyl. Preferably R2 is C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl, and n-butyl. More preferably R2 is C1-C3 alkyl groups, such as methyl, ethyl, n-propyl, or isopropyl. Each of the (NR1R2)w ligands can be independently selected from each other.
(H3-y-z-wXyAz(NR1R2)wSi)3—N (22)
wherein, y=1 or more (and up to 3−z−w), z=0 or more (and up to 3−y−w), w=1 or more (and up to 3−y−z), X is I or Br, A is a halogen other than X, N is nitrogen, R1 can be independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, silyl, alkylsilyl, and unsaturated hydrocarbon, and R2 can be independently selected from the group consisting of alkyl, substituted alkyl, silyl, alkylsilyl, and unsaturated hydrocarbon; preferably n=1-5 and more preferably n=1-3 and most preferably 1-2. Preferably R1 is hydrogen or C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl, and n-butyl. More preferably R1 is hydrogen or C1-C3 alkyl groups, such as methyl, ethyl, n-propyl, or isopropyl. Preferably R2 is C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl, and n-butyl. More preferably R2 is C1-C3 alkyl groups, such as methyl, ethyl, n-propyl, or isopropyl. Each of the (NR1R2) ligands can be independently selected from each other.
In some embodiments, some suitable silicon halide precursors may have at least one of the following more specific formulas:
H2n+2−y−wSinIy(NR1R2)w (23)
wherein, n=1-10, y=1 or more (and up to 2n+2−w), w=1 or more (and up to 2n+2−y), N is nitrogen, R1 can be independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, silyl, alkylsilyl, and unsaturated hydrocarbon, and R2 can be independently selected from the group consisting of alkyl, substituted alkyl, silyl, alkylsilyl, and unsaturated hydrocarbon; preferably n=1-5 and more preferably n=1-3 and most preferably 1-2. Preferably R1 is hydrogen or C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl, and n-butyl. More preferably R1 is hydrogen or C1-C3 alkyl groups, such as methyl, ethyl, n-propyl, or isopropyl. Preferably R2 is C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl, and n-butyl. More preferably R2 is C1-C3 alkyl groups, such as methyl, ethyl, n-propyl, or isopropyl. Each of the (NR1R2)w ligands can be independently selected from each other.
(H3-y-wIy(NR1R2)wSi)3—N (24)
wherein, y=1 or more (and up to 3−w), w=1 or more (and up to 3−y), N is nitrogen, R1 can be independently selected from the group consisting of hydrogen, alkyl, substituted alkyl, silyl, alkylsilyl, and unsaturated hydrocarbon, and R2 can be independently selected from the group consisting of alkyl, substituted alkyl, silyl, alkylsilyl, and unsaturated hydrocarbon; preferably n=1-5 and more preferably n=1-3 and most preferably 1-2. Preferably R1 is hydrogen or C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl, and n-butyl. More preferably R1 is hydrogen or C1-C3 alkyl groups, such as methyl, ethyl, n-propyl, or isopropyl. Preferably R2 is C1-C4 alkyl groups, such as methyl, ethyl, n-propyl, isopropyl, t-butyl, isobutyl, sec-butyl, and n-butyl. More preferably R2 is C1-C3 alkyl groups, such as methyl, ethyl, n-propyl, or isopropyl. Each of the (NR1R2)w ligands can be independently selected from each other.
According to some embodiments of a thermal ALD process, suitable silicon halide precursors can include at least compounds having any one of the general formulas (9) through (24). In general formulas (9) through (18) as well as in general formulas (21) and (22), halides/halogens can include F, Cl, Br and I.
In some embodiments, a silicon halide precursor comprises one or more of the following: SiI4, HSiI3, H2SiI2, H3SiI, Si2I6, HSi2I5, H2Si2I4, H3Si2I3, H4Si2I2, H5Si2I, Si3I8, HSi2I5, H2Si2I4, H3Si2I3, H4Si2I2, H5Si2I, MeSiI3, Me2SiI2, Me3SiI, MeSi2I5, Me2Si2I4, Me3Si2I3, Me4Si2I2, Me5Si2I, HMeSiI2, HMe2SiI, HMeSi2I4, HMe2Si2I3, HMe3Si2I2, HMe4Si2I, H2MeSiI, H2MeSi2I3, H2Me2Si2I2, H2Me3Si2I, H3MeSi2I2, H3Me2Si2I, H4MeSi2I, EtSiI3, Et2SiI2, Et3SiI, EtSi2I5, Et2Si2I4, Et3Si2I3, Et4Si2I2, Et5Si2I, HEtSiI2I2, HEt2SiI, HEtSi2I4, HEt2Si2I3, HEt3Si2I2, HEt4Si2I, H2EtSiI, H2EtSi2I3, H2Et2Si2I2, H2Et3Si2I, H3EtSi2I2, H3Et2Si2I, and H4EtSi2I.
In some embodiments, a silicon halide precursor comprises one or more of the following: EtMeSiI2, Et2MeSiI, EtMe2SiI, EtMeSi2I4, Et2MeSi2I3, EtMe2Si2I3, Et3MeSi2I2, Et2Me2Si2I2, EtMe3Si2I2, Et4MeSi2I, Et3Me2Si2I, Et2Me3Si2I, EtMe4Si2I, HEtMeSiI, HEtMeSi2I3, HEt2MeSi2I2, HEtMe2Si2I2, HEt3MeSi2I, HEt2Me2Si2I, HEtMe3Si2I, H2EtMeSi2I2, H2Et2MeSi2I, H2EtMe2Si2I, H3EtMeSi2I.
In some embodiments, a silicon halide precursor comprises one or more of the following: HSiI3, H2SiI2, H3SiI, H2Si2I4, H4Si2I2, H5Si2I, MeSiI3, Me2SiI2, Me3SiI, Me2Si2I4, Me4Si2I2, HMeSiI2, H2Me2Si2I2, EtSiI3, Et2SiI2, Et3SiI, Et2Si2I4, Et4Si2I2, and HEtSiI2. In some embodiments a silicon halide precursor comprises two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen, seventeen, eighteen, nineteen or more compounds selected from HSiI3, H2SiI2, H3SiI, H2Si2I4, H4Si2I2, H5Si2I, MeSiI3, Me2SiI2, Me3SiI, Me2Si2I4, Me4Si2I2, HMeSiI2, H2Me2Si2I2, EtSiI3, Et2SiI2, Et3SiI, Et2Si2I4, Et4Si2I2, and HEtSiI2, including any combinations thereof. In certain embodiments, the silicon halide precursor is H2SiI2.
In some embodiments, a silicon halide precursor comprises a three iodines and one amine or alkylamine ligands bonded to silicon. In some embodiments silicon halide precursor comprises one or more of the following: (SiI3)NH2, (SiI3)NHMe, (SiI3)NHEt, (SiI3)NHiPr, (SiI3)NHtBu, (SiI3)NMe2, (SiI3)NMeEt, (SiI3)NMeiPr, (SiI3)NMetBu, (SiI3)NEt2, (SiI3)NEtiPr, (SiI3)NEttBu, (SiI3)NiPr2, (SiI3)NiPrtBu, and (SiI3)NtBu2. In some embodiments, a silicon halide precursor comprises two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen or more compounds selected from (SiI3)NH2, (SiI3)NHMe, (SiI3)NHEt, (SiI3)NHiPr, (SiI3)NHtBu, (SiI3)NMe2, (SiI3)NMeEt, (SiI3)NMeiPr, (SiI3)NMetBu, (SiI3)NEt2, (SiI3)NEtiPr, (SiI3)NEttBu, (SiI3)NiPr2, (SiI3)NiPrtBu, (SiI3)NtBu2, and combinations thereof. In some embodiments, a silicon halide precursor comprises two iodines and two amine or alkylamine ligands bonded to silicon. In some embodiments, silicon halide precursor comprises one or more of the following: (SiI2)(NH2)2, (SiI2)(NHMe)2, (SiI2)(NHEt)2, (SiI2)(NHiPr)2, (SiI2)(NHtBu)2, (SiI2)(NMe2)2, (SiI2)(NMeEt)2, (SiI2)(NMeiPr)2, (SiI2)(NMetBu)2, (SiI2)(NEt2)2, (SiI2)(NEtiPr)2, (SiI2)(NEttBu)2, (SiI2)(NiPr2)2, (SiI2)(NiPrtBu)2, and (SiI2)(NtBu)2. In some embodiments, a silicon halide precursor comprises two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen or more compounds selected from (SiI2)(NH2)2, (SiI2)(NHMe)2, (SiI2)(NHEt)2, (SiI2)(NHiPr)2, (SiI2)(NHtBu)2, (SiI2)(NMe2)2, (SiI2)(NMeEt)2, (SiI2)(NMeiPr)2, (SiI2)(NMetBu)2, (SiI2)(NEt2)2, (SiI2)(NEtiPr)2, (SiI2)(NEttBu)2, (SiI2)(NiPr2)2, (SiI2)(NiPrtBu)2, (SiI2)(NtBu)2, and combinations thereof.
In some embodiments, a silicon halide precursor comprises two iodines, one hydrogen and one amine or alkylamine ligand bonded to silicon. In some embodiments silicon halide precursor comprises one or more of the following: (SiI2H)NH2, (SiI2H)NHMe, (SiI2H)NHEt, (SiI2H)NHiPr, (SiI2H)NHtBu, (SiI2H)NMe2, (SiI2H)NMeEt, (SiI2H)NMeiPr, (SiI2H)NMetBu, (SiI2H)NEt2, (SiI2H)NEtiPr, (SiI2H)NEttBu, (SiI2H)NiPr2, (SiI2H)NiPrtBu, and (SiI2H)NtBu2. In some embodiments a silicon halide precursor comprises two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen or more compounds selected from (SiI2H)NH2, (SiI2H)NHMe, (SiI2H)NHEt, (SiI2H)NHiPr, (SiI2H)NHtBu, (SiI2H)NMe2, (SiI2H)NMeEt, (SiI2H)NMeiPr, (SiI2H)NMetBu, (SiI2H)NEt2, (SiI2H)NEtiPr, (SiI2H)NEttBu, (SiI2H)NiPr2, (SiI2H)NiPrtBu, (SiI2H)NtBu2, and combinations thereof.
In some embodiments, a silicon halide precursor comprises one iodine, one hydrogen and two amine or alkylamine ligand bonded to silicon. In some embodiments, silicon halide precursor comprises one or more of the following: (SiIH)(NH2)2, (SiIH)(NHMe)2, (SiIH)(NHEt)2, (SiIH)(NHiPr)2, (SiIH)(NHtBu)2, (SiIH)(NMe2)2, (SiIH)(NMeEt)2, (SiIH)(NMeiPr)2, (SiIH)(NMetBu)2, (SiIH)(NEt2)2, (SiIH)(NEtiPr)2, (SiIH)(NEttBu)2, (SiIH)(NiPr2)2, (SiIH)(NiPrtBu)2, and (SiIH)(NtBu)2. In some embodiments, a silicon halide precursor comprises two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen or more compounds selected from (SiIH)(NH2)2, (SiIH)(NHMe)2, (SiIH)(NHEt)2, (SiIH)(NHiPr)2, (SiIH)(NHtBu)2, (SiIH)(NMe2)2, (SiIH)(NMeEt)2, (SiIH)(NMeiPr)2, (SiIH)(NMetBu)2, (SiIH)(NEt2)2, (SiIH)(NEtiPr)2, (SiIH)(NEttBu)2, (SiIH)(NiPr2)2, (SiIH)(NiPrtBu)2, and (SiIH)(NtBu)2, and combinations thereof.
In some embodiments, a silicon halide precursor comprises one iodine, two hydrogens and one amine or alkylamine ligand bonded to silicon. In some embodiments silicon halide precursor comprises one or more of the following: (SiIH2)NH2, (SiIH2)NHMe, (SiIH2)NHEt, (SiIH2)NHiPr, (SiIH2)NHtBu, (SiIH2)NMe2, (SiIH2)NMeEt, (SiIH2)NMeiPr, (SiIH2)NMetBu, (SiIH2)NEt2, (SiIH2)NEtiPr, (SiIH2)NEttBu, (SiIH2)NiPr2, (SiIH2)NiPrtBu, and (SiIH2)NtBu2. In some embodiments a silicon halide precursor comprises two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen or more compounds selected from (SiIH2)NH2, (SiIH2)NHMe, (SiIH2)NHEt, (SiIH2)NHiPr, (SiIH2)NHtBu, (SiIH2)NMe2, (SiIH2)NMeEt, (SiIH2)NMeiPr, (SiIH2)NMetBu, (SiIH2)NEt2, (SiIH2)NEtiPr, (SiIH2)NEttBu, (SiIH2)NiPr2, (SiIH2)NiPrtBu, (SiIH2)NtBu2, and combinations thereof.
In some embodiments, a silicon halide precursor comprises one iodine and three amine or alkylamine ligands bonded to silicon. In some embodiments, silicon halide precursor comprises one or more of the following: (SiI)(NH2)3, (SiI)(NHMe)3, (SiI)(NHEt)3, (SiI)(NHiPr)3, (SiI)(NHtBu)3, (SiI)(NMe2)3, (SiI)(NMeEt)3, (SiI)(NMeiPr)3, (SiI)(NMetBu)3, (SiI)(NEt2)3, (SiI)(NEtiPr)3, (SiI)(NEttBu)3, (SiI)(NiPr2)3, (SiI)(NiPrtBu)3, and (SiI)(NtBu)3. In some embodiments a silicon halide precursor comprises two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen or more compounds selected from (SiI)(NH2)3, (SiI)(NHMe)3, (SiI)(NHEt)3, (SiI)(NHiPr)3, (SiI)(NHtBu)3, (SiI)(NMe2)3, (SiI)(NMeEt)3, (SiI)(NMeiPr)3, (SiI)(NMetBu)3, (SiI)(NEt2)3, (SiI)(NEtiPr)3, (SiI)(NEttBu)3, (SiI)(NiPr2)3, (SiI)(NiPrtBu)3, (SiI)(NtBu)3, and combinations thereof.
In certain embodiments, a silicon halide precursor comprises two iodines, hydrogen and one amine or alkylamine ligand or two iodines and two alkylamine ligands bonded to silicon and wherein amine or alkylamine ligands are selected from amine NH2—, methylamine MeNH—, dimethylamine Me2N—, ethylmethylamine EtMeN—, ethylamine EtNH—, and diethylamine Et2N—. In some embodiments silicon halide precursor comprises one or more of the following: (SiI2H)NH2, (SiI2H)NHMe, (SiI2H)NHEt, (SiI2H)NMe2, (SiI2H)NMeEt, (SiI2H)NEt2, (SiI2)(NH2)2, (SiI2)(NHMe)2, (SiI2)(NHEt)2, (SiI2)(NMe2)2, (SiI2)(NMeEt)2, and (SiI2)(NEt2)2. In some embodiments a silicon halide precursor comprises two, three, four, five, six, seven, eight, nine, ten, eleven, twelve or more compounds selected from (SiI2H)NH2, (SiI2H)NHMe, (SiI2H)NHEt, (SiI2H)NMe2, (SiI2H)NMeEt, (SiI2H)NEt2, (SiI2)(NH2)2, (SiI2)(NHMe)2, (SiI2)(NHEt)2, (SiI2)(NMe2)2, (SiI2)(NMeEt)2, (SiI2)(NEt2)2, and combinations thereof.
Other Types of Si-Precursors Containing I or Br
A number of suitable silicon halide precursors containing nitrogen, such as iodine or bromine substituted silazanes, or sulphur, may be used in the presently disclosed thermal and plasma ALD processes. In some embodiments silicon halide precursors containing nitrogen, such as iodine or bromine substituted silazanes, may be used in the presently disclosed thermal and plasma ALD processes in which a film with desired quality is to be deposited, for example at least one of the desired WER, WERR, pattern loading effect or/and step coverage features described below.
At least some of the suitable iodine or bromine substituted silicon halide precursors may have the following general formula:
H2n+2−y−z−wSin(EH)n−1XyAzRw (25)
wherein, n=2-10, y=1 or more (and up to 2n+2−z−w), z=0 or more (and up to 2n+2−y−w), w=0 or more (and up to 2n+2−y−z), X is I or Br, E is N or S, preferably N, A is a halogen other than X, R is an organic ligand and can be independently selected from the group consisting of alkoxides, alkylsilyls, alkyl, substituted alkyl, alkylamines and unsaturated hydrocarbon; preferably n=2-5 and more preferably n=2-3 and most preferably 1-2. Preferably R is a C1-C3 alkyl ligand, such as methyl, ethyl, n-propyl or isopropyl.
At least some of the suitable iodine or bromine substituted silazane precursors may have the following general formula:
H2n+2−y−z−wSin(NH)n−1XyAzRw (26)
wherein, n=2-10, y=1 or more (and up to 2n+2−z−w), z=0 or more (and up to 2n+2−y−w), w=0 or more (and up to 2n+2−y−z), X is I or Br, A is a halogen other than X, R is an organic ligand and can be independently selected from the group consisting of alkoxides, alkylsilyls, alkyl, substituted alkyl, alkylamines and unsaturated hydrocarbon; preferably n=2-5 and more preferably n=2-3 and most preferably 2. Preferably R is a C1-C3 alkyl ligand, such as methyl, ethyl, n-propyl or isopropyl.
In some embodiments, the silicon halide precursor comprises Si-compound, such as heterocyclic Si compound, which comprises I or Br. Such cyclic precursors may comprise the following substructure:
—Si-E-Si— (27)
wherein E is N or S, preferably N.
In some embodiments the silicon halide precursor comprises substructure according to formula (27) and example of this kind of compounds is for example, iodine or bromine substituted cyclosilazanes, such iodine or bromine substituted cyclotrisilazane.
In some embodiments, the silicon halide precursor comprises Si-compound, such as silylamine based compound, which comprises I or Br. Such silylamine based Si-precursors may have the following general formula:
(H3-y-z-wXyAzRwSi)3—N (28)
wherein, y=1 or more (and up to 3−z−w), z=0 or more (and up to 3−y−w), w=0 or more (and up to 3−y−z), X is I or Br, A is a halogen other than X, R is an organic ligand and can be independently selected from the group consisting of alkoxides, alkylsilyls, alkyl, substituted alkyl, alkylamines and unsaturated hydrocarbon. Preferably R is a C1-C3 alkyl ligand, such as methyl, ethyl, n-propyl or isopropyl. Each of the three H3-y-z-wXyAzRwSi ligands can be independently selected from each other.
Other Types of Si Containing Precursors
Silicon halide precursors comprising chloride or fluoride may also be used. In such precursor the halogens such as iodide and bromide as described in the above general formula's may be replaced by chloride (Cl) or fluoride (F).
O Precursors
A number of suitable reactants may be used in the presently disclosed processes. These reactant may be used in plasma ALD or plasma CVD processes thereby a layer with a desired quality (at least one of the desired WER, WERR, pattern loading effect or/and step coverage features described below) is deposited.
According to some embodiments, the reactant in a thermal ALD process may be O2, H2O, H2O2, or any number of other suitable oxygen compounds having a O—H bond.
Silicon Dioxide Film Characteristics
The first silicon dioxide thin films deposited according to some of the embodiments discussed herein (irrespective of whether the silicon halide precursor contained bromine or iodine) may achieve impurity levels or concentrations below about 3%, preferably below about 1%, more preferably below about 0.5%, and most preferably below about 0.1%. In some thin films, the total impurity level excluding hydrogen may be below about 5%, preferably below about 2%, more preferably below about 1%, and most preferably below about 0.2%. And in some thin films, hydrogen levels may be below about 30%, preferably below about 20%, more preferably below about 15%, and most preferably below about 10%.
In some embodiments, the deposited silicon dioxide films do not comprise an appreciable amount of carbon. However, in some embodiments a silicon dioxide film comprising carbon is deposited. For example, in some embodiments an ALD reaction is carried out using a silicon halide precursor comprising carbon and a thin silicon dioxide film comprising carbon is deposited. In some embodiments a silicon dioxide film comprising carbon is deposited using a precursor comprising an alkyl group or other carbon-containing ligand. In some embodiments a silicon halide precursor of one of formulas (9)-(28) and comprising an alkyl group is used in a PEALD or thermal ALD process, as described above, to deposit a silicon dioxide film comprising carbon. Different alkyl groups, such as Me or Et, or other carbon-containing ligands may produce different carbon concentrations in the films because of different reaction mechanisms. Thus, different precursors can be selected to produce different carbon concentration in deposited silicon dioxide films. In some embodiments the thin silicon dioxide film comprising carbon may be used, for example, as a low-k spacer. In some embodiments the thin films do not comprise argon.
According to some embodiments, the silicon dioxide thin films may exhibit step coverage and pattern loading effects of greater than about 50%, preferably greater than about 80%, more preferably greater than about 90%, and most preferably greater than about 95%. In some cases step coverage and pattern loading effects can be greater than about 98% and in some case about 100% (within the accuracy of the measurement tool or method). These values can be achieved in aspect ratios of more than 2, preferably in aspect ratios more than 3, more preferably in aspect ratios more than 6 and most preferably in aspect ratios more than 11.
As used herein, “pattern loading effect” is used in accordance with its ordinary meaning in this field. While pattern loading effects may be seen with respect to impurity content, density, electrical properties and etch rate, unless indicated otherwise the term pattern loading effect when used herein refers to the variation in film thickness in an area of the substrate where structures are present. Thus, the pattern loading effect can be given as the film thickness in the sidewall or bottom of a feature inside a three-dimensional structure relative to the film thickness on the sidewall or bottom of the three-dimensional structure/feature facing the open field. As used herein, a 100% pattern loading effect (or a ratio of 1) would represent about a completely uniform film property throughout the substrate regardless of features i.e. in other words there is no pattern loading effect (variance in a particular film property, such as thickness, in features vs. open field).
In some embodiments, silicon dioxide films are deposited to a thicknesses of from about 1 nm to about 50 nm, preferably from about 3 nm to about 30 nm, more preferably from about 4 nm to about 15 nm. These thicknesses can be achieved in feature sizes (width) below about 100 nm, preferably about 50 nm, more preferably below about 30 nm, most preferably below about 20 nm, and in some cases below about 15 nm. According to some embodiments, a silicon dioxide film is deposited on a three-dimensional structure and the thickness at a sidewall may be around 10 nm.
It has been found that in using the silicon dioxide thin films of the present disclosure, thickness differences between top and side may not be as critical for some applications, due to the improved film quality and etch characteristics. Nevertheless, in some embodiments, the thickness gradient along the sidewall may be very important to subsequent applications or processes.
Example PECVD
A silicon dioxide thin layer was deposited at 550° C. with a plasma power of 600 W at a pressure of about 2.6 torr in a plasma enhanced chemical vapor deposition reactor. The O2 flow is 4 splm, the Ar flow is 2.8 splm and a seal He flow of 0.28 splm is applied. H2SiI2 is used as the silicon halide precursor. Si precursor was supplied continuously during plasma step.
Example PEALD
A silicon dioxide thin layer was deposited at 550° C. with a plasma power of 600 W at a pressure of about 2.6 torr in a plasma enhanced atomic layer vapor deposition reactor. The O2 flow was 4 splm, the Ar flow was 2.8 splm and a seal He flow of 0.28 splm was applied. H2SiI2 is used as the silicon halide precursor. The pulse scheme was 0.3 sec/0.8 sec/3 sec/0.1 sec (feed/purge/RF_on/purge). The O is provided continuously during the process. The silicon dioxide layer had the following properties:
Plasma Treatment
As described herein, plasma treatment steps may be used in formation of a variety of materials to enhance film properties. In particular, utilization of a plasma densification step, for example using an argon plasma, may enhance the properties of dioxide films, such as silicon dioxide films. In some embodiments, a process for forming silicon dioxide films comprises depositing the silicon dioxide and treating the deposited silicon dioxide with a plasma treatment. In some embodiments, the silicon dioxide is deposited by a thermal ALD process, and subsequently subjected to a plasma treatment. For example, silicon dioxide may be deposited by a thermal ALD process comprising a plurality of deposition cycles comprising a first phase in which a substrate is contacted with a silicon halide precursor such that silicon species are adsorbed onto a surface of the substrate, and a second phase in which the silicon species adsorbed onto the substrate surface are contacted with an oxygen precursor. As discussed herein, the silicon oxide deposited by the thermal ALD process may be subject to a plasma treatment, for example after each deposition cycle, at intervals during the deposition process or following completion of the silicon oxide deposition process. Unwanted oxidation due to O plasma exposure is well known issue. However SiO2 plasma processes films have typically much higher quality. It is expected that combining thermal SiO2 deposition and plasma treatment both low oxidation and high quality SiO2 films can be achieved. In some embodiments, silicon oxide is deposited by a PEALD process. In some embodiments, a PEALD deposition process comprises a first phase and a second phase. For example, a first phase of a silicon oxide PEALD process may comprise contacting a target substrate with a silicon precursor such that silicon species are adsorbed onto a surface of the target substrate and a second phase of the silicon oxide PEALD process may comprise contacting the silicon species adsorbed onto the surface of the target substrate with a plasma comprising oxygen in order to form silicon oxide. In this part of the deposition process, the plasma may comprise argon ions. For example, a PEALD silicon dioxide deposition cycle may include contacting the target substrate with a silicon precursor, such as those described herein, and an activated oxygen precursor, for example a plasma of oxygen and argon gas. The target substrate may be exposed to activated argon containing species (e.g., Ar+ and/or Ar2+ ions) in this step, which may, for example, densify the layer. In some embodiments, subsequent to deposition of silicon oxide by PEALD, a second plasma treatment step is carried out. The second plasma treatment step may be carried out after each PEALD cycle, at intervals during silicon oxide deposition, or after the PEALD silicon oxide deposition process is complete. The second plasma treatment step may be an Ar plasma treatment step. The second plasma step may, for example, lead to densification of the deposited silicon oxide film or otherwise improve film properties. Thus, the second Ar plasma treatment step may also be referred to as a densification step. The plasma power and/or duration may be greater in the densification step (second Ar plasma treatment step) than in the first oxygen reactant step, as discussed in more detail below. Therefore a low power may be provided during the O plasma step (to minimize substrate oxidation) and a high power during the Ar plasma step to achieve high quality SiO. The densification step may be carried out after every cycle of a PEALD process, or after various intervals of the PEALD deposition process, as discussed in more detail below.
Thus, in some embodiments, one or more silicon dioxide film deposition cycles can be followed by an argon plasma treatment. Utilizing the argon plasma treatment may facilitate formation of silicon dioxide films having certain desired characteristics. Without being limited by any particular theory or mode of operation, application of an argon plasma treatment may increase a density of the silicon dioxide film formed by the silicon dioxide film deposition cycles. In some embodiments, application of an argon plasma treatment can facilitate formation of a silicon dioxide film which demonstrates increased resistance to wet etch (e.g., as compared to silicon dioxide films formed without an argon plasma treatment, in which the top layer may be easily oxidized and demonstrate similar WERR as that of thermal silicon oxide). In some embodiments, application of an argon plasma treatment can facilitate formation of a silicon dioxide film having increased etch rate uniformity of horizontal surfaces relative to vertical surfaces on 3-D features, decreased wet etch rate (WER), and/or decreased wet etch rate ratio (WERR) relative to thermal oxide (TOX).
In some embodiments, utilizing an argon plasma treatment may facilitate formation of silicon dioxide films useful in applications such as hardmasks, sacrificial layers, gate spacers and/or spacer defined double/quadruple patterning (SDDP/SDQP) in state-of-the-art semiconductor devices such as FiNFETs and other multigate transistors.
Although embodiments described herein refer to PEALD deposition of silicon dioxide films, it will be understood that other deposition techniques may also be applicable (e.g., thermal ALD, and/or radical enhanced ALD). Further, the argon plasma treatment may be applied to the deposition of other materials (e.g., metallic materials, dielectric materials, and/or other dioxide materials, such as titanium dioxide (TiO2)).
In some embodiments, plasma power in a PEALD process for depositing silicon dioxide is sufficiently low to reduce or avoid formation of film defects and/or delamination. However, the plasma power may be higher in the argon plasma treatment. Thus, in some embodiments, a plasma power used in an argon plasma treatment is greater than or equal to that used in a PEALD process for depositing silicon dioxide (e.g., an oxygen precursor step of the PEALD process). For example, in a PEALD cycle for forming silicon oxide, a plasma may be formed with a gas comprising oxygen and argon using a reduced plasma power. In some embodiments, a plasma power applied during the argon plasma treatment is up to about 900% that of a plasma power applied during a PEALD process for forming silicon oxide where (e.g., during an oxygen precursor step of the PEALD process). In some embodiments, a plasma power for the oxygen plasma treatment is preferably up to about 400% that of the plasma power used in the oxygen precursor step, more preferably about 100% to about 250% that of the plasma power used in the oxygen precursor step, and most preferably about 100% to about 200% that of the plasma power used in the oxygen precursor step.
In some embodiments, a plasma power used in an argon plasma treatment is less than that used in an oxygen precursor step. For example, a plasma power used in the oxygen plasma treatment can be between about 50% and 100% of a plasma power used in the oxygen precursor step.
Plasma power used in a PEALD silicon dioxide deposition process can depend on various factors, including a geometry of structures and/or material of the target substrate on which the silicon dioxide is deposited. As described herein, plasma power used in a cycle of PEALD silicon dioxide deposition may be about 50 Watts (W) to about 600 W (e.g., in a reaction chamber configured for processing a 300 millimeter (mm) wafer substrate), including for example from about 100 W to about 300 W, and from about 150 W to about 250 W. As described herein, a plasma power applied during an argon plasma treatment may be greater than or equal to a plasma power applied during the precursor step, including for example, about 100 W to about 1000 W, preferably about 125 W to about 600 W, more preferably about 150 W to about 300 W. In some embodiments, a power density of a plasma applied during an oxygen plasma treatment (e.g., in a reaction chamber configured for processing a 300 millimeter (mm) wafer substrate) can be about 0.07 Watts per cubic centimeter (W/cm3) to about 70 W/cm3, preferably about 0.08 W/cm3 to about 0.4 W/cm3 W, and more preferably about 0.1 W/cm3 about 0.2 W/cm3. For ignition of the plasma other gases than argon and hydrogen can be added to the plasma.
A duration of the argon plasma treatment can be selected to obtain desired results. In some embodiments the duration is based, in part, on a thickness of the silicon dioxide film being treated. For example, a shorter argon plasma treatment can be used in the argon plasma treatment applied after each PEALD cycle, while a longer argon plasma treatment can be used when the argon plasma treatment is applied less frequently.
As described herein, a silicon dioxide formation process may include a plurality of deposition cycles for depositing the silicon dioxide film and one or more argon plasma treatments steps, where each deposition cycle can include a silicon precursor step followed by an oxygen precursor step. In some embodiments, a cycle including a plurality of deposition cycles (e.g., a deposition cycle including a silicon precursor step followed by oxygen precursor step) and one or more argon plasma treatment steps, can be repeated a number of times. In some embodiments, a plurality of deposition cycles can be repeated to achieve a desired silicon dioxide film thickness, which then can be followed by one or more Ar plasma treatment steps.
In some embodiments, an Argon plasma treatment of a silicon dioxide deposition process can have a total duration of about 1% to about 100% the total duration in which activated hydrogen containing species are provided in the oxygen precursor step, preferably about 5% to about 75% that of the total duration in which activated hydrogen containing species are provided of in the oxygen precursor step, and more preferably about 10% to about 50%.
The frequency with which the target substrate is exposed to the Ar plasma treatment can be selected to achieve desired final film characteristics. For example, one or more Ar plasma treatments can follow a number of repetitions of cycles in which the target substrate is exposed to one or more silicon halide precursors followed by oxygen precursors for silicon dioxide film growth. In some embodiments, cycles of exposing the target substrate to one or more silicon precursors followed by oxygen precursors can be repeated twenty-five times, before each Ar plasma treatment. For example, an Ar plasma treatment can follow every repetition of twenty-five cycles of exposing the target substrate to one or more silicon precursors followed by oxygen precursors. In some embodiments, an Ar plasma treatment can follow every repetition of fifty cycles of exposing the target substrate to one or more silicon precursors followed by oxygen precursors. In some embodiments, an Ar plasma treatment can follow every repetition of one hundred cycles of exposing the target substrate to one or more silicon precursors followed by oxygen precursors.
Without being limited by any particular theory or mode of operation, a plasma Ar treatment can be applied for densification of the silicon dioxide film, such as through ion bombardment of the silicon dioxide film. In some embodiments, a frequency at which an Ar plasma treatment can be applied during a silicon dioxide film formation process can be after about at least every 100th cycle of silicon dioxide film deposition, preferably after at least every 50th and most preferably after at least every 25th.
In some embodiments, a thickness of the silicon dioxide film formed is less than about 3 nm, preferably less than about 2 nm, and more preferably less than about 1 nm, for example such that an etch rate of most or all of the silicon dioxide film thickness can be improved after being treated by an oxygen plasma treatment. In some embodiments, a silicon dioxide film thickness can be less than about 0.5 nm.
In some embodiments, a number of cycles between Ar plasma treatments can be selected based on a trade-off between silicon dioxide film etch properties and throughput. For example, while good etch properties can be achieved with an argon plasma treatment applied after every deposition cycle but will significantly reduce throughput. Thus, the skilled artisan can adjust the treatment ratio in order to form suitable films in the most efficient manner.
In some embodiments, process for depositing a silicon oxide layer includes a multi-step plasma exposure. For example, an hydrogen H plasma can be provided to perform a H plasma treatment. The method may be similar as the argon plasma as described above with the argon replaced with hydrogen. This time it is not high quality/densification that is accomplished. Hydrogen plasma treatment has two effect: the first effect is to provide more reactive sites (—OH surface group) to increase the growth per cycle (GPC) and a second effect of voluntarily creating a high WER to the layer by H incorporation (less dense films). H2 and O2 cannot be mixed in the reactor, so purge steps are necessary between both gases. H2 plasma is typically, but not necessarily generated with Ar, the Ar/H ration should be <10 preferably <4. High power for the H2 treatment will amplify the two effects described above. Higher conformality can also be achieved due to the isotropic nature of H plasma comprising large amount of radical species. Multiple plasma step may be added/combine of Ar and H plasma step in any ratio to achieve desired film properties: high conformality, low or high WERR.
It will be understood by those of skill in the art that numerous and various modifications can be made without departing from the spirit of the present invention. The described features, structures, characteristics and precursors can be combined in any suitable manner. Therefore, it should be clearly understood that the forms of the present invention are illustrative only and are not intended to limit the scope of the present invention. All modifications and changes are intended to fall within the scope of the invention, as defined by the appended claims.
It is to be understood that the configurations and/or approaches described herein are exemplary in nature, and that these specific embodiments or examples are not to be considered in a limiting sense, because numerous variations are possible. The specific routines or methods described herein may represent one or more of any number of processing strategies. Thus, the various acts illustrated may be performed in the sequence illustrated, in other sequences, or omitted in some cases.
| Number | Name | Date | Kind |
|---|---|---|---|
| D30036 | Rhind | Jan 1899 | S |
| D31889 | Gill | Nov 1899 | S |
| D56051 | Cohn | Aug 1920 | S |
| 2059480 | Obermaier | Nov 1936 | A |
| 2161626 | Loughner et al. | Jun 1939 | A |
| 2266416 | Duclos | Dec 1941 | A |
| 2280778 | Anderson | Apr 1942 | A |
| 2410420 | Bennett | Nov 1946 | A |
| 2563931 | Harrison | Aug 1951 | A |
| 2660061 | Lewis | Nov 1953 | A |
| 2745640 | Cushman | May 1956 | A |
| 2990045 | Root | Sep 1959 | A |
| 3038951 | Mead | Jun 1962 | A |
| 3089507 | Drake et al. | May 1963 | A |
| 3094396 | Flugge et al. | Jun 1963 | A |
| 3232437 | Hultgren | Feb 1966 | A |
| 3263502 | Redwood | Aug 1966 | A |
| 3410349 | Troutman | Nov 1968 | A |
| 3588192 | Drutchas et al. | Jun 1971 | A |
| 3647387 | Benson | Mar 1972 | A |
| 3647716 | Koches | Mar 1972 | A |
| 3713899 | Sebestyen | Jan 1973 | A |
| 3718429 | Williamson | Feb 1973 | A |
| 3833492 | Bollyky | Sep 1974 | A |
| 3854443 | Baerg | Dec 1974 | A |
| 3862397 | Anderson et al. | Jan 1975 | A |
| 3867205 | Schley | Feb 1975 | A |
| 3885504 | Baermann | May 1975 | A |
| 3887790 | Ferguson | Jun 1975 | A |
| 3904371 | Neti | Sep 1975 | A |
| 3913058 | Nishio et al. | Oct 1975 | A |
| 3913617 | van Laar | Oct 1975 | A |
| 3947685 | Meinel | Mar 1976 | A |
| 3960559 | Suzuki | Jun 1976 | A |
| 4054071 | Patejak | Oct 1977 | A |
| 4058430 | Suntola et al. | Nov 1977 | A |
| 4093491 | Whelpton et al. | Jun 1978 | A |
| D249341 | Mertz | Sep 1978 | S |
| 4126027 | Smith et al. | Nov 1978 | A |
| 4134425 | Gussefeld et al. | Jan 1979 | A |
| 4145699 | Hu et al. | Mar 1979 | A |
| 4164959 | Wurzburger | Aug 1979 | A |
| 4176630 | Elmer | Dec 1979 | A |
| 4181330 | Kojima | Jan 1980 | A |
| 4194536 | Stine et al. | Mar 1980 | A |
| 4217463 | Swearingen | Aug 1980 | A |
| 4234449 | Wolson et al. | Nov 1980 | A |
| 4322592 | Martin | Mar 1982 | A |
| 4333735 | Hardy | Jun 1982 | A |
| 4355912 | Haak | Oct 1982 | A |
| 4389973 | Suntola et al. | Jun 1983 | A |
| 4393013 | McMenamin | Jul 1983 | A |
| 4401507 | Engle | Aug 1983 | A |
| 4414492 | Hanlet | Nov 1983 | A |
| 4436674 | McMenamin | Mar 1984 | A |
| 4444990 | Villar | Apr 1984 | A |
| 4454370 | Voznick | Jun 1984 | A |
| 4455193 | Jeuch et al. | Jun 1984 | A |
| 4466766 | Geren et al. | Aug 1984 | A |
| 4479831 | Sandow | Oct 1984 | A |
| 4499354 | Hill et al. | Feb 1985 | A |
| 4512113 | Budinger | Apr 1985 | A |
| 4527005 | McKelvey et al. | Jul 1985 | A |
| 4537001 | Uppstrom | Aug 1985 | A |
| 4548688 | Mathews | Oct 1985 | A |
| 4570328 | Price et al. | Feb 1986 | A |
| 4575636 | Caprari | Mar 1986 | A |
| 4578560 | Tanaka et al. | Mar 1986 | A |
| 4579378 | Snyders | Apr 1986 | A |
| 4579623 | Suzuki et al. | Apr 1986 | A |
| 4590326 | Woldy | May 1986 | A |
| 4611966 | Johnson | Sep 1986 | A |
| 4620998 | Lalvani | Nov 1986 | A |
| D288556 | Wallgren | Mar 1987 | S |
| 4653541 | Oehlschlaeger et al. | Mar 1987 | A |
| 4654226 | Jackson et al. | Mar 1987 | A |
| 4664769 | Cuomo et al. | May 1987 | A |
| 4681134 | Paris | Jul 1987 | A |
| 4718637 | Contin | Jan 1988 | A |
| 4721533 | Phillippi et al. | Jan 1988 | A |
| 4722298 | Rubin et al. | Feb 1988 | A |
| 4724272 | Raniere et al. | Feb 1988 | A |
| 4735259 | Vincent | Apr 1988 | A |
| 4749416 | Greenspan | Jun 1988 | A |
| 4753192 | Goldsmith et al. | Jun 1988 | A |
| 4756794 | Yoder | Jul 1988 | A |
| 4771015 | Kanai | Sep 1988 | A |
| 4780169 | Stark et al. | Oct 1988 | A |
| 4789294 | Sato et al. | Dec 1988 | A |
| 4821674 | deBoer et al. | Apr 1989 | A |
| 4827430 | Aid et al. | May 1989 | A |
| 4830515 | Cortes | May 1989 | A |
| 4837113 | Luttmer et al. | Jun 1989 | A |
| 4837185 | Yau et al. | Jun 1989 | A |
| 4854263 | Chang et al. | Aug 1989 | A |
| 4854266 | Simson et al. | Aug 1989 | A |
| 4857137 | Tachi et al. | Aug 1989 | A |
| 4857382 | Liu et al. | Aug 1989 | A |
| 4882199 | Sadoway et al. | Nov 1989 | A |
| 4916091 | Freeman et al. | Apr 1990 | A |
| 4934831 | Volbrecht | Jun 1990 | A |
| 4949848 | Kos | Aug 1990 | A |
| D311126 | Crowley | Oct 1990 | S |
| 4976996 | Monkowski et al. | Dec 1990 | A |
| 4978567 | Miller | Dec 1990 | A |
| 4984904 | Nakano et al. | Jan 1991 | A |
| 4985114 | Okudaira | Jan 1991 | A |
| 4986215 | Yamada | Jan 1991 | A |
| 4987856 | Hey | Jan 1991 | A |
| 4989992 | Piai | Feb 1991 | A |
| 4991614 | Hammel | Feb 1991 | A |
| 5013691 | Lory et al. | May 1991 | A |
| 5027746 | Frijlink | Jul 1991 | A |
| 5028366 | Harakal et al. | Jul 1991 | A |
| 5057436 | Ball | Oct 1991 | A |
| 5060322 | Delepine | Oct 1991 | A |
| 5061083 | Grimm et al. | Oct 1991 | A |
| 5062386 | Christensen | Nov 1991 | A |
| 5065698 | Koike | Nov 1991 | A |
| 5071258 | Usher et al. | Dec 1991 | A |
| 5074017 | Toya et al. | Dec 1991 | A |
| 5098638 | Sawada | Mar 1992 | A |
| 5098865 | Machado | Mar 1992 | A |
| 5104514 | Quartarone | Apr 1992 | A |
| 5108192 | Mailliet et al. | Apr 1992 | A |
| 5116018 | Friemoth et al. | May 1992 | A |
| D327534 | Manville | Jun 1992 | S |
| 5119760 | McMillan et al. | Jun 1992 | A |
| 5130003 | Conrad | Jul 1992 | A |
| 5137286 | Whitford | Aug 1992 | A |
| 5154301 | Kos | Oct 1992 | A |
| 5158128 | Inoue et al. | Oct 1992 | A |
| 5167716 | Boitnott et al. | Dec 1992 | A |
| 5176451 | Sasada | Jan 1993 | A |
| 5178682 | Tsukamoto et al. | Jan 1993 | A |
| 5181779 | Shia et al. | Jan 1993 | A |
| 5183511 | Yamazaki et al. | Feb 1993 | A |
| 5192717 | Kawakami | Mar 1993 | A |
| 5194401 | Adams et al. | Mar 1993 | A |
| 5199603 | Prescott | Apr 1993 | A |
| 5213650 | Wang et al. | May 1993 | A |
| 5221556 | Hawkins et al. | Jun 1993 | A |
| 5225366 | Yoder et al. | Jul 1993 | A |
| 5226383 | Bhat | Jul 1993 | A |
| 5228114 | Suzuki | Jul 1993 | A |
| 5242539 | Kumihashi et al. | Sep 1993 | A |
| 5243195 | Nishi | Sep 1993 | A |
| 5243202 | Mori et al. | Sep 1993 | A |
| 5246218 | Yap et al. | Sep 1993 | A |
| 5246500 | Samata et al. | Sep 1993 | A |
| 5259881 | Edwards et al. | Nov 1993 | A |
| 5266526 | Aoyama | Nov 1993 | A |
| 5271967 | Kramer et al. | Dec 1993 | A |
| 5278494 | Obigane | Jan 1994 | A |
| 5284519 | Gadgil | Feb 1994 | A |
| 5288684 | Yamazaki et al. | Feb 1994 | A |
| 5294778 | Carman et al. | Mar 1994 | A |
| 5306666 | Izumi | Apr 1994 | A |
| 5306946 | Yamamoto | Apr 1994 | A |
| 5310456 | Kadomura | May 1994 | A |
| 5314570 | Ikegaya et al. | May 1994 | A |
| 5315092 | Takahashi et al. | May 1994 | A |
| 5326427 | Jerbic | Jul 1994 | A |
| 5336327 | Lee | Aug 1994 | A |
| 5354580 | Goela et al. | Oct 1994 | A |
| 5356478 | Chen et al. | Oct 1994 | A |
| 5356672 | Schmitt et al. | Oct 1994 | A |
| 5360269 | Ogawa et al. | Nov 1994 | A |
| 5364667 | Rhieu | Nov 1994 | A |
| D353452 | Groenhoff | Dec 1994 | S |
| 5374315 | Deboer et al. | Dec 1994 | A |
| 5380367 | Bertone | Jan 1995 | A |
| 5382311 | Ishikawa et al. | Jan 1995 | A |
| 5388945 | Garric et al. | Feb 1995 | A |
| 5404082 | Hernandez et al. | Apr 1995 | A |
| 5407449 | Zinger | Apr 1995 | A |
| 5413813 | Cruse et al. | May 1995 | A |
| 5414221 | Gardner | May 1995 | A |
| 5415753 | Hurwitt et al. | May 1995 | A |
| 5421893 | Perlov | Jun 1995 | A |
| 5422139 | Fischer | Jun 1995 | A |
| 5423942 | Robbins et al. | Jun 1995 | A |
| 5430011 | Tanaka et al. | Jul 1995 | A |
| 5444217 | Moore | Aug 1995 | A |
| 5453124 | Moslehi et al. | Sep 1995 | A |
| 5494494 | Mizuno et al. | Feb 1996 | A |
| 5496408 | Motoda et al. | Mar 1996 | A |
| 5504042 | Cho et al. | Apr 1996 | A |
| 5514439 | Sibley | May 1996 | A |
| 5518549 | Hellwig | May 1996 | A |
| 5523616 | Yasuhide | Jun 1996 | A |
| 5527111 | Lysen et al. | Jun 1996 | A |
| 5527417 | Iida et al. | Jun 1996 | A |
| 5531835 | Fodor et al. | Jul 1996 | A |
| 5540898 | Davidson | Jul 1996 | A |
| 5558717 | Zhao et al. | Sep 1996 | A |
| 5559046 | Oishi et al. | Sep 1996 | A |
| 5574247 | Nishitani et al. | Nov 1996 | A |
| 5576629 | Turner | Nov 1996 | A |
| 5577331 | Suzuki | Nov 1996 | A |
| 5583736 | Anderson et al. | Dec 1996 | A |
| 5589002 | Su | Dec 1996 | A |
| 5589110 | Motoda et al. | Dec 1996 | A |
| 5595606 | Fujikawa et al. | Jan 1997 | A |
| 5601641 | Stephens | Feb 1997 | A |
| 5604410 | Vollkommer et al. | Feb 1997 | A |
| 5616264 | Nishi et al. | Apr 1997 | A |
| 5616947 | Tamura | Apr 1997 | A |
| 5621982 | Yamashita | Apr 1997 | A |
| 5632919 | MacCracken et al. | May 1997 | A |
| D380527 | Velez | Jul 1997 | S |
| 5656093 | Burkhart et al. | Aug 1997 | A |
| 5663899 | Zvonar et al. | Sep 1997 | A |
| 5665608 | Chapple-Sokol et al. | Sep 1997 | A |
| 5679215 | Barnes et al. | Oct 1997 | A |
| 5681779 | Pasch et al. | Oct 1997 | A |
| 5683517 | Shan | Nov 1997 | A |
| 5695567 | Kordina | Dec 1997 | A |
| 5697706 | Ciaravino et al. | Dec 1997 | A |
| 5700729 | Lee et al. | Dec 1997 | A |
| 5708825 | Sotomayor | Jan 1998 | A |
| 5711811 | Suntola et al. | Jan 1998 | A |
| 5716133 | Hosokawa et al. | Feb 1998 | A |
| 5718574 | Shimazu | Feb 1998 | A |
| D392855 | Pillow | Mar 1998 | S |
| 5724748 | Brooks | Mar 1998 | A |
| 5728223 | Murakarni et al. | Mar 1998 | A |
| 5730801 | Tepman et al. | Mar 1998 | A |
| 5732744 | Barr et al. | Mar 1998 | A |
| 5736314 | Hayes et al. | Apr 1998 | A |
| 5753835 | Gustin | May 1998 | A |
| 5761328 | Solberg et al. | Jun 1998 | A |
| 5777838 | Tamagawa et al. | Jul 1998 | A |
| 5779203 | Edlinger | Jul 1998 | A |
| 5781693 | Balance et al. | Jul 1998 | A |
| 5782979 | Kaneno | Jul 1998 | A |
| 5791782 | Wooten et al. | Aug 1998 | A |
| 5792272 | Van Os et al. | Aug 1998 | A |
| 5796074 | Edelstein et al. | Aug 1998 | A |
| 5801104 | Schuegraf et al. | Sep 1998 | A |
| 5806980 | Berrian | Sep 1998 | A |
| 5813851 | Nakao | Sep 1998 | A |
| 5819092 | Ferguson et al. | Oct 1998 | A |
| 5819434 | Herchen et al. | Oct 1998 | A |
| 5827435 | Seiji | Oct 1998 | A |
| 5827757 | Robinson, Jr. et al. | Oct 1998 | A |
| 5836483 | Disel | Nov 1998 | A |
| 5837058 | Chen et al. | Nov 1998 | A |
| 5837320 | Hampden-Smith et al. | Nov 1998 | A |
| 5844683 | Pavloski et al. | Dec 1998 | A |
| 5846332 | Zhao et al. | Dec 1998 | A |
| 5851294 | Young et al. | Dec 1998 | A |
| 5852879 | Schumaier | Dec 1998 | A |
| 5853484 | Jeong | Dec 1998 | A |
| 5855680 | Soininen et al. | Jan 1999 | A |
| 5855681 | Maydan et al. | Jan 1999 | A |
| 5857777 | Schuh | Jan 1999 | A |
| 5863123 | Lee | Jan 1999 | A |
| 5865205 | Wilmer | Feb 1999 | A |
| 5873942 | Park | Feb 1999 | A |
| 5877095 | Tamura et al. | Mar 1999 | A |
| 5879128 | Tietz et al. | Mar 1999 | A |
| 5884640 | Fishkin et al. | Mar 1999 | A |
| D409894 | McClurg | May 1999 | S |
| 5908672 | Ryu | Jun 1999 | A |
| 5916365 | Sherman | Jun 1999 | A |
| D412270 | Fredrickson | Jul 1999 | S |
| 5920798 | Higuchi et al. | Jul 1999 | A |
| 5937323 | Orczyk et al. | Aug 1999 | A |
| 5947718 | Weaver | Sep 1999 | A |
| 5954375 | Trickle et al. | Sep 1999 | A |
| 5961775 | Fujimura | Oct 1999 | A |
| 5968275 | Lee et al. | Oct 1999 | A |
| 5970621 | Bazydola | Oct 1999 | A |
| 5975492 | Brenes | Nov 1999 | A |
| 5979506 | Aarseth | Nov 1999 | A |
| 5982931 | Ishimaru | Nov 1999 | A |
| 5984391 | Vanderpot et al. | Nov 1999 | A |
| 5987480 | Donohue et al. | Nov 1999 | A |
| 5997588 | Goodwin | Dec 1999 | A |
| 5997768 | Scully | Dec 1999 | A |
| 5998870 | Lee et al. | Dec 1999 | A |
| 6001267 | Van Os et al. | Dec 1999 | A |
| D419652 | Hall et al. | Jan 2000 | S |
| 6013553 | Wallace | Jan 2000 | A |
| 6013920 | Gordon et al. | Jan 2000 | A |
| 6015465 | Kholodenko et al. | Jan 2000 | A |
| 6017779 | Miyasaka | Jan 2000 | A |
| 6017818 | Lu | Jan 2000 | A |
| 6024799 | Chen | Feb 2000 | A |
| 6035101 | Sajoto et al. | Mar 2000 | A |
| 6042652 | Hyun | Mar 2000 | A |
| 6044860 | Nue | Apr 2000 | A |
| 6045260 | Schwartz et al. | Apr 2000 | A |
| 6048154 | Wytman | Apr 2000 | A |
| 6050506 | Guo et al. | Apr 2000 | A |
| 6054678 | Miyazaki | Apr 2000 | A |
| 6060691 | Minami et al. | May 2000 | A |
| 6060721 | Huang | May 2000 | A |
| 6068441 | Raaijmakers et al. | May 2000 | A |
| 6072163 | Armstrong | Jun 2000 | A |
| 6073973 | Boscaljon et al. | Jun 2000 | A |
| 6074443 | Venkatesh | Jun 2000 | A |
| 6083321 | Lei et al. | Jul 2000 | A |
| 6086677 | Umotoy et al. | Jul 2000 | A |
| 6091062 | Pfahnl et al. | Jul 2000 | A |
| 6093252 | Wengert et al. | Jul 2000 | A |
| 6093253 | Lofgren | Jul 2000 | A |
| 6096267 | Kishkovich | Aug 2000 | A |
| 6099302 | Hong et al. | Aug 2000 | A |
| 6102565 | Kita et al. | Aug 2000 | A |
| 6104011 | Juliano | Aug 2000 | A |
| 6104401 | Parsons | Aug 2000 | A |
| 6106678 | Shufflebotham | Aug 2000 | A |
| 6119710 | Brown | Sep 2000 | A |
| 6121061 | Van Bilsen et al. | Sep 2000 | A |
| 6121158 | Benchikha et al. | Sep 2000 | A |
| 6122036 | Yamasaki et al. | Sep 2000 | A |
| 6124600 | Moroishi et al. | Sep 2000 | A |
| 6125789 | Gupta et al. | Oct 2000 | A |
| 6126848 | Li et al. | Oct 2000 | A |
| 6129044 | Zhao et al. | Oct 2000 | A |
| 6129546 | Sada | Oct 2000 | A |
| 6134807 | Komino | Oct 2000 | A |
| 6137240 | Bogdan et al. | Oct 2000 | A |
| 6140252 | Cho et al. | Oct 2000 | A |
| 6148761 | Majewski et al. | Nov 2000 | A |
| 6158941 | Muka et al. | Dec 2000 | A |
| 6160244 | Ohashi | Dec 2000 | A |
| 6161500 | Kopacz et al. | Dec 2000 | A |
| 6162323 | Koshimizu et al. | Dec 2000 | A |
| 6174809 | Kang et al. | Jan 2001 | B1 |
| 6178918 | Van Os et al. | Jan 2001 | B1 |
| 6180979 | Hofman et al. | Jan 2001 | B1 |
| 6187672 | Zhao | Feb 2001 | B1 |
| 6187691 | Fukuda | Feb 2001 | B1 |
| 6190634 | Lieber et al. | Feb 2001 | B1 |
| 6191399 | Van Bilsen | Feb 2001 | B1 |
| 6194037 | Terasaki et al. | Feb 2001 | B1 |
| 6201999 | Jevtic | Mar 2001 | B1 |
| 6203613 | Gates et al. | Mar 2001 | B1 |
| 6207932 | Yoo | Mar 2001 | B1 |
| 6212789 | Kato | Apr 2001 | B1 |
| 6214122 | Thompson | Apr 2001 | B1 |
| 6217658 | Orczyk et al. | Apr 2001 | B1 |
| 6218288 | Li et al. | Apr 2001 | B1 |
| 6225020 | Jung et al. | May 2001 | B1 |
| 6235858 | Swarup et al. | May 2001 | B1 |
| 6242359 | Misra | Jun 2001 | B1 |
| 6243654 | Johnson et al. | Jun 2001 | B1 |
| 6245665 | Yokoyama | Jun 2001 | B1 |
| 6250250 | Maishev et al. | Jun 2001 | B1 |
| 6257758 | Culbertson | Jul 2001 | B1 |
| 6264467 | Andreas et al. | Jul 2001 | B1 |
| 6271148 | Kao | Aug 2001 | B1 |
| 6274878 | Li et al. | Aug 2001 | B1 |
| 6281098 | Wang | Aug 2001 | B1 |
| 6281141 | Das et al. | Aug 2001 | B1 |
| 6284050 | Shi et al. | Sep 2001 | B1 |
| 6287965 | Kang et al. | Sep 2001 | B1 |
| 6293700 | Lund et al. | Sep 2001 | B1 |
| D449873 | Bronson | Oct 2001 | S |
| 6296909 | Spitsberg | Oct 2001 | B1 |
| 6299133 | Waragai et al. | Oct 2001 | B2 |
| 6302964 | Umotoy et al. | Oct 2001 | B1 |
| 6303523 | Cheung | Oct 2001 | B2 |
| 6305898 | Yamagishi et al. | Oct 2001 | B1 |
| 6311016 | Yanagawa et al. | Oct 2001 | B1 |
| 6312525 | Bright et al. | Nov 2001 | B1 |
| 6315512 | Tabrizi et al. | Nov 2001 | B1 |
| 6316162 | Jung et al. | Nov 2001 | B1 |
| D451893 | Robson | Dec 2001 | S |
| D452220 | Robson | Dec 2001 | S |
| 6325858 | Wengert | Dec 2001 | B1 |
| 6326597 | Lubomirsky et al. | Dec 2001 | B1 |
| 6329297 | Balish | Dec 2001 | B1 |
| 6342427 | Choi et al. | Jan 2002 | B1 |
| 6344084 | Koinuma et al. | Feb 2002 | B1 |
| 6344232 | Jones et al. | Feb 2002 | B1 |
| 6347636 | Xia | Feb 2002 | B1 |
| 6350391 | Livshits et al. | Feb 2002 | B1 |
| 6352945 | Matsuki | Mar 2002 | B1 |
| D455024 | Mimick et al. | Apr 2002 | S |
| 6367410 | Leahey et al. | Apr 2002 | B1 |
| 6368773 | Jung et al. | Apr 2002 | B1 |
| 6368987 | Kopacz et al. | Apr 2002 | B1 |
| 6370796 | Zucker | Apr 2002 | B1 |
| 6372583 | Tyagi | Apr 2002 | B1 |
| 6374831 | Chandran | Apr 2002 | B1 |
| 6375312 | Ikeda et al. | Apr 2002 | B1 |
| 6375750 | Van Os et al. | Apr 2002 | B1 |
| D457609 | Piano | May 2002 | S |
| 6383566 | Zagdoun | May 2002 | B1 |
| 6383955 | Matsuki | May 2002 | B1 |
| 6387207 | Janakiraman | May 2002 | B1 |
| 6391803 | Kim et al. | May 2002 | B1 |
| 6395650 | Callegari et al. | May 2002 | B1 |
| 6398184 | Sowada et al. | Jun 2002 | B1 |
| 6410459 | Blalock et al. | Jun 2002 | B2 |
| 6413321 | Kim et al. | Jul 2002 | B1 |
| 6413583 | Moghadam et al. | Jul 2002 | B1 |
| 6420279 | Ono et al. | Jul 2002 | B1 |
| D461233 | Whalen | Aug 2002 | S |
| D461882 | Piano | Aug 2002 | S |
| 6432849 | Endo et al. | Aug 2002 | B1 |
| 6435798 | Satoh | Aug 2002 | B1 |
| 6435865 | Tseng et al. | Aug 2002 | B1 |
| 6436819 | Zhang | Aug 2002 | B1 |
| 6437444 | Andideh | Aug 2002 | B2 |
| 6438502 | Awtrey | Aug 2002 | B1 |
| 6441350 | Stoddard et al. | Aug 2002 | B1 |
| 6445574 | Saw et al. | Sep 2002 | B1 |
| 6446573 | Hirayama et al. | Sep 2002 | B2 |
| 6447232 | Davis et al. | Sep 2002 | B1 |
| 6447651 | Ishikawa et al. | Sep 2002 | B1 |
| 6448192 | Kaushik | Sep 2002 | B1 |
| 6450757 | Saeki | Sep 2002 | B1 |
| 6451713 | Tay et al. | Sep 2002 | B1 |
| 6454860 | Metzner et al. | Sep 2002 | B2 |
| 6455225 | Kong et al. | Sep 2002 | B1 |
| 6455445 | Matsuki | Sep 2002 | B2 |
| 6461435 | Littau et al. | Oct 2002 | B1 |
| 6468924 | Lee | Oct 2002 | B2 |
| 6471779 | Nishio et al. | Oct 2002 | B1 |
| 6472266 | Yu et al. | Oct 2002 | B1 |
| 6475276 | Elers et al. | Nov 2002 | B1 |
| 6475930 | Junker et al. | Nov 2002 | B1 |
| 6478872 | Chae et al. | Nov 2002 | B1 |
| 6482331 | Lu et al. | Nov 2002 | B2 |
| 6482663 | Buckland | Nov 2002 | B1 |
| 6483989 | Okada et al. | Nov 2002 | B1 |
| 6494065 | Babbitt | Dec 2002 | B2 |
| 6494998 | Brcka | Dec 2002 | B1 |
| 6496819 | Bello et al. | Dec 2002 | B1 |
| 6499533 | Yamada | Dec 2002 | B2 |
| 6503079 | Kogano et al. | Jan 2003 | B2 |
| 6503562 | Saito et al. | Jan 2003 | B1 |
| 6503826 | Oda | Jan 2003 | B1 |
| 6506253 | Sakuma | Jan 2003 | B2 |
| 6507410 | Robertson et al. | Jan 2003 | B1 |
| 6511539 | Raaijmakers | Jan 2003 | B1 |
| 6514313 | Spiegelman | Feb 2003 | B1 |
| 6514666 | Choi et al. | Feb 2003 | B1 |
| 6521295 | Remington | Feb 2003 | B1 |
| 6521547 | Chang et al. | Feb 2003 | B1 |
| 6528430 | Kwan | Mar 2003 | B2 |
| 6528767 | Bagley et al. | Mar 2003 | B2 |
| 6531193 | Fonash et al. | Mar 2003 | B2 |
| 6531412 | Conti et al. | Mar 2003 | B2 |
| 6534133 | Kaloyeros et al. | Mar 2003 | B1 |
| 6534395 | Werkhoven et al. | Mar 2003 | B2 |
| 6536950 | Green | Mar 2003 | B1 |
| 6544906 | Rotondaro et al. | Apr 2003 | B2 |
| 6552209 | Lei et al. | Apr 2003 | B1 |
| 6558755 | Berry et al. | May 2003 | B2 |
| 6559026 | Rossman et al. | May 2003 | B1 |
| 6566278 | Harvey et al. | May 2003 | B1 |
| 6569239 | Arai et al. | May 2003 | B2 |
| 6569971 | Roh et al. | May 2003 | B2 |
| 6573030 | Fairbairn et al. | Jun 2003 | B1 |
| 6574644 | Hsu et al. | Jun 2003 | B2 |
| 6576062 | Matsuse | Jun 2003 | B2 |
| 6576064 | Griffiths et al. | Jun 2003 | B2 |
| 6576300 | Berry et al. | Jun 2003 | B1 |
| 6576564 | Agarwal | Jun 2003 | B2 |
| 6578589 | Mayusumi | Jun 2003 | B1 |
| 6579833 | McNallan et al. | Jun 2003 | B1 |
| 6580050 | Miller et al. | Jun 2003 | B1 |
| 6583048 | Vincent et al. | Jun 2003 | B1 |
| 6589707 | Lee et al. | Jul 2003 | B2 |
| 6589868 | Rossman | Jul 2003 | B2 |
| 6590251 | Kang et al. | Jul 2003 | B2 |
| 6594550 | Okrah | Jul 2003 | B1 |
| 6596653 | Tan | Jul 2003 | B2 |
| 6598559 | Vellore et al. | Jul 2003 | B1 |
| 6607868 | Choi | Aug 2003 | B2 |
| 6607948 | Sugiyama et al. | Aug 2003 | B1 |
| 6608745 | Tsuruta et al. | Aug 2003 | B2 |
| 6620251 | Kitano | Sep 2003 | B2 |
| 6624064 | Sahin | Sep 2003 | B1 |
| 6627268 | Fair et al. | Sep 2003 | B1 |
| 6627503 | Ma et al. | Sep 2003 | B2 |
| 6632478 | Gaillard et al. | Oct 2003 | B2 |
| 6633364 | Hayashi | Oct 2003 | B2 |
| 6635117 | Kinnard et al. | Oct 2003 | B1 |
| 6638839 | Deng et al. | Oct 2003 | B2 |
| 6645304 | Yamaguchi | Nov 2003 | B2 |
| 6648974 | Ogliari et al. | Nov 2003 | B1 |
| 6649921 | Cekic et al. | Nov 2003 | B1 |
| 6652924 | Sherman | Nov 2003 | B2 |
| 6656281 | Ueda | Dec 2003 | B1 |
| 6660662 | Ishikawa et al. | Dec 2003 | B2 |
| 6662817 | Yamagishi | Dec 2003 | B2 |
| 6673196 | Oyabu | Jan 2004 | B1 |
| 6676290 | Lu | Jan 2004 | B1 |
| 6682971 | Tsuneda et al. | Jan 2004 | B2 |
| 6682973 | Paton et al. | Jan 2004 | B1 |
| D486891 | Cronce | Feb 2004 | S |
| 6684659 | Tanaka et al. | Feb 2004 | B1 |
| 6688784 | Templeton | Feb 2004 | B1 |
| 6689220 | Nguyen | Feb 2004 | B1 |
| 6692575 | Omstead et al. | Feb 2004 | B1 |
| 6692576 | Halpin et al. | Feb 2004 | B2 |
| 6699003 | Saeki | Mar 2004 | B2 |
| 6699399 | Qian et al. | Mar 2004 | B1 |
| 6709989 | Ramdani et al. | Mar 2004 | B2 |
| 6710364 | Guldi et al. | Mar 2004 | B2 |
| 6710857 | Kondo | Mar 2004 | B2 |
| 6713824 | Mikata | Mar 2004 | B1 |
| 6716571 | Gabriel | Apr 2004 | B2 |
| 6720260 | Fair et al. | Apr 2004 | B1 |
| 6722837 | Inui | Apr 2004 | B2 |
| 6723642 | Lim et al. | Apr 2004 | B1 |
| 6730614 | Lim et al. | May 2004 | B1 |
| 6732006 | Haanstra et al. | May 2004 | B2 |
| 6734090 | Agarwala et al. | May 2004 | B2 |
| 6740853 | Johnson et al. | May 2004 | B1 |
| 6743475 | Skarp et al. | Jun 2004 | B2 |
| 6743738 | Todd et al. | Jun 2004 | B2 |
| 6745095 | Ben-Dov | Jun 2004 | B1 |
| 6753507 | Fure et al. | Jun 2004 | B2 |
| 6755221 | Jeong et al. | Jun 2004 | B2 |
| 6756085 | Waldfried | Jun 2004 | B2 |
| 6756293 | Li et al. | Jun 2004 | B2 |
| 6756318 | Nguyen et al. | Jun 2004 | B2 |
| 6759098 | Han | Jul 2004 | B2 |
| 6760981 | Leap | Jul 2004 | B2 |
| 6784108 | Donohoe et al. | Aug 2004 | B1 |
| D497977 | Engelbrektsson | Nov 2004 | S |
| 6811960 | Lee et al. | Nov 2004 | B2 |
| 6815350 | Kim et al. | Nov 2004 | B2 |
| 6820570 | Kilpela et al. | Nov 2004 | B2 |
| 6821910 | Adomaitis et al. | Nov 2004 | B2 |
| 6824665 | Shelnut et al. | Nov 2004 | B2 |
| 6825134 | Law et al. | Nov 2004 | B2 |
| 6828235 | Takano | Dec 2004 | B2 |
| 6831004 | Byun | Dec 2004 | B2 |
| 6835039 | Van Den Berg | Dec 2004 | B2 |
| 6846146 | Inui | Jan 2005 | B2 |
| 6846515 | Vrtis | Jan 2005 | B2 |
| 6846742 | Rossman | Jan 2005 | B2 |
| 6847014 | Benjamin et al. | Jan 2005 | B1 |
| 6858524 | Haukka et al. | Feb 2005 | B2 |
| 6858547 | Metzner | Feb 2005 | B2 |
| 6863019 | Shamouilian | Mar 2005 | B2 |
| 6863281 | Endou et al. | Mar 2005 | B2 |
| 6864041 | Brown | Mar 2005 | B2 |
| 6872258 | Park et al. | Mar 2005 | B2 |
| 6872259 | Strang | Mar 2005 | B2 |
| 6874247 | Hsu | Apr 2005 | B1 |
| 6874480 | Ismailov | Apr 2005 | B1 |
| 6875677 | Conley, Jr. et al. | Apr 2005 | B1 |
| 6876017 | Goodner | Apr 2005 | B2 |
| 6878402 | Chiang et al. | Apr 2005 | B2 |
| 6884066 | Nguyen et al. | Apr 2005 | B2 |
| 6884295 | Ishii | Apr 2005 | B2 |
| 6884319 | Kim | Apr 2005 | B2 |
| D505590 | Greiner | May 2005 | S |
| 6889211 | Yoshiura et al. | May 2005 | B1 |
| 6889864 | Lindfors et al. | May 2005 | B2 |
| 6895158 | Alyward et al. | May 2005 | B2 |
| 6899507 | Yamagishi et al. | May 2005 | B2 |
| 6909839 | Wang et al. | Jun 2005 | B2 |
| 6911092 | Sneh | Jun 2005 | B2 |
| 6913152 | Zuk | Jul 2005 | B2 |
| 6913796 | Albano et al. | Jul 2005 | B2 |
| 6917755 | Nguyen et al. | Jul 2005 | B2 |
| 6924078 | Lee et al. | Aug 2005 | B2 |
| 6929700 | Tan et al. | Aug 2005 | B2 |
| 6930041 | Agarwal | Aug 2005 | B2 |
| 6930059 | Conley, Jr. et al. | Aug 2005 | B2 |
| 6935269 | Lee et al. | Aug 2005 | B2 |
| 6939817 | Sandhu et al. | Sep 2005 | B2 |
| 6942753 | Choi et al. | Sep 2005 | B2 |
| 6951587 | Narushima | Oct 2005 | B1 |
| 6953609 | Carollo | Oct 2005 | B2 |
| 6955836 | Kumagai et al. | Oct 2005 | B2 |
| 6972055 | Sferlazzo | Dec 2005 | B2 |
| 6972478 | Waite et al. | Dec 2005 | B1 |
| 6974781 | Timmermans et al. | Dec 2005 | B2 |
| 6975921 | Verhaar | Dec 2005 | B2 |
| 6976822 | Woodruff | Dec 2005 | B2 |
| 6981832 | Zinger et al. | Jan 2006 | B2 |
| 6982046 | Srivastava et al. | Jan 2006 | B2 |
| 6984595 | Yamazaki | Jan 2006 | B1 |
| 6985788 | Haanstra et al. | Jan 2006 | B2 |
| 6987155 | Roh et al. | Jan 2006 | B2 |
| 6990430 | Hosek | Jan 2006 | B2 |
| 7005227 | Yueh et al. | Feb 2006 | B2 |
| 7005391 | Min | Feb 2006 | B2 |
| 7010580 | Fu et al. | Mar 2006 | B1 |
| 7017514 | Shepherd et al. | Mar 2006 | B1 |
| 7018941 | Cui et al. | Mar 2006 | B2 |
| 7021881 | Yamagishi | Apr 2006 | B2 |
| 7036453 | Ishikawa et al. | May 2006 | B2 |
| 7041609 | Vaartstra | May 2006 | B2 |
| 7045430 | Ahn et al. | May 2006 | B2 |
| 7049247 | Gates et al. | May 2006 | B2 |
| 7053009 | Conley, Jr. et al. | May 2006 | B2 |
| 7055875 | Bonora | Jun 2006 | B2 |
| 7062161 | Kusuda et al. | Jun 2006 | B2 |
| 7070178 | Van Der Toorn et al. | Jul 2006 | B2 |
| 7071051 | Jeon et al. | Jul 2006 | B1 |
| 7073834 | Matsumoto et al. | Jul 2006 | B2 |
| 7080545 | Dimeo et al. | Jul 2006 | B2 |
| 7084060 | Furukawa | Aug 2006 | B1 |
| 7084079 | Conti et al. | Aug 2006 | B2 |
| 7085623 | Siegers | Aug 2006 | B2 |
| 7088003 | Gates et al. | Aug 2006 | B2 |
| 7090394 | Hashikura et al. | Aug 2006 | B2 |
| 7092287 | Beulens et al. | Aug 2006 | B2 |
| 7098149 | Lukas | Aug 2006 | B2 |
| 7101763 | Anderson et al. | Sep 2006 | B1 |
| 7109098 | Ramaswamy et al. | Sep 2006 | B1 |
| 7109114 | Chen et al. | Sep 2006 | B2 |
| 7111232 | Bascom | Sep 2006 | B1 |
| 7115838 | Kurara et al. | Oct 2006 | B2 |
| 7122085 | Shero et al. | Oct 2006 | B2 |
| 7122222 | Xiao et al. | Oct 2006 | B2 |
| 7129165 | Basol et al. | Oct 2006 | B2 |
| 7132360 | Schaeffer et al. | Nov 2006 | B2 |
| 7135421 | Ahn et al. | Nov 2006 | B2 |
| 7143897 | Guzman et al. | Dec 2006 | B1 |
| 7147766 | Uzoh et al. | Dec 2006 | B2 |
| 7153542 | Nguyen et al. | Dec 2006 | B2 |
| 7156380 | Soininen | Jan 2007 | B2 |
| 7163393 | Adachi et al. | Jan 2007 | B2 |
| 7163721 | Zhang et al. | Jan 2007 | B2 |
| 7163900 | Weber | Jan 2007 | B2 |
| 7168852 | Linnarsson | Jan 2007 | B2 |
| 7172497 | Basol et al. | Feb 2007 | B2 |
| 7186648 | Rozbicki | Mar 2007 | B1 |
| 7192824 | Ahn et al. | Mar 2007 | B2 |
| 7192892 | Ahn et al. | Mar 2007 | B2 |
| 7195693 | Cowans | Mar 2007 | B2 |
| 7201943 | Park et al. | Apr 2007 | B2 |
| 7204887 | Kawamura et al. | Apr 2007 | B2 |
| 7205246 | MacNeil et al. | Apr 2007 | B2 |
| 7205247 | Lee et al. | Apr 2007 | B2 |
| 7207763 | Lee | Apr 2007 | B2 |
| 7208389 | Tipton et al. | Apr 2007 | B1 |
| 7210925 | Adachi | May 2007 | B2 |
| 7211524 | Ryu et al. | May 2007 | B2 |
| 7211525 | Shanker | May 2007 | B1 |
| 7214630 | Varadarajan et al. | May 2007 | B1 |
| 7223014 | Lojen | May 2007 | B2 |
| 7208413 | Byun et al. | Jun 2007 | B2 |
| 7234476 | Arai | Jun 2007 | B2 |
| 7235137 | Kitayama et al. | Jun 2007 | B2 |
| 7235482 | Wu | Jun 2007 | B2 |
| 7235501 | Ahn et al. | Jun 2007 | B2 |
| 7238596 | Kouvetakis et al. | Jul 2007 | B2 |
| 7238616 | Agarwal | Jul 2007 | B2 |
| 7238653 | Lee et al. | Jul 2007 | B2 |
| 7265061 | Cho et al. | Sep 2007 | B1 |
| 7274867 | Peukert | Sep 2007 | B2 |
| D553104 | Oohashi et al. | Oct 2007 | S |
| 7279256 | Son | Oct 2007 | B2 |
| 7290813 | Bonora | Nov 2007 | B2 |
| 7294581 | Haverkort et al. | Nov 2007 | B2 |
| 7296460 | Dimeo et al. | Nov 2007 | B2 |
| 7297641 | Todd et al. | Nov 2007 | B2 |
| 7298009 | Yan et al. | Nov 2007 | B2 |
| D557226 | Uchino et al. | Dec 2007 | S |
| 7307028 | Goto et al. | Dec 2007 | B2 |
| 7307178 | Kiyomori et al. | Dec 2007 | B2 |
| 7312148 | Ramaswamy et al. | Dec 2007 | B2 |
| 7312162 | Ramaswamy et al. | Dec 2007 | B2 |
| 7312494 | Ahn et al. | Dec 2007 | B2 |
| 7320544 | Hsieh | Jan 2008 | B2 |
| 7323401 | Ramaswamy et al. | Jan 2008 | B2 |
| 7326657 | Xia et al. | Feb 2008 | B2 |
| 7327948 | Shrinivasan | Feb 2008 | B1 |
| 7329947 | Adachi et al. | Feb 2008 | B2 |
| 7335611 | Ramaswamy et al. | Feb 2008 | B2 |
| 7351057 | Berenbak et al. | Apr 2008 | B2 |
| 7354847 | Chan et al. | Apr 2008 | B2 |
| 7354873 | Fukazawa et al. | Apr 2008 | B2 |
| 7356762 | van Driel | Apr 2008 | B2 |
| 7357138 | Ji et al. | Apr 2008 | B2 |
| 7361447 | Jung | Apr 2008 | B2 |
| 7376520 | Wong | May 2008 | B2 |
| 7379785 | Higashi et al. | May 2008 | B2 |
| 7381644 | Soubramonium et al. | Jun 2008 | B1 |
| 7387685 | Choi et al. | Jun 2008 | B2 |
| 7393207 | Imai | Jul 2008 | B2 |
| 7393418 | Yokogawa | Jul 2008 | B2 |
| 7393736 | Ahn et al. | Jul 2008 | B2 |
| 7393765 | Hanawa et al. | Jul 2008 | B2 |
| 7396491 | Marking et al. | Jul 2008 | B2 |
| 7399388 | Moghadam et al. | Jul 2008 | B2 |
| 7399570 | Lee et al. | Jul 2008 | B2 |
| 7402534 | Mahajani | Jul 2008 | B2 |
| 7405166 | Liang et al. | Jul 2008 | B2 |
| 7405454 | Ahn et al. | Jul 2008 | B2 |
| D575713 | Ratcliffe | Aug 2008 | S |
| 7410290 | Tanaka | Aug 2008 | B2 |
| 7410666 | Elers | Aug 2008 | B2 |
| 7411352 | Madocks | Aug 2008 | B2 |
| 7414281 | Fastow | Aug 2008 | B1 |
| D576001 | Brunderman | Sep 2008 | S |
| 7422635 | Zheng et al. | Sep 2008 | B2 |
| 7422653 | Blahnik et al. | Sep 2008 | B2 |
| 7422775 | Ramaswamy et al. | Sep 2008 | B2 |
| 7429532 | Ramaswamy et al. | Sep 2008 | B2 |
| 7431966 | Derderian et al. | Oct 2008 | B2 |
| 7432476 | Morita et al. | Oct 2008 | B2 |
| 7437060 | Wang et al. | Oct 2008 | B2 |
| 7442275 | Cowans | Oct 2008 | B2 |
| 7467632 | Lee et al. | Dec 2008 | B2 |
| 7475588 | Dimeo et al. | Jan 2009 | B2 |
| 7476291 | Wang et al. | Jan 2009 | B2 |
| 7479198 | Guffrey | Jan 2009 | B2 |
| 7482247 | Papasouliotis | Jan 2009 | B1 |
| 7482283 | Yamasaki et al. | Jan 2009 | B2 |
| D585968 | Elkins et al. | Feb 2009 | S |
| 7489389 | Shibazaki et al. | Feb 2009 | B2 |
| 7494882 | Vitale | Feb 2009 | B2 |
| 7497614 | Gaff | Mar 2009 | B2 |
| 7498242 | Kumar et al. | Mar 2009 | B2 |
| 7501292 | Matsushita et al. | Mar 2009 | B2 |
| 7501355 | Bhatia et al. | Mar 2009 | B2 |
| 7503980 | Kida et al. | Mar 2009 | B2 |
| D590933 | Vansell | Apr 2009 | S |
| 7514375 | Shanker et al. | Apr 2009 | B1 |
| D593969 | Li | Jun 2009 | S |
| 7541297 | Mallick et al. | Jun 2009 | B2 |
| 7547363 | Tomiyasu et al. | Jun 2009 | B2 |
| 7547633 | Ranish et al. | Jun 2009 | B2 |
| 7550396 | Frohberg et al. | Jun 2009 | B2 |
| 7561982 | Rund et al. | Jul 2009 | B2 |
| 7563715 | Haukka et al. | Jul 2009 | B2 |
| 7566891 | Rocha-Alvarez et al. | Jul 2009 | B2 |
| 7575968 | Sadaka et al. | Aug 2009 | B2 |
| 7579285 | Zimmerman et al. | Aug 2009 | B2 |
| 7579785 | Shinmen et al. | Aug 2009 | B2 |
| D600223 | Aggarwal | Sep 2009 | S |
| 7582555 | Lang | Sep 2009 | B1 |
| 7582575 | Fukazawa et al. | Sep 2009 | B2 |
| 7589003 | Kouvetakis et al. | Sep 2009 | B2 |
| 7589029 | Derderian et al. | Sep 2009 | B2 |
| 7591601 | Matsuoka et al. | Sep 2009 | B2 |
| D602575 | Breda | Oct 2009 | S |
| 7598513 | Kouvetakis et al. | Oct 2009 | B2 |
| 7601223 | Lindfors et al. | Oct 2009 | B2 |
| 7601225 | Tuominen et al. | Oct 2009 | B2 |
| 7601652 | Singh et al. | Oct 2009 | B2 |
| 7611751 | Elers | Nov 2009 | B2 |
| 7611980 | Wells et al. | Nov 2009 | B2 |
| 7618226 | Takizawa | Nov 2009 | B2 |
| 7621672 | Ripley | Nov 2009 | B2 |
| 7622369 | Lee et al. | Nov 2009 | B1 |
| 7622378 | Liu et al. | Nov 2009 | B2 |
| 7623940 | Huskamp et al. | Nov 2009 | B2 |
| D606952 | Lee | Dec 2009 | S |
| 7625820 | Papasouliotis | Dec 2009 | B1 |
| 7629277 | Ghatnagar | Dec 2009 | B2 |
| 7632549 | Goundar | Dec 2009 | B2 |
| 7640142 | Tachikawa et al. | Dec 2009 | B2 |
| 7645341 | Kennedy et al. | Jan 2010 | B2 |
| 7645484 | Ishizaka | Jan 2010 | B2 |
| 7648927 | Singh et al. | Jan 2010 | B2 |
| 7651269 | Comendant | Jan 2010 | B2 |
| 7651583 | Kent et al. | Jan 2010 | B2 |
| 7651955 | Ravish et al. | Jan 2010 | B2 |
| 7651959 | Fukazawa et al. | Jan 2010 | B2 |
| 7651961 | Clark | Jan 2010 | B2 |
| D609652 | Nagasaka | Feb 2010 | S |
| D609655 | Sugimoto | Feb 2010 | S |
| 7661299 | Kusunoki | Feb 2010 | B2 |
| 7678197 | Maki | Mar 2010 | B2 |
| 7678715 | Mungekar et al. | Mar 2010 | B2 |
| 7682454 | Sneh | Mar 2010 | B2 |
| 7682657 | Sherman | Mar 2010 | B2 |
| D613829 | Griffin et al. | Apr 2010 | S |
| D614153 | Fondurulia et al. | Apr 2010 | S |
| D614267 | Breda | Apr 2010 | S |
| D614268 | Breda | Apr 2010 | S |
| D614593 | Lee | Apr 2010 | S |
| 7690881 | Yamagishi | Apr 2010 | B2 |
| 7691205 | Ikedo | Apr 2010 | B2 |
| 7692171 | Kaszuba et al. | Apr 2010 | B2 |
| 7695808 | Tuma | Apr 2010 | B2 |
| 7713874 | Milligan | May 2010 | B2 |
| 7716993 | Ozawa et al. | May 2010 | B2 |
| 7720560 | Menser et al. | May 2010 | B2 |
| 7723648 | Tsukamoto et al. | May 2010 | B2 |
| 7727864 | Elers | Jun 2010 | B2 |
| 7732343 | Niroomand et al. | Jun 2010 | B2 |
| 7736437 | Cadwell et al. | Jun 2010 | B2 |
| 7736528 | Okita et al. | Jun 2010 | B2 |
| 7740705 | Li | Jun 2010 | B2 |
| 7745346 | Hausmann et al. | Jun 2010 | B2 |
| 7748760 | Kushida | Jul 2010 | B2 |
| 7749563 | Zheng et al. | Jul 2010 | B2 |
| 7753584 | Gambino et al. | Jul 2010 | B2 |
| 7754621 | Putjkonen | Jul 2010 | B2 |
| 7763869 | Matsushita et al. | Jul 2010 | B2 |
| 7767262 | Clark | Aug 2010 | B2 |
| 7771796 | Kohno et al. | Aug 2010 | B2 |
| 7780440 | Shibagaki et al. | Aug 2010 | B2 |
| 7781352 | Fukazawa et al. | Aug 2010 | B2 |
| 7789559 | Waser et al. | Sep 2010 | B2 |
| 7789965 | Matsushita et al. | Sep 2010 | B2 |
| 7790633 | Tarafdar et al. | Sep 2010 | B1 |
| 7798096 | Mahajani et al. | Sep 2010 | B2 |
| 7803722 | Liang | Sep 2010 | B2 |
| 7806587 | Kobayashi | Oct 2010 | B2 |
| 7807566 | Tsuji et al. | Oct 2010 | B2 |
| 7807578 | Bencher et al. | Oct 2010 | B2 |
| 7816278 | Reed et al. | Oct 2010 | B2 |
| 7824492 | Tois et al. | Nov 2010 | B2 |
| 7825040 | Fukazawa et al. | Nov 2010 | B1 |
| 7829460 | Streck et al. | Nov 2010 | B2 |
| 7833353 | Furukawahara et al. | Nov 2010 | B2 |
| 7838084 | Derderian et al. | Nov 2010 | B2 |
| 7842518 | Miyajima | Nov 2010 | B2 |
| 7842622 | Lee et al. | Nov 2010 | B1 |
| D629874 | Hermans | Dec 2010 | S |
| 7850449 | Yang et al. | Dec 2010 | B2 |
| 7851019 | Tuominen et al. | Dec 2010 | B2 |
| 7851232 | van Schravendijk et al. | Dec 2010 | B2 |
| 7858519 | Liu et al. | Dec 2010 | B2 |
| 7858533 | Liu et al. | Dec 2010 | B2 |
| 7865070 | Nakamura | Jan 2011 | B2 |
| 7871198 | Rempe et al. | Jan 2011 | B2 |
| 7874726 | Jacobs et al. | Jan 2011 | B2 |
| 7884918 | Hattori | Feb 2011 | B2 |
| 7888233 | Gauri | Feb 2011 | B1 |
| D634329 | Wastrom | Mar 2011 | S |
| D634719 | Yasuda et al. | Mar 2011 | S |
| 7897215 | Fair et al. | Mar 2011 | B1 |
| 7902582 | Forbes et al. | Mar 2011 | B2 |
| 7906174 | Wu et al. | Mar 2011 | B1 |
| 7910288 | Abatchev et al. | Mar 2011 | B2 |
| 7915139 | Lang | Mar 2011 | B1 |
| 7915667 | Knoefler et al. | Mar 2011 | B2 |
| 7919416 | Lee et al. | Apr 2011 | B2 |
| 7925378 | Gilchrist et al. | Apr 2011 | B2 |
| 7935940 | Smargiassi | May 2011 | B1 |
| 7939447 | Bauer et al. | May 2011 | B2 |
| 7942969 | Riker et al. | May 2011 | B2 |
| 7946762 | Yednak | May 2011 | B2 |
| 7951262 | Koshiishi et al. | May 2011 | B2 |
| 7955516 | Chandrachood et al. | Jun 2011 | B2 |
| 7955650 | Tsuji | Jun 2011 | B2 |
| 7957708 | Karschnia et al. | Jun 2011 | B2 |
| 7963736 | Takizawa et al. | Jun 2011 | B2 |
| 7967913 | Hua et al. | Jun 2011 | B2 |
| 7972980 | Lee et al. | Jul 2011 | B2 |
| 7977256 | Liu et al. | Jul 2011 | B2 |
| 7981751 | Zhu et al. | Jul 2011 | B2 |
| D643055 | Takahashi | Aug 2011 | S |
| 7989736 | Park et al. | Aug 2011 | B2 |
| 7992318 | Kawaji | Aug 2011 | B2 |
| 7994721 | Espiau et al. | Aug 2011 | B2 |
| 7997795 | Schwagerman et al. | Aug 2011 | B2 |
| 7998875 | DeYoung | Aug 2011 | B2 |
| 8003174 | Fukazawa | Aug 2011 | B2 |
| 8003919 | Goto et al. | Aug 2011 | B2 |
| 8004198 | Bakre et al. | Aug 2011 | B2 |
| 8020315 | Nishimura | Sep 2011 | B2 |
| 8030129 | Jeong | Oct 2011 | B2 |
| 8033771 | Gage et al. | Oct 2011 | B1 |
| 8038835 | Hayashi et al. | Oct 2011 | B2 |
| 8041197 | Kasai et al. | Oct 2011 | B2 |
| 8041450 | Takizawa et al. | Oct 2011 | B2 |
| 8043972 | Liu et al. | Oct 2011 | B1 |
| 8046193 | Yetter et al. | Oct 2011 | B2 |
| 8048783 | Chung et al. | Nov 2011 | B2 |
| 8055378 | Numakura | Nov 2011 | B2 |
| 8060252 | Gage et al. | Nov 2011 | B2 |
| 8083853 | Choi et al. | Nov 2011 | B2 |
| D651291 | Liebson et al. | Dec 2011 | S |
| 8071451 | Berry | Dec 2011 | B2 |
| 8071452 | Raisanen | Dec 2011 | B2 |
| 8072578 | Yasuda et al. | Dec 2011 | B2 |
| 8076230 | Wei | Dec 2011 | B2 |
| 8076237 | Uzoh | Dec 2011 | B2 |
| 8076250 | Rajagopalan | Dec 2011 | B1 |
| 8076251 | Akae et al. | Dec 2011 | B2 |
| 8078310 | Nishimoto et al. | Dec 2011 | B2 |
| 8082946 | Laverdiere et al. | Dec 2011 | B2 |
| 8084104 | Shinriki et al. | Dec 2011 | B2 |
| 8084372 | You et al. | Dec 2011 | B2 |
| D652896 | Gether | Jan 2012 | S |
| 8092604 | Tomiyasu et al. | Jan 2012 | B2 |
| 8100583 | Aggarwal | Jan 2012 | B2 |
| D653734 | Sisk | Feb 2012 | S |
| D654884 | Honma | Feb 2012 | S |
| D655055 | Toll | Feb 2012 | S |
| 8110099 | Hersey et al. | Feb 2012 | B2 |
| 8114734 | Yang et al. | Feb 2012 | B2 |
| 8119466 | Avouris | Feb 2012 | B2 |
| 8129290 | Balseanu et al. | Mar 2012 | B2 |
| 8137462 | Fondurulia et al. | Mar 2012 | B2 |
| 8137465 | Shrinivasan et al. | Mar 2012 | B1 |
| 8138104 | Balseanu et al. | Mar 2012 | B2 |
| 8138676 | Mills | Mar 2012 | B2 |
| 8142862 | Lee et al. | Mar 2012 | B2 |
| 8143174 | Xia et al. | Mar 2012 | B2 |
| 8147242 | Shibagaki et al. | Apr 2012 | B2 |
| 8158512 | Ji et al. | Apr 2012 | B2 |
| 8172947 | Shibata et al. | May 2012 | B2 |
| 8173554 | Lee et al. | May 2012 | B2 |
| 8178436 | King et al. | May 2012 | B2 |
| 8187679 | Dickey et al. | May 2012 | B2 |
| 8187951 | Wang | May 2012 | B1 |
| 8192901 | Kageyama | Jun 2012 | B2 |
| 8196234 | Glunk | Jun 2012 | B2 |
| 8197915 | Oka et al. | Jun 2012 | B2 |
| 8216380 | White et al. | Jul 2012 | B2 |
| 8231799 | Bera et al. | Jul 2012 | B2 |
| D665055 | Yanagisawa et al. | Aug 2012 | S |
| 8241991 | Hsieh et al. | Aug 2012 | B2 |
| 8242028 | van Schravendijk | Aug 2012 | B1 |
| 8242031 | Mallick et al. | Aug 2012 | B2 |
| 8246900 | Kasai et al. | Aug 2012 | B2 |
| 8252114 | Vukovic | Aug 2012 | B2 |
| 8252659 | Huyghabaert et al. | Aug 2012 | B2 |
| 8252691 | Beynet et al. | Aug 2012 | B2 |
| 8267633 | Obikane | Sep 2012 | B2 |
| 8272516 | Salvador | Sep 2012 | B2 |
| 8278176 | Bauer et al. | Oct 2012 | B2 |
| 8282769 | Iizuka | Oct 2012 | B2 |
| 8282847 | Romano | Oct 2012 | B2 |
| 8287648 | Reed et al. | Oct 2012 | B2 |
| 8293016 | Bahng et al. | Oct 2012 | B2 |
| 8293642 | Kim | Oct 2012 | B2 |
| 8298951 | Nakano | Oct 2012 | B1 |
| 8307472 | Saxon et al. | Nov 2012 | B1 |
| 8309173 | Tuominen et al. | Nov 2012 | B2 |
| 8323413 | Son | Dec 2012 | B2 |
| 8328939 | Choi et al. | Dec 2012 | B2 |
| 8329599 | Fukazawa et al. | Dec 2012 | B2 |
| 8334219 | Lee et al. | Dec 2012 | B2 |
| 8349083 | Takasuka et al. | Jan 2013 | B2 |
| D676943 | Kluss | Feb 2013 | S |
| 8367528 | Bauer et al. | Feb 2013 | B2 |
| 8372204 | Nakamura | Feb 2013 | B2 |
| 8378464 | Kato et al. | Feb 2013 | B2 |
| 8393091 | Kawamoto | Mar 2013 | B2 |
| 8394466 | Hong et al. | Mar 2013 | B2 |
| 8398773 | Jdira et al. | Mar 2013 | B2 |
| 8404499 | Moffatt | Mar 2013 | B2 |
| 8415258 | Akae | Apr 2013 | B2 |
| 8415259 | Lee et al. | Apr 2013 | B2 |
| 8440259 | Chiang et al. | May 2013 | B2 |
| 8444120 | Gregg et al. | May 2013 | B2 |
| 8445075 | Xu et al. | May 2013 | B2 |
| 8450191 | Wang | May 2013 | B2 |
| 8465811 | Ueda | Jun 2013 | B2 |
| 8466411 | Arai | Jun 2013 | B2 |
| 8470187 | Ha | Jun 2013 | B2 |
| 8484846 | Dhindsa | Jul 2013 | B2 |
| 8492170 | Xie et al. | Jul 2013 | B2 |
| 8496377 | Harr et al. | Jul 2013 | B2 |
| 8496756 | Cruse et al. | Jul 2013 | B2 |
| 8497213 | Yasui et al. | Jul 2013 | B2 |
| 8501599 | Ueno et al. | Aug 2013 | B2 |
| 8506162 | Schick et al. | Aug 2013 | B2 |
| 8506713 | Takagi | Aug 2013 | B2 |
| 8529701 | Morita | Sep 2013 | B2 |
| 8535767 | Kimura | Sep 2013 | B1 |
| D691974 | Osada et al. | Oct 2013 | S |
| 8551892 | Nakano | Oct 2013 | B2 |
| 8563443 | Fukazawa | Oct 2013 | B2 |
| 8569184 | Oka | Oct 2013 | B2 |
| 8586484 | Matsuyama et al. | Nov 2013 | B2 |
| 8591659 | Fang et al. | Nov 2013 | B1 |
| 8592005 | Ueda | Nov 2013 | B2 |
| D695240 | Iida et al. | Dec 2013 | S |
| 8608885 | Goto et al. | Dec 2013 | B2 |
| 8614047 | Ayothi et al. | Dec 2013 | B2 |
| 8616765 | Darabnia et al. | Dec 2013 | B2 |
| 8617411 | Singh | Dec 2013 | B2 |
| 8633115 | Chang et al. | Jan 2014 | B2 |
| D698904 | Milligan et al. | Feb 2014 | S |
| 8642488 | Liu et al. | Feb 2014 | B2 |
| 8647722 | Kobayashi et al. | Feb 2014 | B2 |
| 8664627 | Ishikawa et al. | Mar 2014 | B1 |
| 8667654 | Gros-Jean | Mar 2014 | B2 |
| 8668957 | Dussarrat et al. | Mar 2014 | B2 |
| 8669185 | Onizawa | Mar 2014 | B2 |
| 8679958 | Takamure et al. | Mar 2014 | B2 |
| D702188 | Jacobs | Apr 2014 | S |
| 8683943 | Onodera et al. | Apr 2014 | B2 |
| 8710580 | Sakuma et al. | Apr 2014 | B2 |
| 8711338 | Liu et al. | Apr 2014 | B2 |
| D705745 | Kurs et al. | May 2014 | S |
| D705762 | Yu | May 2014 | S |
| 8664127 | Bhatia et al. | May 2014 | B2 |
| 8720965 | Hino et al. | May 2014 | B2 |
| 8721791 | Choi et al. | May 2014 | B2 |
| 8722510 | Watanabe et al. | May 2014 | B2 |
| 8722546 | Fukazawa et al. | May 2014 | B2 |
| 8726837 | Patalay et al. | May 2014 | B2 |
| 8728832 | Raisanen et al. | May 2014 | B2 |
| 8742668 | Nakano et al. | Jun 2014 | B2 |
| 8759223 | Sapre et al. | Jun 2014 | B2 |
| 8764085 | Urabe | Jul 2014 | B2 |
| 8779502 | Sakuma et al. | Jul 2014 | B2 |
| 8784950 | Fukazawa et al. | Jul 2014 | B2 |
| 8784951 | Fukazawa et al. | Jul 2014 | B2 |
| 8785215 | Kobayashi et al. | Jul 2014 | B2 |
| 8785311 | Miyoshi | Jul 2014 | B2 |
| 8790743 | Omari | Jul 2014 | B1 |
| 8790749 | Omori et al. | Jul 2014 | B2 |
| 8802201 | Raisanen et al. | Aug 2014 | B2 |
| 8820809 | Ando et al. | Sep 2014 | B2 |
| 8821640 | Cleary et al. | Sep 2014 | B2 |
| 8841182 | Chen et al. | Sep 2014 | B1 |
| 8845806 | Aida et al. | Sep 2014 | B2 |
| 8846502 | Haukka et al. | Sep 2014 | B2 |
| D715410 | Lohmann | Oct 2014 | S |
| 8864202 | Schrameyer | Oct 2014 | B1 |
| D716742 | Jang et al. | Nov 2014 | S |
| 8877655 | Shero et al. | Nov 2014 | B2 |
| 8882923 | Saido et al. | Nov 2014 | B2 |
| 8883270 | Shero et al. | Nov 2014 | B2 |
| 8901016 | Ha et al. | Dec 2014 | B2 |
| 8911553 | Baluja et al. | Dec 2014 | B2 |
| 8911826 | Adachi et al. | Dec 2014 | B2 |
| 8912101 | Tsuji et al. | Dec 2014 | B2 |
| D720838 | Yamagishi et al. | Jan 2015 | S |
| 8927906 | Tadokoro et al. | Jan 2015 | B2 |
| 8933375 | Dunn et al. | Jan 2015 | B2 |
| 8940646 | Chandrasekharan | Jan 2015 | B1 |
| D723153 | Borkholder | Feb 2015 | S |
| 8945305 | Marsh | Feb 2015 | B2 |
| 8945306 | Tsuda | Feb 2015 | B2 |
| 8945339 | Kakimoto | Feb 2015 | B2 |
| 8946830 | Jung et al. | Feb 2015 | B2 |
| 8956971 | Huakka | Feb 2015 | B2 |
| 8956983 | Swaminathan | Feb 2015 | B2 |
| D723330 | York | Mar 2015 | S |
| D724553 | Choi | Mar 2015 | S |
| D724701 | Yamagishi et al. | Mar 2015 | S |
| D725168 | Yamagishi | Mar 2015 | S |
| 8967608 | Mitsumori et al. | Mar 2015 | B2 |
| 8974868 | Ishikawa et al. | Mar 2015 | B2 |
| 8986456 | Fondurulia et al. | Mar 2015 | B2 |
| 8991214 | Hoshino et al. | Mar 2015 | B2 |
| 8991887 | Shin et al. | Mar 2015 | B2 |
| 8993054 | Jung et al. | Mar 2015 | B2 |
| 8993457 | Ramkumar et al. | Mar 2015 | B1 |
| D726365 | Weigensberg | Apr 2015 | S |
| D726884 | Yamagishi et al. | Apr 2015 | S |
| 8999102 | Miyoshi et al. | Apr 2015 | B2 |
| 9005539 | Halpin et al. | Apr 2015 | B2 |
| 9017481 | Pettinger et al. | Apr 2015 | B1 |
| 9017933 | Liu et al. | Apr 2015 | B2 |
| 9018093 | Tsuji et al. | Apr 2015 | B2 |
| 9018111 | Milligan et al. | Apr 2015 | B2 |
| 9018567 | de Ridder et al. | Apr 2015 | B2 |
| 9021985 | Alokozai et al. | May 2015 | B2 |
| 9023737 | Beynet et al. | May 2015 | B2 |
| 9023738 | Kato et al. | May 2015 | B2 |
| 9029253 | Milligan et al. | May 2015 | B2 |
| 9029272 | Nakano | May 2015 | B1 |
| D732145 | Yamagishi | Jun 2015 | S |
| D732644 | Yamagishi et al. | Jun 2015 | S |
| D733261 | Yamagishi et al. | Jun 2015 | S |
| D733262 | Yamagishi et al. | Jul 2015 | S |
| D733843 | Yamagishi | Jul 2015 | S |
| D734377 | Hirakida | Jul 2015 | S |
| D735836 | Yamagishi et al. | Aug 2015 | S |
| 9096931 | Yednak et al. | Aug 2015 | B2 |
| 9099505 | Kusakabe et al. | Aug 2015 | B2 |
| 9117657 | Nakano et al. | Aug 2015 | B2 |
| 9117866 | Marquardt et al. | Aug 2015 | B2 |
| D739222 | Chadbourne | Sep 2015 | S |
| 9123510 | Nakano et al. | Sep 2015 | B2 |
| 9123577 | Fujimoto et al. | Sep 2015 | B2 |
| 9129897 | Pore et al. | Sep 2015 | B2 |
| 9136108 | Matsushita et al. | Sep 2015 | B2 |
| 9136180 | Machkaoutsan | Sep 2015 | B2 |
| 9142393 | Okabe et al. | Sep 2015 | B2 |
| 9142437 | Fosnight et al. | Sep 2015 | B2 |
| 9153441 | Takamure et al. | Oct 2015 | B2 |
| 9166012 | Sim et al. | Oct 2015 | B2 |
| 9169975 | Sarin et al. | Oct 2015 | B2 |
| 9171714 | Mori | Oct 2015 | B2 |
| 9171716 | Fukuda | Oct 2015 | B2 |
| D742202 | Cyphers et al. | Nov 2015 | S |
| D743357 | Vyne | Nov 2015 | S |
| D743513 | Yamagishi | Nov 2015 | S |
| 9177784 | Raisanen et al. | Nov 2015 | B2 |
| 9184047 | Liu et al. | Nov 2015 | B2 |
| 9190263 | Ishikawa et al. | Nov 2015 | B2 |
| 9190264 | Yuasa et al. | Nov 2015 | B2 |
| 9196483 | Lee et al. | Nov 2015 | B1 |
| 9202727 | Dunn et al. | Dec 2015 | B2 |
| 9214333 | Sims et al. | Dec 2015 | B1 |
| 9228259 | Haukka et al. | Jan 2016 | B2 |
| 9240412 | Xie et al. | Jan 2016 | B2 |
| 9245742 | Haukka | Jan 2016 | B2 |
| 9252024 | Lam et al. | Feb 2016 | B2 |
| 9257274 | Kang et al. | Feb 2016 | B2 |
| 9267850 | Aggarwal | Feb 2016 | B2 |
| 9281277 | Baek et al. | Mar 2016 | B2 |
| 9284642 | Nakano | Mar 2016 | B2 |
| 9297705 | Aggarwal | Mar 2016 | B2 |
| 9299557 | Tolle et al. | Mar 2016 | B2 |
| 9299595 | Dunn et al. | Mar 2016 | B2 |
| D753269 | Yamagishi et al. | Apr 2016 | S |
| D753629 | Plattard | Apr 2016 | S |
| 9305836 | Gates et al. | Apr 2016 | B1 |
| 9312155 | Mori | Apr 2016 | B2 |
| 9315897 | Byun | Apr 2016 | B2 |
| 9324811 | Weeks | Apr 2016 | B2 |
| 9324846 | Camillo | Apr 2016 | B1 |
| 9341296 | Yednak | May 2016 | B2 |
| 9343297 | Fukazawa et al. | May 2016 | B1 |
| 9343308 | Isii | May 2016 | B2 |
| 9343343 | Mori | May 2016 | B2 |
| 9343350 | Arai | May 2016 | B2 |
| 9349620 | Kamata et al. | May 2016 | B2 |
| 9353441 | Chung | May 2016 | B2 |
| 9365924 | Nonaka | Jun 2016 | B2 |
| 9368352 | Takamure et al. | Jun 2016 | B2 |
| 9370863 | Tsuji et al. | Jun 2016 | B2 |
| 9384987 | Jung et al. | Jul 2016 | B2 |
| 9390909 | Pasquale et al. | Jul 2016 | B2 |
| 9394608 | Shero et al. | Jul 2016 | B2 |
| 9396934 | Tolle | Jul 2016 | B2 |
| 9396956 | Fukazawa | Jul 2016 | B1 |
| 9404587 | Shugrue | Aug 2016 | B2 |
| 9412564 | Milligan | Aug 2016 | B2 |
| 9412582 | Sasaki et al. | Aug 2016 | B2 |
| 9443725 | Liu et al. | Sep 2016 | B2 |
| 9447498 | Shiba et al. | Sep 2016 | B2 |
| 9449793 | Shaji et al. | Sep 2016 | B2 |
| 9455138 | Fukazawa | Sep 2016 | B1 |
| 9464352 | Nakano et al. | Oct 2016 | B2 |
| 9478414 | Kobayashi et al. | Oct 2016 | B2 |
| 9478415 | Kimura | Oct 2016 | B2 |
| D770993 | Yoshida et al. | Nov 2016 | S |
| 9484191 | Winkler | Nov 2016 | B2 |
| 9514927 | Tolle et al. | Dec 2016 | B2 |
| 9514932 | Mallick et al. | Dec 2016 | B2 |
| 9543180 | Kamiya | Jan 2017 | B2 |
| 9556516 | Takamure | Jan 2017 | B2 |
| 9558931 | Tang | Jan 2017 | B2 |
| 9564314 | Takamure et al. | Feb 2017 | B2 |
| 9574268 | Dunn et al. | Feb 2017 | B1 |
| 9589770 | Winkler | Mar 2017 | B2 |
| 9605342 | Alokozai et al. | Mar 2017 | B2 |
| 9605343 | Winkler | Mar 2017 | B2 |
| 9607837 | Namba | Mar 2017 | B1 |
| D783351 | Fujino et al. | Apr 2017 | S |
| 9613801 | Carcasi et al. | Apr 2017 | B2 |
| 9627221 | Zaitsu et al. | Apr 2017 | B1 |
| D785766 | Sato | May 2017 | S |
| D787458 | Kim et al. | May 2017 | S |
| 9640416 | Arai | May 2017 | B2 |
| 9640448 | Ikegawa et al. | May 2017 | B2 |
| 9647114 | Margetis | May 2017 | B2 |
| 9657845 | Shugrue | May 2017 | B2 |
| 9659799 | Lawson | May 2017 | B2 |
| 9663857 | Nakano et al. | May 2017 | B2 |
| D789888 | Jang et al. | Jun 2017 | S |
| 9685320 | Kang et al. | Jun 2017 | B2 |
| 9691771 | Lansalot-Matras | Jun 2017 | B2 |
| 9698031 | Kobayashi et al. | Jul 2017 | B2 |
| 9708707 | Ditizio et al. | Jul 2017 | B2 |
| 9708708 | Isobe et al. | Jul 2017 | B2 |
| 9711345 | Shiba et al. | Jul 2017 | B2 |
| D793352 | Hill | Aug 2017 | S |
| D793572 | Kozuka et al. | Aug 2017 | S |
| 9735024 | Zaitsu | Aug 2017 | B2 |
| 9741559 | Shimura et al. | Aug 2017 | B2 |
| 9748145 | Kannan et al. | Aug 2017 | B1 |
| D796458 | Jang et al. | Sep 2017 | S |
| 9754779 | Ishikawa | Sep 2017 | B1 |
| 9754818 | Shin et al. | Sep 2017 | B2 |
| 9759489 | Kaneko | Sep 2017 | B2 |
| 9790595 | Jung et al. | Oct 2017 | B2 |
| 9793115 | Tolle | Oct 2017 | B2 |
| 9793135 | Zaitsu et al. | Oct 2017 | B1 |
| 9793148 | Yamagishi et al. | Oct 2017 | B2 |
| D802546 | Jang et al. | Nov 2017 | S |
| 9808246 | Shelton et al. | Nov 2017 | B2 |
| 9812319 | Fukazawa et al. | Nov 2017 | B1 |
| 9812320 | Pore et al. | Nov 2017 | B1 |
| 9859151 | Niskanen | Jan 2018 | B1 |
| 9887082 | Pore et al. | Feb 2018 | B1 |
| 9890456 | Tolle et al. | Feb 2018 | B2 |
| 9891521 | Kang et al. | Feb 2018 | B2 |
| 9892908 | Pettinger et al. | Feb 2018 | B2 |
| 9892913 | Margetis et al. | Feb 2018 | B2 |
| 9899291 | Kato | Feb 2018 | B2 |
| 9899405 | Kim | Feb 2018 | B2 |
| 9905420 | Margetis et al. | Feb 2018 | B2 |
| 9909492 | Tang | Feb 2018 | B2 |
| 9909214 | Suemori | Mar 2018 | B2 |
| 9911676 | Tang | Mar 2018 | B2 |
| 9916980 | Knaepen | Mar 2018 | B1 |
| 9929011 | Hawryluk et al. | Mar 2018 | B2 |
| 9960072 | Coomer | May 2018 | B2 |
| 9984869 | Blanquart | May 2018 | B1 |
| 10032628 | Xie et al. | Jun 2018 | B2 |
| 10023960 | Alokozai | Jul 2018 | B2 |
| 10032792 | Kim et al. | Jul 2018 | B2 |
| 10043661 | Kato et al. | Aug 2018 | B2 |
| 10083836 | Milligan | Sep 2018 | B2 |
| D830981 | Jeong et al. | Oct 2018 | S |
| 10087522 | Raisanen et al. | Oct 2018 | B2 |
| 10087525 | Schmotzer et al. | Oct 2018 | B2 |
| 10090316 | Ootsuka | Oct 2018 | B2 |
| 10103040 | Oosterlaken et al. | Oct 2018 | B1 |
| 20010001953 | Griffiths et al. | May 2001 | A1 |
| 20010003191 | Kovacs et al. | Jun 2001 | A1 |
| 20010006070 | Shang | Jul 2001 | A1 |
| 20010007645 | Honma | Jul 2001 | A1 |
| 20010014514 | Geusic | Aug 2001 | A1 |
| 20010017103 | Takeshita et al. | Aug 2001 | A1 |
| 20010018267 | Shinriki et al. | Aug 2001 | A1 |
| 20010019777 | Tanaka et al. | Sep 2001 | A1 |
| 20010019900 | Hasegawa | Sep 2001 | A1 |
| 20010020715 | Yamasaki | Sep 2001 | A1 |
| 20010028924 | Sherman | Oct 2001 | A1 |
| 20010031535 | Agnello et al. | Oct 2001 | A1 |
| 20010038783 | Nakashima et al. | Nov 2001 | A1 |
| 20010040511 | Bushner et al. | Nov 2001 | A1 |
| 20010046765 | Cappellani et al. | Nov 2001 | A1 |
| 20010049080 | Asano | Dec 2001 | A1 |
| 20010049202 | Maeda et al. | Dec 2001 | A1 |
| 20020001974 | Chan | Jan 2002 | A1 |
| 20020001976 | Danek | Jan 2002 | A1 |
| 20020005400 | Gat et al. | Jan 2002 | A1 |
| 20020009119 | Matthew et al. | Jan 2002 | A1 |
| 20020011210 | Satoh et al. | Jan 2002 | A1 |
| 20020011211 | Halpin | Jan 2002 | A1 |
| 20020013792 | Imielinski et al. | Jan 2002 | A1 |
| 20020014204 | Pyo | Feb 2002 | A1 |
| 20020014483 | Suzuki et al. | Feb 2002 | A1 |
| 20020016829 | Defosse | Feb 2002 | A1 |
| 20020023677 | Zheng | Feb 2002 | A1 |
| 20020031644 | Malofsky et al. | Mar 2002 | A1 |
| 20020041931 | Suntola et al. | Apr 2002 | A1 |
| 20020043337 | Goodman et al. | Apr 2002 | A1 |
| 20020081826 | Rotondaro et al. | Apr 2002 | A1 |
| 20020064592 | Datta et al. | May 2002 | A1 |
| 20020064598 | Wang et al. | May 2002 | A1 |
| 20020069222 | McNeely | Jun 2002 | A1 |
| 20020076507 | Chiang et al. | Jun 2002 | A1 |
| 20020078893 | Van Os et al. | Jun 2002 | A1 |
| 20020079714 | Soucy et al. | Jun 2002 | A1 |
| 20020088542 | Nishikawa et al. | Jul 2002 | A1 |
| 20020096211 | Zheng | Jul 2002 | A1 |
| 20020098627 | Pomarede et al. | Jul 2002 | A1 |
| 20020108670 | Baker et al. | Aug 2002 | A1 |
| 20020109115 | Cederstav et al. | Aug 2002 | A1 |
| 20020110695 | Yang et al. | Aug 2002 | A1 |
| 20020110991 | Li | Aug 2002 | A1 |
| 20020112114 | Blair et al. | Aug 2002 | A1 |
| 20020114886 | Chou et al. | Aug 2002 | A1 |
| 20020115252 | Haukka et al. | Aug 2002 | A1 |
| 20020124883 | Zheng | Sep 2002 | A1 |
| 20020127350 | Ishikawa et al. | Sep 2002 | A1 |
| 20020134511 | Ushioda et al. | Sep 2002 | A1 |
| 20020136214 | Do et al. | Sep 2002 | A1 |
| 20020136909 | Yang | Sep 2002 | A1 |
| 20020139775 | Chang | Oct 2002 | A1 |
| 20020146512 | Rossman | Oct 2002 | A1 |
| 20020151327 | Levitt | Oct 2002 | A1 |
| 20020152244 | Dean et al. | Oct 2002 | A1 |
| 20020155219 | Wang et al. | Oct 2002 | A1 |
| 20020164420 | Derderian et al. | Nov 2002 | A1 |
| 20020172768 | Endo et al. | Nov 2002 | A1 |
| 20020174106 | Martin | Nov 2002 | A1 |
| 20020179011 | Jonnalagadda et al. | Dec 2002 | A1 |
| 20020184111 | Swanson | Dec 2002 | A1 |
| 20020187650 | Blalock et al. | Dec 2002 | A1 |
| 20020187656 | Tan et al. | Dec 2002 | A1 |
| 20020197849 | Mandal | Dec 2002 | A1 |
| 20030002562 | Yerlikaya et al. | Jan 2003 | A1 |
| 20030003607 | Kagoshima | Jan 2003 | A1 |
| 20030003635 | Paranjpe et al. | Jan 2003 | A1 |
| 20030003696 | Gelatos et al. | Jan 2003 | A1 |
| 20030010451 | Tzu | Jan 2003 | A1 |
| 20030010452 | Park et al. | Jan 2003 | A1 |
| 20030012632 | Saeki | Jan 2003 | A1 |
| 20030015294 | Wang | Jan 2003 | A1 |
| 20030015596 | Evans | Jan 2003 | A1 |
| 20030017268 | Hu | Jan 2003 | A1 |
| 20030019428 | Ku et al. | Jan 2003 | A1 |
| 20030019580 | Strang | Jan 2003 | A1 |
| 20030022523 | Irino et al. | Jan 2003 | A1 |
| 20030023338 | Chin et al. | Jan 2003 | A1 |
| 20030024901 | Ishikawa | Feb 2003 | A1 |
| 20030025146 | Narwankar et al. | Feb 2003 | A1 |
| 20030029303 | Hasegawa et al. | Feb 2003 | A1 |
| 20030029381 | Nishibayashi | Feb 2003 | A1 |
| 20030029475 | Hua et al. | Feb 2003 | A1 |
| 20030035002 | Moles | Feb 2003 | A1 |
| 20030036272 | Shamouilian et al. | Feb 2003 | A1 |
| 20030040158 | Saitoh | Feb 2003 | A1 |
| 20030040841 | Nasr et al. | Feb 2003 | A1 |
| 20030042419 | Katsumata et al. | Mar 2003 | A1 |
| 20030049372 | Cook et al. | Mar 2003 | A1 |
| 20030049375 | Nguyen et al. | Mar 2003 | A1 |
| 20030049937 | Suzuki | Mar 2003 | A1 |
| 20030054670 | Wang et al. | Mar 2003 | A1 |
| 20030059535 | Luo et al. | Mar 2003 | A1 |
| 20030059980 | Chen et al. | Mar 2003 | A1 |
| 20030065413 | Liteplo et al. | Apr 2003 | A1 |
| 20030066826 | Lee et al. | Apr 2003 | A1 |
| 20030071015 | Chinn et al. | Apr 2003 | A1 |
| 20030075925 | Lindfors et al. | Apr 2003 | A1 |
| 20030082296 | Elers et al. | May 2003 | A1 |
| 20030082307 | Chung et al. | May 2003 | A1 |
| 20030091938 | Fairbairn et al. | May 2003 | A1 |
| 20030094133 | Yoshidome et al. | May 2003 | A1 |
| 20030109107 | Hsieh et al. | Jun 2003 | A1 |
| 20030109951 | Hsiung et al. | Jun 2003 | A1 |
| 20030111963 | Tolmachev et al. | Jun 2003 | A1 |
| 20030116087 | Nguyen | Jun 2003 | A1 |
| 20030168750 | Basceri et al. | Jun 2003 | A1 |
| 20030121608 | Chen | Jul 2003 | A1 |
| 20030133854 | Tabata et al. | Jul 2003 | A1 |
| 20030134038 | Paranjpe | Jul 2003 | A1 |
| 20030141820 | White et al. | Jul 2003 | A1 |
| 20030143328 | Chen | Jul 2003 | A1 |
| 20030157436 | Manger et al. | Aug 2003 | A1 |
| 20030159656 | Tan | Aug 2003 | A1 |
| 20030168001 | Sneh | Sep 2003 | A1 |
| 20030168699 | Honda | Sep 2003 | A1 |
| 20030170583 | Nakashima | Sep 2003 | A1 |
| 20030173490 | Lappen | Sep 2003 | A1 |
| 20030180458 | Sneh | Sep 2003 | A1 |
| 20030183156 | Dando | Oct 2003 | A1 |
| 20030183856 | Wieczorek et al. | Oct 2003 | A1 |
| 20030188685 | Wang | Oct 2003 | A1 |
| 20030192875 | Bieker et al. | Oct 2003 | A1 |
| 20030198587 | Kaloyeros | Oct 2003 | A1 |
| 20030201541 | Kim | Oct 2003 | A1 |
| 20030209323 | Yokogaki | Nov 2003 | A1 |
| 20030209326 | Lee et al. | Nov 2003 | A1 |
| 20030211735 | Rossman | Nov 2003 | A1 |
| 20030217915 | Ouellet | Nov 2003 | A1 |
| 20030219972 | Green | Nov 2003 | A1 |
| 20030226840 | Dalton | Dec 2003 | A1 |
| 20030228772 | Cowans | Dec 2003 | A1 |
| 20030231698 | Yamaguchi | Dec 2003 | A1 |
| 20030232138 | Tuominen et al. | Dec 2003 | A1 |
| 20030232491 | Yamaguchi | Dec 2003 | A1 |
| 20040002224 | Chono et al. | Jan 2004 | A1 |
| 20040009307 | Koh et al. | Jan 2004 | A1 |
| 20040009679 | Yeo et al. | Jan 2004 | A1 |
| 20040010772 | McKenna et al. | Jan 2004 | A1 |
| 20040013577 | Ganguli et al. | Jan 2004 | A1 |
| 20040013818 | Moon et al. | Jan 2004 | A1 |
| 20040016637 | Yang | Jan 2004 | A1 |
| 20040018304 | Chung et al. | Jan 2004 | A1 |
| 20040018307 | Park et al. | Jan 2004 | A1 |
| 20040018723 | Byun et al. | Jan 2004 | A1 |
| 20040018750 | Sophie et al. | Jan 2004 | A1 |
| 20040023516 | Londergan et al. | Feb 2004 | A1 |
| 20040026372 | Takenaka et al. | Feb 2004 | A1 |
| 20040029052 | Park et al. | Feb 2004 | A1 |
| 20040036129 | Forbes et al. | Feb 2004 | A1 |
| 20040037675 | Zinger et al. | Feb 2004 | A1 |
| 20040048439 | Soman | Mar 2004 | A1 |
| 20040048492 | Ishikawa et al. | Mar 2004 | A1 |
| 20040050325 | Samoilov | Mar 2004 | A1 |
| 20040062081 | Drewes | Apr 2004 | A1 |
| 20040063289 | Ohta | Apr 2004 | A1 |
| 20040071897 | Verplancken et al. | Apr 2004 | A1 |
| 20040077182 | Lim et al. | Apr 2004 | A1 |
| 20040079960 | Shakuda | Apr 2004 | A1 |
| 20040080697 | Song | Apr 2004 | A1 |
| 20040082171 | Shin et al. | Apr 2004 | A1 |
| 20040087141 | Ramanathan et al. | May 2004 | A1 |
| 20040094402 | Gopalraja | May 2004 | A1 |
| 20040099213 | Adomaitis et al. | May 2004 | A1 |
| 20040101622 | Park et al. | May 2004 | A1 |
| 20040103914 | Cheng et al. | Jun 2004 | A1 |
| 20040106249 | Huotari | Jun 2004 | A1 |
| 20040124131 | Aitchison | Jul 2004 | A1 |
| 20040124549 | Curran | Jul 2004 | A1 |
| 20040126990 | Ohta | Jul 2004 | A1 |
| 20040129211 | Blonigan et al. | Jul 2004 | A1 |
| 20040129671 | Ji et al. | Jul 2004 | A1 |
| 20040134429 | Yamanaka | Jul 2004 | A1 |
| 20040144311 | Chen | Jul 2004 | A1 |
| 20040144980 | Ahn et al. | Jul 2004 | A1 |
| 20040146644 | Xia et al. | Jul 2004 | A1 |
| 20040151844 | Zhang et al. | Aug 2004 | A1 |
| 20040151845 | Nguyen et al. | Aug 2004 | A1 |
| 20040152287 | Sherrill et al. | Aug 2004 | A1 |
| 20040159343 | Shimbara et al. | Aug 2004 | A1 |
| 20040168627 | Conley et al. | Sep 2004 | A1 |
| 20040169032 | Murayama et al. | Sep 2004 | A1 |
| 20040187777 | Okamoto et al. | Sep 2004 | A1 |
| 20040187790 | Bader | Sep 2004 | A1 |
| 20040187928 | Ambrosina | Sep 2004 | A1 |
| 20040198069 | Metzner et al. | Oct 2004 | A1 |
| 20040200499 | Harvey et al. | Oct 2004 | A1 |
| 20040203251 | Kawaguchi et al. | Oct 2004 | A1 |
| 20040206305 | Choi et al. | Oct 2004 | A1 |
| 20040209477 | Buxbaum et al. | Oct 2004 | A1 |
| 20040211357 | Gadgil | Oct 2004 | A1 |
| 20040212947 | Nguyen | Oct 2004 | A1 |
| 20040213921 | Leu | Oct 2004 | A1 |
| 20040214399 | Ahn et al. | Oct 2004 | A1 |
| 20040214445 | Shimizu et al. | Oct 2004 | A1 |
| 20040217217 | Han et al. | Nov 2004 | A1 |
| 20040219793 | Hishiya et al. | Nov 2004 | A1 |
| 20040221807 | Verghese et al. | Nov 2004 | A1 |
| 20040231600 | Lee | Nov 2004 | A1 |
| 20040238523 | Kuibira et al. | Dec 2004 | A1 |
| 20040241998 | Hanson | Dec 2004 | A1 |
| 20040247779 | Selvamanickam et al. | Dec 2004 | A1 |
| 20040250600 | Bevers et al. | Dec 2004 | A1 |
| 20040253867 | Matsumoto | Dec 2004 | A1 |
| 20040261712 | Hayashi et al. | Dec 2004 | A1 |
| 20040266011 | Lee et al. | Dec 2004 | A1 |
| 20050000428 | Shero et al. | Jan 2005 | A1 |
| 20050003662 | Jurisch et al. | Jan 2005 | A1 |
| 20050008799 | Tomiyasu et al. | Jan 2005 | A1 |
| 20050019026 | Wang et al. | Jan 2005 | A1 |
| 20050019494 | Moghadam et al. | Jan 2005 | A1 |
| 20050020071 | Sonobe et al. | Jan 2005 | A1 |
| 20050023624 | Ahn et al. | Feb 2005 | A1 |
| 20050034674 | Ono | Feb 2005 | A1 |
| 20050037154 | Koh et al. | Feb 2005 | A1 |
| 20050037610 | Cha | Feb 2005 | A1 |
| 20050042778 | Peukert | Feb 2005 | A1 |
| 20050048797 | Fukazawa | Mar 2005 | A1 |
| 20050051093 | Makino et al. | Mar 2005 | A1 |
| 20050054228 | March | Mar 2005 | A1 |
| 20050059262 | Yin et al. | Mar 2005 | A1 |
| 20050064207 | Senzaki et al. | Mar 2005 | A1 |
| 20050064719 | Liu | Mar 2005 | A1 |
| 20050066893 | Soininen | Mar 2005 | A1 |
| 20050069651 | Miyoshi | Mar 2005 | A1 |
| 20050070123 | Hirano | Mar 2005 | A1 |
| 20050070729 | Kiyomori et al. | Mar 2005 | A1 |
| 20050072357 | Shero et al. | Apr 2005 | A1 |
| 20050074983 | Shinriki et al. | Apr 2005 | A1 |
| 20050092247 | Schmidt | May 2005 | A1 |
| 20050092249 | Kilpela et al. | May 2005 | A1 |
| 20050092733 | Ito et al. | May 2005 | A1 |
| 20050095770 | Kumagai et al. | May 2005 | A1 |
| 20050098107 | Du Bois et al. | May 2005 | A1 |
| 20050100669 | Kools et al. | May 2005 | A1 |
| 20050101154 | Huang | May 2005 | A1 |
| 20050101843 | Quinn et al. | May 2005 | A1 |
| 20050106893 | Wilk | May 2005 | A1 |
| 20050110069 | Kil et al. | May 2005 | A1 |
| 20050118804 | Byun et al. | Jun 2005 | A1 |
| 20050118837 | Todd | Jun 2005 | A1 |
| 20050120805 | Lane | Jun 2005 | A1 |
| 20050120962 | Ushioda et al. | Jun 2005 | A1 |
| 20050123690 | Derderian et al. | Jun 2005 | A1 |
| 20050130427 | Seok-Jun | Jun 2005 | A1 |
| 20050132957 | El-Raghy | Jun 2005 | A1 |
| 20050133161 | Carpenter et al. | Jun 2005 | A1 |
| 20050141591 | Sakano | Jun 2005 | A1 |
| 20050142361 | Nakanishi | Jun 2005 | A1 |
| 20050145338 | Park et al. | Jul 2005 | A1 |
| 20050153571 | Senzaki | Jul 2005 | A1 |
| 20050172895 | Kijima et al. | Aug 2005 | A1 |
| 20050173003 | Laverdiere et al. | Aug 2005 | A1 |
| 20050175789 | Helms | Aug 2005 | A1 |
| 20050181535 | Yun et al. | Aug 2005 | A1 |
| 20050181555 | Haukka et al. | Aug 2005 | A1 |
| 20050187647 | Wang et al. | Aug 2005 | A1 |
| 20050191828 | Al-Bayati et al. | Sep 2005 | A1 |
| 20050199013 | Vandroux et al. | Sep 2005 | A1 |
| 20050208718 | Lim et al. | Sep 2005 | A1 |
| 20050211167 | Gunji | Sep 2005 | A1 |
| 20050212119 | Shero | Sep 2005 | A1 |
| 20050214457 | Schmitt et al. | Sep 2005 | A1 |
| 20050214458 | Meiere | Sep 2005 | A1 |
| 20050208778 | Li | Oct 2005 | A1 |
| 20050218462 | Ahn et al. | Oct 2005 | A1 |
| 20050221618 | AmRhein et al. | Oct 2005 | A1 |
| 20050223982 | Park et al. | Oct 2005 | A1 |
| 20050223994 | Blomiley et al. | Oct 2005 | A1 |
| 20050227502 | Schmitt et al. | Oct 2005 | A1 |
| 20050229848 | Shinriki | Oct 2005 | A1 |
| 20050229849 | Silvetti et al. | Oct 2005 | A1 |
| 20050229972 | Hoshi et al. | Oct 2005 | A1 |
| 20050233477 | Yamazaki et al. | Oct 2005 | A1 |
| 20050241176 | Shero et al. | Nov 2005 | A1 |
| 20050241763 | Huang et al. | Nov 2005 | A1 |
| 20050245058 | Lee et al. | Nov 2005 | A1 |
| 20050249876 | Kawahara et al. | Nov 2005 | A1 |
| 20050250340 | Chen et al. | Nov 2005 | A1 |
| 20050251990 | Choi | Nov 2005 | A1 |
| 20050252449 | Nguyen et al. | Nov 2005 | A1 |
| 20050255257 | Choi et al. | Nov 2005 | A1 |
| 20050258280 | Goto et al. | Nov 2005 | A1 |
| 20050260347 | Narwankar et al. | Nov 2005 | A1 |
| 20050260850 | Loke | Nov 2005 | A1 |
| 20050263072 | Balasubramanian et al. | Dec 2005 | A1 |
| 20050263075 | Wang et al. | Dec 2005 | A1 |
| 20050263932 | Heugel | Dec 2005 | A1 |
| 20050271813 | Kher et al. | Dec 2005 | A1 |
| 20050274323 | Seidel et al. | Dec 2005 | A1 |
| 20050277271 | Beintner | Dec 2005 | A1 |
| 20050282101 | Adachi | Dec 2005 | A1 |
| 20050285097 | Shang et al. | Dec 2005 | A1 |
| 20050287725 | Kitagawa | Dec 2005 | A1 |
| 20050287771 | Seamons et al. | Dec 2005 | A1 |
| 20060000411 | Seo | Jan 2006 | A1 |
| 20060013674 | Elliott et al. | Jan 2006 | A1 |
| 20060013946 | Park et al. | Jan 2006 | A1 |
| 20060014384 | Lee et al. | Jan 2006 | A1 |
| 20060014397 | Seamons et al. | Jan 2006 | A1 |
| 20060016783 | Wu et al. | Jan 2006 | A1 |
| 20060019033 | Muthukrishnan et al. | Jan 2006 | A1 |
| 20060019502 | Park et al. | Jan 2006 | A1 |
| 20060021572 | Wolden | Feb 2006 | A1 |
| 20060021703 | Umotoy et al. | Feb 2006 | A1 |
| 20060024439 | Tuominen et al. | Feb 2006 | A2 |
| 20060026314 | Franchuk et al. | Feb 2006 | A1 |
| 20060040054 | Pearlstein et al. | Feb 2006 | A1 |
| 20060040508 | Ji | Feb 2006 | A1 |
| 20060046518 | Hill et al. | Mar 2006 | A1 |
| 20060051520 | Behle et al. | Mar 2006 | A1 |
| 20060051925 | Ahn et al. | Mar 2006 | A1 |
| 20060057828 | Omura | Mar 2006 | A1 |
| 20060060930 | Metz et al. | Mar 2006 | A1 |
| 20060062910 | Meiere | Mar 2006 | A1 |
| 20060063346 | Lee et al. | Mar 2006 | A1 |
| 20060068104 | Ishizaka | Mar 2006 | A1 |
| 20060068121 | Lee et al. | Mar 2006 | A1 |
| 20060068125 | Radhakrishnan | Mar 2006 | A1 |
| 20060087638 | Hirayanagi | Apr 2006 | A1 |
| 20060096540 | Choi | May 2006 | A1 |
| 20060099782 | Ritenour | May 2006 | A1 |
| 20060105566 | Waldfried et al. | May 2006 | A1 |
| 20060107898 | Blomberg | May 2006 | A1 |
| 20060110934 | Fukuchi | May 2006 | A1 |
| 20060113675 | Chang et al. | Jun 2006 | A1 |
| 20060113806 | Tsuji et al. | Jun 2006 | A1 |
| 20060128142 | Whelan et al. | Jun 2006 | A1 |
| 20060128168 | Ahn et al. | Jun 2006 | A1 |
| 20060130767 | Herchen | Jun 2006 | A1 |
| 20060137609 | Puchacz et al. | Jun 2006 | A1 |
| 20060147626 | Blomberg | Jul 2006 | A1 |
| 20060148180 | Ahn et al. | Jul 2006 | A1 |
| 20060154424 | Yang et al. | Jul 2006 | A1 |
| 20060156981 | Fondurulia | Jul 2006 | A1 |
| 20060163612 | Kouvetakis et al. | Jul 2006 | A1 |
| 20060166428 | Kamioka | Jul 2006 | A1 |
| 20060172531 | Lin et al. | Aug 2006 | A1 |
| 20060175669 | Kim et al. | Aug 2006 | A1 |
| 20060177855 | Utermohlen | Aug 2006 | A1 |
| 20060182885 | Lei et al. | Aug 2006 | A1 |
| 20060188360 | Bonora et al. | Aug 2006 | A1 |
| 20060191555 | Yoshida et al. | Aug 2006 | A1 |
| 20060193979 | Meiere et al. | Aug 2006 | A1 |
| 20060196420 | Ushakov et al. | Sep 2006 | A1 |
| 20060199357 | Wan et al. | Sep 2006 | A1 |
| 20060205223 | Smayling | Sep 2006 | A1 |
| 20060208215 | Metzner et al. | Sep 2006 | A1 |
| 20060211243 | Ishizaka et al. | Sep 2006 | A1 |
| 20060211259 | Maes | Sep 2006 | A1 |
| 20060213439 | Ishizaka | Sep 2006 | A1 |
| 20060216942 | Kim et al. | Sep 2006 | A1 |
| 20060219169 | Chen et al. | Oct 2006 | A1 |
| 20060223301 | Vanhaelemeersch et al. | Oct 2006 | A1 |
| 20060226117 | Bertram et al. | Oct 2006 | A1 |
| 20060228496 | Choi | Oct 2006 | A1 |
| 20060228863 | Zhang et al. | Oct 2006 | A1 |
| 20060228888 | Lee et al. | Oct 2006 | A1 |
| 20060236934 | Choi et al. | Oct 2006 | A1 |
| 20060240574 | Yoshie | Oct 2006 | A1 |
| 20060240662 | Conley et al. | Oct 2006 | A1 |
| 20060249253 | Dando | Nov 2006 | A1 |
| 20060251827 | Nowak | Nov 2006 | A1 |
| 20060252228 | Jeng | Nov 2006 | A1 |
| 20060252351 | Kundracik | Nov 2006 | A1 |
| 20060257563 | Doh et al. | Nov 2006 | A1 |
| 20060257584 | Derderian et al. | Nov 2006 | A1 |
| 20060258078 | Lee et al. | Nov 2006 | A1 |
| 20060258173 | Xiao et al. | Nov 2006 | A1 |
| 20060260545 | Ramaswamy et al. | Nov 2006 | A1 |
| 20060263522 | Byun | Nov 2006 | A1 |
| 20060264060 | Ramaswamy et al. | Nov 2006 | A1 |
| 20060264066 | Bartholomew | Nov 2006 | A1 |
| 20060266289 | Verghese et al. | Nov 2006 | A1 |
| 20060269690 | Watanabe et al. | Nov 2006 | A1 |
| 20060269692 | Balseanu | Nov 2006 | A1 |
| 20060275933 | Du Bois et al. | Dec 2006 | A1 |
| 20060278524 | Stowell | Dec 2006 | A1 |
| 20060283629 | Kikuchi et al. | Dec 2006 | A1 |
| 20060286774 | Singh et al. | Dec 2006 | A1 |
| 20060286775 | Singh et al. | Dec 2006 | A1 |
| 20060286818 | Wang et al. | Dec 2006 | A1 |
| 20060286819 | Seutter | Dec 2006 | A1 |
| 20060291982 | Tanaka | Dec 2006 | A1 |
| 20070006806 | Imai | Jan 2007 | A1 |
| 20070010072 | Bailey et al. | Jan 2007 | A1 |
| 20070012402 | Sneh | Jan 2007 | A1 |
| 20070020830 | Speranza | Jan 2007 | A1 |
| 20070020953 | Tsai et al. | Jan 2007 | A1 |
| 20070022954 | Iizuka et al. | Feb 2007 | A1 |
| 20070026148 | Arai et al. | Feb 2007 | A1 |
| 20070028842 | Inagawa et al. | Feb 2007 | A1 |
| 20070031598 | Okuyama et al. | Feb 2007 | A1 |
| 20070031599 | Gschwandtner et al. | Feb 2007 | A1 |
| 20070032082 | Ramaswamy et al. | Feb 2007 | A1 |
| 20070034477 | Inui | Feb 2007 | A1 |
| 20070037412 | Dip et al. | Feb 2007 | A1 |
| 20070042117 | Kupurao et al. | Feb 2007 | A1 |
| 20070049053 | Mahajani | Mar 2007 | A1 |
| 20070054499 | Jang | Mar 2007 | A1 |
| 20070056843 | Ye et al. | Mar 2007 | A1 |
| 20070056850 | Ye et al. | Mar 2007 | A1 |
| 20070059948 | Metzner et al. | Mar 2007 | A1 |
| 20070062439 | Wada et al. | Mar 2007 | A1 |
| 20070062453 | Ishikawa | Mar 2007 | A1 |
| 20070065578 | McDougall | Mar 2007 | A1 |
| 20070066010 | Ando | Mar 2007 | A1 |
| 20070066079 | Kolster et al. | Mar 2007 | A1 |
| 20070066084 | Wajda et al. | Mar 2007 | A1 |
| 20070077355 | Chacin et al. | Apr 2007 | A1 |
| 20070082132 | Shinriki | Apr 2007 | A1 |
| 20070082500 | Norman et al. | Apr 2007 | A1 |
| 20070084405 | Kim | Apr 2007 | A1 |
| 20070087579 | Kitayama et al. | Apr 2007 | A1 |
| 20070089670 | Ikedo | Apr 2007 | A1 |
| 20070096194 | Streck et al. | May 2007 | A1 |
| 20070098527 | Hall et al. | May 2007 | A1 |
| 20070107845 | Ishizawa et al. | May 2007 | A1 |
| 20070111470 | Smythe | May 2007 | A1 |
| 20070111545 | Lee et al. | May 2007 | A1 |
| 20070116873 | Li et al. | May 2007 | A1 |
| 20070116888 | Faguet | May 2007 | A1 |
| 20070119370 | Ma et al. | May 2007 | A1 |
| 20070123037 | Lee et al. | May 2007 | A1 |
| 20070123189 | Saito et al. | May 2007 | A1 |
| 20070125762 | Cui et al. | Jun 2007 | A1 |
| 20070128538 | Fairbairn et al. | Jun 2007 | A1 |
| 20070128876 | Fukiage | Jun 2007 | A1 |
| 20070128888 | Goto et al. | Jun 2007 | A1 |
| 20070129621 | Kellogg et al. | Jun 2007 | A1 |
| 20070134942 | Ahn et al. | Jun 2007 | A1 |
| 20070137794 | Qiu et al. | Jun 2007 | A1 |
| 20070146621 | Yeom | Jun 2007 | A1 |
| 20070148350 | Rahtu | Jun 2007 | A1 |
| 20070148990 | Deboer et al. | Jun 2007 | A1 |
| 20070155138 | Tomasini et al. | Jul 2007 | A1 |
| 20070157466 | Kida et al. | Jul 2007 | A1 |
| 20070158026 | Amikura | Jul 2007 | A1 |
| 20070163440 | Kim et al. | Jul 2007 | A1 |
| 20070163625 | Lee | Jul 2007 | A1 |
| 20070166457 | Yamoto et al. | Jul 2007 | A1 |
| 20070166966 | Todd et al. | Jul 2007 | A1 |
| 20070166999 | Vaarstra | Jul 2007 | A1 |
| 20070173071 | Afzali-Ardakani et al. | Jul 2007 | A1 |
| 20070175393 | Nishimura et al. | Aug 2007 | A1 |
| 20070175397 | Tomiyasu et al. | Aug 2007 | A1 |
| 20070178235 | Yamada et al. | Aug 2007 | A1 |
| 20070186952 | Honda et al. | Aug 2007 | A1 |
| 20070187363 | Oka et al. | Aug 2007 | A1 |
| 20070202678 | Plombon et al. | Aug 2007 | A1 |
| 20070207275 | Nowak et al. | Sep 2007 | A1 |
| 20070209590 | Li | Sep 2007 | A1 |
| 20070210890 | Hsu et al. | Sep 2007 | A1 |
| 20070215048 | Suzuki et al. | Sep 2007 | A1 |
| 20070218200 | Suzuki et al. | Sep 2007 | A1 |
| 20070218705 | Matsuki et al. | Sep 2007 | A1 |
| 20070224777 | Hamelin | Sep 2007 | A1 |
| 20070224833 | Morisada et al. | Sep 2007 | A1 |
| 20070232031 | Singh et al. | Oct 2007 | A1 |
| 20070232071 | Balseanu et al. | Oct 2007 | A1 |
| 20070232501 | Tonomura | Oct 2007 | A1 |
| 20070234955 | Suzuki et al. | Oct 2007 | A1 |
| 20070237697 | Clark | Oct 2007 | A1 |
| 20070237698 | Clark | Oct 2007 | A1 |
| 20070237699 | Clark | Oct 2007 | A1 |
| 20070241688 | DeVancentis et al. | Oct 2007 | A1 |
| 20070248767 | Okura | Oct 2007 | A1 |
| 20070249131 | Allen et al. | Oct 2007 | A1 |
| 20070251444 | Gros-Jean et al. | Nov 2007 | A1 |
| 20070251456 | Herchen et al. | Nov 2007 | A1 |
| 20070252244 | Srividya et al. | Nov 2007 | A1 |
| 20070252532 | DeVancentis et al. | Nov 2007 | A1 |
| 20070258506 | Schwagerman et al. | Nov 2007 | A1 |
| 20070264807 | Leone et al. | Nov 2007 | A1 |
| 20070266945 | Shuto et al. | Nov 2007 | A1 |
| 20070269983 | Sneh | Nov 2007 | A1 |
| 20070275166 | Thridandam et al. | Nov 2007 | A1 |
| 20070277735 | Mokhesi et al. | Dec 2007 | A1 |
| 20070281082 | Mokhesi et al. | Dec 2007 | A1 |
| 20070281105 | Mokhesi et al. | Dec 2007 | A1 |
| 20070281496 | Ingle et al. | Dec 2007 | A1 |
| 20070298362 | Rocha-Alvarez et al. | Dec 2007 | A1 |
| 20080003824 | Padhi et al. | Jan 2008 | A1 |
| 20080003838 | Haukka et al. | Jan 2008 | A1 |
| 20080006208 | Ueno et al. | Jan 2008 | A1 |
| 20080018004 | Steidl | Jan 2008 | A1 |
| 20080020591 | Balseanu et al. | Jan 2008 | A1 |
| 20080020593 | Wang et al. | Jan 2008 | A1 |
| 20080023436 | Gros-Jean et al. | Jan 2008 | A1 |
| 20080026574 | Brcka | Jan 2008 | A1 |
| 20080026597 | Munro et al. | Jan 2008 | A1 |
| 20080029790 | Ahn et al. | Feb 2008 | A1 |
| 20080031708 | Bonora et al. | Feb 2008 | A1 |
| 20080036354 | Letz et al. | Feb 2008 | A1 |
| 20080038485 | Fukazawa et al. | Feb 2008 | A1 |
| 20080042165 | Sugizaki | Feb 2008 | A1 |
| 20080043803 | Bandoh | Feb 2008 | A1 |
| 20080050536 | Aing et al. | Feb 2008 | A1 |
| 20080050538 | Hirata | Feb 2008 | A1 |
| 20080054332 | Kim et al. | Mar 2008 | A1 |
| 20080054813 | Espiau et al. | Mar 2008 | A1 |
| 20080056860 | Natume | Mar 2008 | A1 |
| 20080057659 | Forbes et al. | Mar 2008 | A1 |
| 20080061667 | Gaertner et al. | Mar 2008 | A1 |
| 20080066778 | Matsushita et al. | Mar 2008 | A1 |
| 20080069955 | Hong et al. | Mar 2008 | A1 |
| 20080075562 | Maria et al. | Mar 2008 | A1 |
| 20080075881 | Won et al. | Mar 2008 | A1 |
| 20080076266 | Fukazawa et al. | Mar 2008 | A1 |
| 20080081104 | Hasebe et al. | Apr 2008 | A1 |
| 20080081113 | Clark | Apr 2008 | A1 |
| 20080081121 | Morita et al. | Apr 2008 | A1 |
| 20080085226 | Fondurulia et al. | Apr 2008 | A1 |
| 20080092815 | Chen et al. | Apr 2008 | A1 |
| 20080102203 | Wu | May 2008 | A1 |
| 20080113094 | Casper | May 2008 | A1 |
| 20080113096 | Mahajani | May 2008 | A1 |
| 20080113097 | Mahajani et al. | May 2008 | A1 |
| 20080118334 | Bonora | May 2008 | A1 |
| 20080121177 | Bang et al. | May 2008 | A1 |
| 20080121626 | Thomas et al. | May 2008 | A1 |
| 20080124197 | van der Meulen et al. | May 2008 | A1 |
| 20080124908 | Forbes et al. | May 2008 | A1 |
| 20080124946 | Xiao et al. | May 2008 | A1 |
| 20080132046 | Walther | Jun 2008 | A1 |
| 20080133154 | Krauss et al. | Jun 2008 | A1 |
| 20080142483 | Hua | Jun 2008 | A1 |
| 20080149031 | Chu et al. | Jun 2008 | A1 |
| 20080152463 | Chidambaram et al. | Jun 2008 | A1 |
| 20080153311 | Padhi et al. | Jun 2008 | A1 |
| 20080157157 | Tonomura | Jul 2008 | A1 |
| 20080157365 | Ott et al. | Jul 2008 | A1 |
| 20080173237 | Collins | Jul 2008 | A1 |
| 20080173238 | Nakashima et al. | Jul 2008 | A1 |
| 20080173240 | Furukawahara | Jul 2008 | A1 |
| 20080173326 | Gu et al. | Jul 2008 | A1 |
| 20080176375 | Erben et al. | Jul 2008 | A1 |
| 20080178805 | Paterson et al. | Jul 2008 | A1 |
| 20080179104 | Zhang | Jul 2008 | A1 |
| 20080179715 | Coppa | Jul 2008 | A1 |
| 20080182075 | Chopra | Jul 2008 | A1 |
| 20080182390 | Lemmi et al. | Jul 2008 | A1 |
| 20080191193 | Li et al. | Aug 2008 | A1 |
| 20080199977 | Weigel et al. | Aug 2008 | A1 |
| 20080202416 | Provencher | Aug 2008 | A1 |
| 20080202689 | Kim | Aug 2008 | A1 |
| 20080203487 | Hohage et al. | Aug 2008 | A1 |
| 20080205483 | Rempe et al. | Aug 2008 | A1 |
| 20080211423 | Shinmen et al. | Sep 2008 | A1 |
| 20080211526 | Shinma | Sep 2008 | A1 |
| 20080216077 | Emani et al. | Sep 2008 | A1 |
| 20080216742 | Takebayashi | Sep 2008 | A1 |
| 20080220619 | Matsushita et al. | Sep 2008 | A1 |
| 20080224240 | Ahn et al. | Sep 2008 | A1 |
| 20080228306 | Yetter et al. | Sep 2008 | A1 |
| 20080233288 | Clark | Sep 2008 | A1 |
| 20080237572 | Chui et al. | Oct 2008 | A1 |
| 20080241384 | Jeong | Oct 2008 | A1 |
| 20080241387 | Keto | Oct 2008 | A1 |
| 20080242116 | Clark | Oct 2008 | A1 |
| 20080248310 | Kim et al. | Oct 2008 | A1 |
| 20080257494 | Hayashi et al. | Oct 2008 | A1 |
| 20080260963 | Yoon et al. | Oct 2008 | A1 |
| 20080261413 | Mahajani | Oct 2008 | A1 |
| 20080264337 | Sano et al. | Oct 2008 | A1 |
| 20080267598 | Nakamura | Oct 2008 | A1 |
| 20080268635 | Yu et al. | Oct 2008 | A1 |
| 20080277715 | Ohmi et al. | Nov 2008 | A1 |
| 20080282970 | Heys et al. | Nov 2008 | A1 |
| 20080283962 | Dyer | Nov 2008 | A1 |
| 20080289574 | Jacobs et al. | Nov 2008 | A1 |
| 20080291964 | Shrimpling | Nov 2008 | A1 |
| 20080295872 | Riker et al. | Dec 2008 | A1 |
| 20080298945 | Cox | Dec 2008 | A1 |
| 20080299326 | Fukazawa | Dec 2008 | A1 |
| 20080299758 | Harada et al. | Dec 2008 | A1 |
| 20080302303 | Choi et al. | Dec 2008 | A1 |
| 20080305014 | Honda | Dec 2008 | A1 |
| 20080305246 | Choi et al. | Dec 2008 | A1 |
| 20080305443 | Nakamura | Dec 2008 | A1 |
| 20080315292 | Ji et al. | Dec 2008 | A1 |
| 20080317972 | Hendriks | Dec 2008 | A1 |
| 20090000550 | Tran et al. | Jan 2009 | A1 |
| 20090000551 | Choi et al. | Jan 2009 | A1 |
| 20090011145 | Yun | Jan 2009 | A1 |
| 20090011608 | Nabatame | Jan 2009 | A1 |
| 20090017631 | Bencher | Jan 2009 | A1 |
| 20090020072 | Mizunaga et al. | Jan 2009 | A1 |
| 20090023229 | Matsushita | Jan 2009 | A1 |
| 20090029503 | Arai | Jan 2009 | A1 |
| 20090029528 | Sanchez et al. | Jan 2009 | A1 |
| 20090029564 | Yamashita et al. | Jan 2009 | A1 |
| 20090033907 | Watson | Feb 2009 | A1 |
| 20090035947 | Horii | Feb 2009 | A1 |
| 20090041952 | Yoon et al. | Feb 2009 | A1 |
| 20090041984 | Mayers et al. | Feb 2009 | A1 |
| 20090042344 | Ye et al. | Feb 2009 | A1 |
| 20090042408 | Maeda | Feb 2009 | A1 |
| 20090045829 | Awazu | Feb 2009 | A1 |
| 20090050621 | Awazu | Feb 2009 | A1 |
| 20090052498 | Halpin et al. | Feb 2009 | A1 |
| 20090053023 | Wakabayashi | Feb 2009 | A1 |
| 20090053906 | Miya et al. | Feb 2009 | A1 |
| 20090056629 | Katz et al. | Mar 2009 | A1 |
| 20090057269 | Katz et al. | Mar 2009 | A1 |
| 20090061083 | Chiang et al. | Mar 2009 | A1 |
| 20090061644 | Chiang et al. | Mar 2009 | A1 |
| 20090061647 | Mallick et al. | Mar 2009 | A1 |
| 20090075491 | Liu et al. | Mar 2009 | A1 |
| 20090085156 | Dewey et al. | Apr 2009 | A1 |
| 20090090382 | Morisada | Apr 2009 | A1 |
| 20090093094 | Ye et al. | Apr 2009 | A1 |
| 20090095221 | Tam et al. | Apr 2009 | A1 |
| 20090104351 | Kakegawa | Apr 2009 | A1 |
| 20090104789 | Mallick et al. | Apr 2009 | A1 |
| 20090107404 | Ogliari et al. | Apr 2009 | A1 |
| 20090108308 | Yang et al. | Apr 2009 | A1 |
| 20090112458 | Nakai | Apr 2009 | A1 |
| 20090120580 | Kagoshima et al. | May 2009 | A1 |
| 20090122293 | Shibazaki | May 2009 | A1 |
| 20090122458 | Lischer et al. | May 2009 | A1 |
| 20090124131 | Breunsbach et al. | May 2009 | A1 |
| 20090130331 | Asai | May 2009 | A1 |
| 20090130859 | Itatani et al. | May 2009 | A1 |
| 20090136668 | Gregg et al. | May 2009 | A1 |
| 20090136683 | Fukasawa et al. | May 2009 | A1 |
| 20090139657 | Lee et al. | Jun 2009 | A1 |
| 20090142905 | Yamazaki | Jun 2009 | A1 |
| 20090142935 | Fukazawa et al. | Jun 2009 | A1 |
| 20090146322 | Weling et al. | Jun 2009 | A1 |
| 20090156015 | Park et al. | Jun 2009 | A1 |
| 20090159000 | Aggarwal et al. | Jun 2009 | A1 |
| 20090159424 | Liu et al. | Jun 2009 | A1 |
| 20090162996 | Ramaswarmy et al. | Jun 2009 | A1 |
| 20090163038 | Miyoshi | Jun 2009 | A1 |
| 20090165715 | Oh | Jul 2009 | A1 |
| 20090179365 | Lerner et al. | Jul 2009 | A1 |
| 20090186571 | Haro | Jul 2009 | A1 |
| 20090197015 | Kudela et al. | Aug 2009 | A1 |
| 20090200494 | Hatem | Aug 2009 | A1 |
| 20090204403 | Hollander et al. | Aug 2009 | A1 |
| 20090206056 | Xu | Aug 2009 | A1 |
| 20090209081 | Matero | Aug 2009 | A1 |
| 20090211523 | Kuppurao et al. | Aug 2009 | A1 |
| 20090211525 | Sarigiannis et al. | Aug 2009 | A1 |
| 20090227094 | Bateman | Sep 2009 | A1 |
| 20090230211 | Kobayashi et al. | Sep 2009 | A1 |
| 20090236014 | Wilson | Sep 2009 | A1 |
| 20090236276 | Kurth et al. | Sep 2009 | A1 |
| 20090239386 | Suzaki et al. | Sep 2009 | A1 |
| 20090242957 | Ma et al. | Oct 2009 | A1 |
| 20090246374 | Vukovic | Oct 2009 | A1 |
| 20090246399 | Goundar | Oct 2009 | A1 |
| 20090246971 | Reid et al. | Oct 2009 | A1 |
| 20090250955 | Aoki | Oct 2009 | A1 |
| 20090255901 | Okita | Oct 2009 | A1 |
| 20090261331 | Yang et al. | Oct 2009 | A1 |
| 20090269506 | Okura et al. | Oct 2009 | A1 |
| 20090269941 | Raisanen | Oct 2009 | A1 |
| 20090275205 | Kiehlbauch et al. | Nov 2009 | A1 |
| 20090277510 | Shikata | Nov 2009 | A1 |
| 20090283041 | Tomiyasu et al. | Nov 2009 | A1 |
| 20090283217 | Lubomirsky et al. | Nov 2009 | A1 |
| 20090286400 | Heo et al. | Nov 2009 | A1 |
| 20090286402 | Xia et al. | Nov 2009 | A1 |
| 20090289300 | Sasaki et al. | Nov 2009 | A1 |
| 20090302434 | Pallem et al. | Dec 2009 | A1 |
| 20090304558 | Patton | Dec 2009 | A1 |
| 20090308315 | de Ridder | Dec 2009 | A1 |
| 20090308425 | Yednak | Dec 2009 | A1 |
| 20090311857 | Todd et al. | Dec 2009 | A1 |
| 20090315093 | Li et al. | Dec 2009 | A1 |
| 20090320754 | Oya | Dec 2009 | A1 |
| 20090325391 | De Vusser et al. | Dec 2009 | A1 |
| 20090325469 | Koo et al. | Dec 2009 | A1 |
| 20100001409 | Humbert et al. | Jan 2010 | A1 |
| 20100003406 | Lam et al. | Jan 2010 | A1 |
| 20100006031 | Choi et al. | Jan 2010 | A1 |
| 20100006923 | Fujitsuka | Jan 2010 | A1 |
| 20100014479 | Kim | Jan 2010 | A1 |
| 20100015813 | McGinnis et al. | Jan 2010 | A1 |
| 20100018460 | Singh et al. | Jan 2010 | A1 |
| 20100024727 | Kim et al. | Feb 2010 | A1 |
| 20100024872 | Kishimoto | Feb 2010 | A1 |
| 20100025796 | Dabiran | Feb 2010 | A1 |
| 20100032587 | Hosch et al. | Feb 2010 | A1 |
| 20100032842 | Herdt et al. | Feb 2010 | A1 |
| 20100040441 | Obikane | Feb 2010 | A1 |
| 20100041179 | Lee | Feb 2010 | A1 |
| 20100041243 | Cheng et al. | Feb 2010 | A1 |
| 20100050943 | Kato et al. | Mar 2010 | A1 |
| 20100051597 | Morita et al. | Mar 2010 | A1 |
| 20100055312 | Kato et al. | Mar 2010 | A1 |
| 20100055442 | Kellock | Mar 2010 | A1 |
| 20100058984 | Marubayashi | Mar 2010 | A1 |
| 20100065758 | Liu et al. | Mar 2010 | A1 |
| 20100068009 | Kimura | Mar 2010 | A1 |
| 20100068891 | Hatanaka et al. | Mar 2010 | A1 |
| 20100075507 | Chang et al. | Mar 2010 | A1 |
| 20100081094 | Hasebe et al. | Apr 2010 | A1 |
| 20100089320 | Kim | Apr 2010 | A1 |
| 20100089870 | Hiroshima et al. | Apr 2010 | A1 |
| 20100090149 | Thompson et al. | Apr 2010 | A1 |
| 20100092696 | Shinriki | Apr 2010 | A1 |
| 20100093187 | Lee et al. | Apr 2010 | A1 |
| 20100102417 | Ganguli et al. | Apr 2010 | A1 |
| 20100105936 | Tada et al. | Apr 2010 | A1 |
| 20100112496 | Nakajima et al. | May 2010 | A1 |
| 20100116207 | Givens | May 2010 | A1 |
| 20100116209 | Kato | May 2010 | A1 |
| 20100124610 | Aikawa et al. | May 2010 | A1 |
| 20100124618 | Kobayashi et al. | May 2010 | A1 |
| 20100124621 | Kobayashi et al. | May 2010 | A1 |
| 20100126415 | Ishino et al. | May 2010 | A1 |
| 20100126539 | Lee et al. | May 2010 | A1 |
| 20100126605 | Stones | May 2010 | A1 |
| 20100129990 | Nishizawa et al. | May 2010 | A1 |
| 20100130015 | Nakajima et al. | May 2010 | A1 |
| 20100130017 | Luo et al. | May 2010 | A1 |
| 20100130105 | Lee | May 2010 | A1 |
| 20100134023 | Mills | Jun 2010 | A1 |
| 20100136216 | Tsuei et al. | Jun 2010 | A1 |
| 20100140221 | Kikuchi et al. | Jun 2010 | A1 |
| 20100143609 | Fukazawa et al. | Jun 2010 | A1 |
| 20100144162 | Lee et al. | Jun 2010 | A1 |
| 20100144968 | Lee et al. | Jun 2010 | A1 |
| 20100145547 | Darabnia et al. | Jun 2010 | A1 |
| 20100151206 | Wu et al. | Jun 2010 | A1 |
| 20100159638 | Jeong | Jun 2010 | A1 |
| 20100162752 | Tabata et al. | Jul 2010 | A1 |
| 20100162956 | Murakami et al. | Jul 2010 | A1 |
| 20100163524 | Arai | Jul 2010 | A1 |
| 20100163937 | Clendenning | Jul 2010 | A1 |
| 20100168404 | Girolami et al. | Jul 2010 | A1 |
| 20100170441 | Won et al. | Jul 2010 | A1 |
| 20100170868 | Lin et al. | Jul 2010 | A1 |
| 20100173432 | White et al. | Jul 2010 | A1 |
| 20100178137 | Chintalapati et al. | Jul 2010 | A1 |
| 20100178423 | Shimizu et al. | Jul 2010 | A1 |
| 20100180819 | Hatanaka et al. | Jul 2010 | A1 |
| 20100183825 | Becker et al. | Jul 2010 | A1 |
| 20100184302 | Lee et al. | Jul 2010 | A1 |
| 20100186669 | Shin et al. | Jul 2010 | A1 |
| 20100193501 | Zucker et al. | Aug 2010 | A1 |
| 20100195392 | Freeman | Aug 2010 | A1 |
| 20100202860 | Reed | Aug 2010 | A1 |
| 20100221452 | Kang | Sep 2010 | A1 |
| 20100229795 | Tanabe | Sep 2010 | A1 |
| 20100230051 | Iizuka | Sep 2010 | A1 |
| 20100230863 | Moench et al. | Sep 2010 | A1 |
| 20100233885 | Kushibiki et al. | Sep 2010 | A1 |
| 20100233886 | Yang et al. | Sep 2010 | A1 |
| 20100236691 | Yamazaki | Sep 2010 | A1 |
| 20100243166 | Hayashi et al. | Sep 2010 | A1 |
| 20100244688 | Braun et al. | Sep 2010 | A1 |
| 20100248465 | Yi et al. | Sep 2010 | A1 |
| 20100255198 | Cleary et al. | Oct 2010 | A1 |
| 20100255218 | Oka et al. | Oct 2010 | A1 |
| 20100255625 | De Vries | Oct 2010 | A1 |
| 20100255658 | Aggarwal | Oct 2010 | A1 |
| 20100259152 | Yasuda et al. | Oct 2010 | A1 |
| 20100266765 | White et al. | Oct 2010 | A1 |
| 20100267248 | Ma | Oct 2010 | A1 |
| 20100270675 | Harada | Oct 2010 | A1 |
| 20100246630 | Kaszynski et al. | Nov 2010 | A1 |
| 20100275846 | Kitagawa | Nov 2010 | A1 |
| 20100282163 | Aggarwal et al. | Nov 2010 | A1 |
| 20100282170 | Nishizawa | Nov 2010 | A1 |
| 20100282645 | Wang | Nov 2010 | A1 |
| 20100285237 | Ditizio et al. | Nov 2010 | A1 |
| 20100285319 | Kwak et al. | Nov 2010 | A1 |
| 20100294199 | Tran et al. | Nov 2010 | A1 |
| 20100297391 | Kley | Nov 2010 | A1 |
| 20100301752 | Bakre et al. | Dec 2010 | A1 |
| 20100304047 | Yang et al. | Dec 2010 | A1 |
| 20100307415 | Shero et al. | Dec 2010 | A1 |
| 20100317198 | Antonelli | Dec 2010 | A1 |
| 20100322604 | Fondurulia et al. | Dec 2010 | A1 |
| 20100326358 | Choi | Dec 2010 | A1 |
| 20110000619 | Suh | Jan 2011 | A1 |
| 20110006402 | Zhou | Jan 2011 | A1 |
| 20110006406 | Urbanowicz et al. | Jan 2011 | A1 |
| 20110014359 | Hashim | Jan 2011 | A1 |
| 20110014795 | Lee | Jan 2011 | A1 |
| 20110027725 | Tsutsumi et al. | Feb 2011 | A1 |
| 20110027999 | Sparks et al. | Feb 2011 | A1 |
| 20110034039 | Liang et al. | Feb 2011 | A1 |
| 20110045610 | van Schravendijk | Feb 2011 | A1 |
| 20110046314 | Klipp et al. | Feb 2011 | A1 |
| 20110048642 | Mihara et al. | Mar 2011 | A1 |
| 20110049100 | Han et al. | Mar 2011 | A1 |
| 20110052833 | Hanawa et al. | Mar 2011 | A1 |
| 20110053383 | Shero et al. | Mar 2011 | A1 |
| 20110056513 | Hombach et al. | Mar 2011 | A1 |
| 20110056626 | Brown et al. | Mar 2011 | A1 |
| 20110057248 | Ma et al. | Mar 2011 | A1 |
| 20110061810 | Ganguly et al. | Mar 2011 | A1 |
| 20110070380 | Shero et al. | Mar 2011 | A1 |
| 20110081519 | Dillingh | Apr 2011 | A1 |
| 20110083496 | Lin et al. | Apr 2011 | A1 |
| 20110086516 | Lee et al. | Apr 2011 | A1 |
| 20110089469 | Merckling | Apr 2011 | A1 |
| 20110097901 | Banna et al. | Apr 2011 | A1 |
| 20110107512 | Gilbert | May 2011 | A1 |
| 20110108194 | Yoshioka et al. | May 2011 | A1 |
| 20110108741 | Ingram | May 2011 | A1 |
| 20110108929 | Meng | May 2011 | A1 |
| 20110117490 | Bae et al. | May 2011 | A1 |
| 20110117737 | Agarwala et al. | May 2011 | A1 |
| 20110117749 | Sheu | May 2011 | A1 |
| 20110124196 | Lee | May 2011 | A1 |
| 20110139272 | Matsumoto et al. | Jun 2011 | A1 |
| 20110139748 | Donnelly et al. | Jun 2011 | A1 |
| 20110140172 | Chu | Jun 2011 | A1 |
| 20110143032 | Vrtis et al. | Jun 2011 | A1 |
| 20110143461 | Fish et al. | Jun 2011 | A1 |
| 20110159202 | Matsushita | Jun 2011 | A1 |
| 20110159673 | Hanawa et al. | Jun 2011 | A1 |
| 20110159680 | Yoo | Jun 2011 | A1 |
| 20110168330 | Sakaue et al. | Jul 2011 | A1 |
| 20110171775 | Yamamoto et al. | Jul 2011 | A1 |
| 20110175011 | Ehrne et al. | Jul 2011 | A1 |
| 20110180233 | Bera et al. | Jul 2011 | A1 |
| 20110183079 | Jackson et al. | Jul 2011 | A1 |
| 20110183269 | Zhu | Jul 2011 | A1 |
| 20110183527 | Cho | Jul 2011 | A1 |
| 20110192820 | Yeom et al. | Aug 2011 | A1 |
| 20110198417 | Detmar et al. | Aug 2011 | A1 |
| 20110198736 | Shero et al. | Aug 2011 | A1 |
| 20110210468 | Shannon et al. | Sep 2011 | A1 |
| 20110220874 | Hanrath | Sep 2011 | A1 |
| 20110236600 | Fox et al. | Sep 2011 | A1 |
| 20110237040 | Ng et al. | Sep 2011 | A1 |
| 20110239936 | Suzaki et al. | Oct 2011 | A1 |
| 20110254052 | Kouvetakis | Oct 2011 | A1 |
| 20110256675 | Avouris | Oct 2011 | A1 |
| 20110256726 | Lavoie et al. | Oct 2011 | A1 |
| 20110256727 | Beynet et al. | Oct 2011 | A1 |
| 20110256734 | Hausmann et al. | Oct 2011 | A1 |
| 20110263107 | Chung et al. | Oct 2011 | A1 |
| 20110265549 | Cruse et al. | Nov 2011 | A1 |
| 20110265715 | Keller | Nov 2011 | A1 |
| 20110265725 | Tsuji | Nov 2011 | A1 |
| 20110265951 | Xu et al. | Nov 2011 | A1 |
| 20110275018 | Matteo et al. | Nov 2011 | A1 |
| 20110275166 | Shero et al. | Nov 2011 | A1 |
| 20110277690 | Rozenzon et al. | Nov 2011 | A1 |
| 20110281417 | Gordon et al. | Nov 2011 | A1 |
| 20110283933 | Makarov et al. | Nov 2011 | A1 |
| 20110291243 | Seamons | Dec 2011 | A1 |
| 20110294075 | Chen et al. | Dec 2011 | A1 |
| 20110294288 | Lee et al. | Dec 2011 | A1 |
| 20110298062 | Ganguli et al. | Dec 2011 | A1 |
| 20110300720 | Fu | Dec 2011 | A1 |
| 20110308453 | Su et al. | Dec 2011 | A1 |
| 20110308460 | Hong et al. | Dec 2011 | A1 |
| 20110312191 | Ohkura et al. | Dec 2011 | A1 |
| 20120003500 | Yoshida et al. | Jan 2012 | A1 |
| 20120006489 | Okita | Jan 2012 | A1 |
| 20120009802 | Lavoie | Jan 2012 | A1 |
| 20120024227 | Takasuka et al. | Feb 2012 | A1 |
| 20120024479 | Palagashvili et al. | Feb 2012 | A1 |
| 20120028454 | Swaminathan et al. | Feb 2012 | A1 |
| 20120031333 | Kurita et al. | Feb 2012 | A1 |
| 20120032311 | Gates | Feb 2012 | A1 |
| 20120033695 | Hayashi et al. | Feb 2012 | A1 |
| 20120036732 | Varadarajan | Feb 2012 | A1 |
| 20120040528 | Kim et al. | Feb 2012 | A1 |
| 20120043556 | Dube et al. | Feb 2012 | A1 |
| 20120046421 | Darling et al. | Feb 2012 | A1 |
| 20120052681 | Marsh | Mar 2012 | A1 |
| 20120058630 | Quinn | Mar 2012 | A1 |
| 20120064690 | Hirota et al. | Mar 2012 | A1 |
| 20120068242 | Shin et al. | Mar 2012 | A1 |
| 20120070136 | Koelmel et al. | Mar 2012 | A1 |
| 20120070997 | Larson | Mar 2012 | A1 |
| 20120074533 | Aoyama | Mar 2012 | A1 |
| 20120077349 | Li et al. | Mar 2012 | A1 |
| 20120080756 | Suzuki | Apr 2012 | A1 |
| 20120090704 | Laverdiere et al. | Apr 2012 | A1 |
| 20120098107 | Raisanen et al. | Apr 2012 | A1 |
| 20120100464 | Kageyama | Apr 2012 | A1 |
| 20120103264 | Choi et al. | May 2012 | A1 |
| 20120103939 | Wu et al. | May 2012 | A1 |
| 20120107607 | Takaki et al. | May 2012 | A1 |
| 20120108039 | Zajaji | May 2012 | A1 |
| 20120114877 | Lee | May 2012 | A1 |
| 20120115250 | Ariga et al. | May 2012 | A1 |
| 20120115257 | Matsuyam et al. | May 2012 | A1 |
| 20120119337 | Sasaki et al. | May 2012 | A1 |
| 20120121823 | Chhabra | May 2012 | A1 |
| 20120122275 | Koo et al. | May 2012 | A1 |
| 20120122302 | Weisman et al. | May 2012 | A1 |
| 20120128897 | Xiao et al. | May 2012 | A1 |
| 20120135145 | Je et al. | May 2012 | A1 |
| 20120149213 | Nittala | Jun 2012 | A1 |
| 20120156108 | Fondurulia et al. | Jun 2012 | A1 |
| 20120156890 | Yim et al. | Jun 2012 | A1 |
| 20120160172 | Wamura et al. | Jun 2012 | A1 |
| 20120161405 | Mohn | Jun 2012 | A1 |
| 20120164327 | Sato | Jun 2012 | A1 |
| 20120164837 | Tan et al. | Jun 2012 | A1 |
| 20120164842 | Watanabe | Jun 2012 | A1 |
| 20120170170 | Gros-Jean | Jul 2012 | A1 |
| 20120171391 | Won | Jul 2012 | A1 |
| 20120171874 | Thridandam et al. | Jul 2012 | A1 |
| 20120175751 | Gatineau et al. | Jul 2012 | A1 |
| 20120183689 | Suzuki et al. | Jul 2012 | A1 |
| 20120187083 | Hashizume | Jul 2012 | A1 |
| 20120187305 | Elam et al. | Jul 2012 | A1 |
| 20120190178 | Wang et al. | Jul 2012 | A1 |
| 20120190185 | Rogers | Jul 2012 | A1 |
| 20120196048 | Ueda | Aug 2012 | A1 |
| 20120196450 | Balseanu et al. | Aug 2012 | A1 |
| 20120207456 | Kim et al. | Aug 2012 | A1 |
| 20120212121 | Lin | Aug 2012 | A1 |
| 20120214318 | Fukazawa et al. | Aug 2012 | A1 |
| 20120216743 | Itoh et al. | Aug 2012 | A1 |
| 20120219824 | Prolier | Aug 2012 | A1 |
| 20120220139 | Lee et al. | Aug 2012 | A1 |
| 20120225561 | Watanabe | Sep 2012 | A1 |
| 20120231771 | Marcus | Sep 2012 | A1 |
| 20120238074 | Santhanam et al. | Sep 2012 | A1 |
| 20120240858 | Taniyama et al. | Sep 2012 | A1 |
| 20120241411 | Darling et al. | Sep 2012 | A1 |
| 20120252229 | Timans et al. | Oct 2012 | A1 |
| 20120263876 | Haukka et al. | Oct 2012 | A1 |
| 20120264051 | Angelov et al. | Oct 2012 | A1 |
| 20120270339 | Xie et al. | Oct 2012 | A1 |
| 20120270393 | Pore et al. | Oct 2012 | A1 |
| 20120289053 | Holland et al. | Nov 2012 | A1 |
| 20120289057 | DeDontney | Nov 2012 | A1 |
| 20120295427 | Bauer | Nov 2012 | A1 |
| 20120304935 | Oosterlaken et al. | Dec 2012 | A1 |
| 20120305026 | Nomura et al. | Dec 2012 | A1 |
| 20120305196 | Mori et al. | Dec 2012 | A1 |
| 20120305987 | Hirler et al. | Dec 2012 | A1 |
| 20120310440 | Darabnia et al. | Dec 2012 | A1 |
| 20120315113 | Hiroki | Dec 2012 | A1 |
| 20120318334 | Bedell et al. | Dec 2012 | A1 |
| 20120321786 | Satitpunwaycha et al. | Dec 2012 | A1 |
| 20120322252 | Son et al. | Dec 2012 | A1 |
| 20120325148 | Yamagishi et al. | Dec 2012 | A1 |
| 20120328780 | Yamagishi et al. | Dec 2012 | A1 |
| 20130005122 | Schwarzenbach et al. | Jan 2013 | A1 |
| 20130011983 | Tsai | Jan 2013 | A1 |
| 20130014697 | Kanayama | Jan 2013 | A1 |
| 20130014896 | Shoji et al. | Jan 2013 | A1 |
| 20130019944 | Hekmatshoar-Tabai et al. | Jan 2013 | A1 |
| 20130019945 | Hekmatshoar-Tabai et al. | Jan 2013 | A1 |
| 20130020246 | Hoots et al. | Jan 2013 | A1 |
| 20130023129 | Reed | Jan 2013 | A1 |
| 20130025786 | Davidkovich et al. | Jan 2013 | A1 |
| 20130026451 | Bangsaruntip et al. | Jan 2013 | A1 |
| 20130037858 | Hong et al. | Feb 2013 | A1 |
| 20130037886 | Tsai et al. | Feb 2013 | A1 |
| 20130048606 | Mao et al. | Feb 2013 | A1 |
| 20130052585 | Ayothi et al. | Feb 2013 | A1 |
| 20130061755 | Frederick | Mar 2013 | A1 |
| 20130064973 | Chen et al. | Mar 2013 | A1 |
| 20130065189 | Yoshii et al. | Mar 2013 | A1 |
| 20130068727 | Okita | Mar 2013 | A1 |
| 20130068970 | Matsushita | Mar 2013 | A1 |
| 20130078392 | Xiao et al. | Mar 2013 | A1 |
| 20130081702 | Mohammed et al. | Apr 2013 | A1 |
| 20130082274 | Yang | Apr 2013 | A1 |
| 20130084156 | Shimamoto | Apr 2013 | A1 |
| 20130084714 | Oka et al. | Apr 2013 | A1 |
| 20130089716 | Krishnamurthy et al. | Apr 2013 | A1 |
| 20130095664 | Matero et al. | Apr 2013 | A1 |
| 20130095973 | Kroneberger et al. | Apr 2013 | A1 |
| 20130104988 | Yednak et al. | May 2013 | A1 |
| 20130104992 | Yednak et al. | May 2013 | A1 |
| 20130115383 | Lu et al. | May 2013 | A1 |
| 20130115763 | Takamure et al. | May 2013 | A1 |
| 20130115768 | Pore et al. | May 2013 | A1 |
| 20130122712 | Kim et al. | May 2013 | A1 |
| 20130126515 | Shero et al. | May 2013 | A1 |
| 20130129577 | Halpin et al. | May 2013 | A1 |
| 20130134148 | Tachikawa | May 2013 | A1 |
| 20130143401 | Yu et al. | Jun 2013 | A1 |
| 20130157409 | Vaidya | Jun 2013 | A1 |
| 20130160709 | White | Jun 2013 | A1 |
| 20130161629 | Han et al. | Jun 2013 | A1 |
| 20130168354 | Kanarik | Jul 2013 | A1 |
| 20130171818 | Kim et al. | Jul 2013 | A1 |
| 20130175596 | Cheng et al. | Jul 2013 | A1 |
| 20130180448 | Sakaue et al. | Jul 2013 | A1 |
| 20130183814 | Huang et al. | Jul 2013 | A1 |
| 20130189854 | Hausmann et al. | Jul 2013 | A1 |
| 20130203266 | Hintze | Aug 2013 | A1 |
| 20130209940 | Sakamoto et al. | Aug 2013 | A1 |
| 20130210241 | Lavoie et al. | Aug 2013 | A1 |
| 20130214232 | Tendulkar et al. | Aug 2013 | A1 |
| 20130217239 | Mallick et al. | Aug 2013 | A1 |
| 20130217240 | Mallick et al. | Aug 2013 | A1 |
| 20130217241 | Underwood et al. | Aug 2013 | A1 |
| 20130217243 | Underwood et al. | Aug 2013 | A1 |
| 20130224964 | Fukazawa | Aug 2013 | A1 |
| 20130230814 | Dunn et al. | Sep 2013 | A1 |
| 20130256265 | Darling et al. | Oct 2013 | A1 |
| 20130256838 | Sanchez et al. | Oct 2013 | A1 |
| 20130256962 | Ranish | Oct 2013 | A1 |
| 20130264659 | Jung | Oct 2013 | A1 |
| 20130269612 | Cheng et al. | Oct 2013 | A1 |
| 20130270676 | Lindert et al. | Oct 2013 | A1 |
| 20130276978 | Bluck et al. | Oct 2013 | A1 |
| 20130285155 | Glass | Oct 2013 | A1 |
| 20130287526 | Bluck et al. | Oct 2013 | A1 |
| 20130288480 | Sanchez et al. | Oct 2013 | A1 |
| 20130288485 | Liang et al. | Oct 2013 | A1 |
| 20130292047 | Tian et al. | Nov 2013 | A1 |
| 20130292676 | Milligan et al. | Nov 2013 | A1 |
| 20130292807 | Raisanen et al. | Nov 2013 | A1 |
| 20130295779 | Chandra et al. | Nov 2013 | A1 |
| 20130302999 | Won | Nov 2013 | A1 |
| 20130313656 | Tong | Nov 2013 | A1 |
| 20130319290 | Xiao et al. | Dec 2013 | A1 |
| 20130320429 | Thomas | Dec 2013 | A1 |
| 20130323435 | Xiao et al. | Dec 2013 | A1 |
| 20130330165 | Wimplinger | Dec 2013 | A1 |
| 20130330911 | Huang et al. | Dec 2013 | A1 |
| 20130330933 | Fukazawa et al. | Dec 2013 | A1 |
| 20130333619 | Omari | Dec 2013 | A1 |
| 20130337583 | Kobayashi et al. | Dec 2013 | A1 |
| 20130337653 | Kovalgin et al. | Dec 2013 | A1 |
| 20130340619 | Tammera | Dec 2013 | A1 |
| 20130344248 | Clark | Dec 2013 | A1 |
| 20140000843 | Dunn et al. | Jan 2014 | A1 |
| 20140001520 | Glass | Jan 2014 | A1 |
| 20140014642 | Elliot et al. | Jan 2014 | A1 |
| 20140014644 | Akiba et al. | Jan 2014 | A1 |
| 20140015186 | Wessel et al. | Jan 2014 | A1 |
| 20140020619 | Vincent et al. | Jan 2014 | A1 |
| 20140023794 | Mahajani et al. | Jan 2014 | A1 |
| 20140027884 | Tang et al. | Jan 2014 | A1 |
| 20140033978 | Adachi et al. | Feb 2014 | A1 |
| 20140036274 | Marquardt et al. | Feb 2014 | A1 |
| 20140047705 | Singh | Feb 2014 | A1 |
| 20140048765 | Ma et al. | Feb 2014 | A1 |
| 20140056679 | Yamabe et al. | Feb 2014 | A1 |
| 20140056770 | Bedard et al. | Feb 2014 | A1 |
| 20140057454 | Subramonium | Feb 2014 | A1 |
| 20140058179 | Stevens et al. | Feb 2014 | A1 |
| 20140060147 | Sarin et al. | Mar 2014 | A1 |
| 20140061770 | Lee | Mar 2014 | A1 |
| 20140062304 | Nakano et al. | Mar 2014 | A1 |
| 20140065841 | Matero | Mar 2014 | A1 |
| 20140067110 | Lawson et al. | Mar 2014 | A1 |
| 20140073143 | Alokozai et al. | Mar 2014 | A1 |
| 20140076861 | Cornelius et al. | Mar 2014 | A1 |
| 20140077240 | Roucka et al. | Mar 2014 | A1 |
| 20140084341 | Weeks | Mar 2014 | A1 |
| 20140087544 | Tolle | Mar 2014 | A1 |
| 20140094027 | Azumo et al. | Apr 2014 | A1 |
| 20140096716 | Chung et al. | Apr 2014 | A1 |
| 20140097468 | Okita | Apr 2014 | A1 |
| 20140099798 | Tsuji | Apr 2014 | A1 |
| 20140103145 | White et al. | Apr 2014 | A1 |
| 20140106574 | Kang et al. | Apr 2014 | A1 |
| 20140110798 | Cai | Apr 2014 | A1 |
| 20140113457 | Sims | Apr 2014 | A1 |
| 20140116335 | Tsuji et al. | May 2014 | A1 |
| 20140120487 | Kaneko | May 2014 | A1 |
| 20140120723 | Fu et al. | May 2014 | A1 |
| 20140120738 | Jung | May 2014 | A1 |
| 20140127907 | Yang | May 2014 | A1 |
| 20140138779 | Xie et al. | May 2014 | A1 |
| 20140141625 | Fukazawa et al. | May 2014 | A1 |
| 20140144500 | Cao et al. | May 2014 | A1 |
| 20140158786 | Santo | Jun 2014 | A1 |
| 20140159170 | Raisanen et al. | Jun 2014 | A1 |
| 20140167187 | Kuo et al. | Jun 2014 | A1 |
| 20140174354 | Arai | Jun 2014 | A1 |
| 20140175054 | Carlson et al. | Jun 2014 | A1 |
| 20140182053 | Huang | Jul 2014 | A1 |
| 20140191389 | Lee et al. | Jul 2014 | A1 |
| 20140193983 | Lavoie | Jul 2014 | A1 |
| 20140202386 | Taga | Jul 2014 | A1 |
| 20140202388 | Um et al. | Jul 2014 | A1 |
| 20140209976 | Yang et al. | Jul 2014 | A1 |
| 20140217065 | Winkler et al. | Aug 2014 | A1 |
| 20140220247 | Haukka et al. | Aug 2014 | A1 |
| 20140225065 | Rachmady et al. | Aug 2014 | A1 |
| 20140227072 | Lee et al. | Aug 2014 | A1 |
| 20140227861 | Wu et al. | Aug 2014 | A1 |
| 20140227881 | Lubomirsky et al. | Aug 2014 | A1 |
| 20140234550 | Winter et al. | Aug 2014 | A1 |
| 20140251953 | Winkler et al. | Sep 2014 | A1 |
| 20140251954 | Winkler et al. | Sep 2014 | A1 |
| 20140252134 | Chen | Sep 2014 | A1 |
| 20140252479 | Utomo et al. | Sep 2014 | A1 |
| 20140260684 | Christmann | Sep 2014 | A1 |
| 20140264902 | Ting et al. | Sep 2014 | A1 |
| 20140272194 | Xiao et al. | Sep 2014 | A1 |
| 20140273428 | Shero | Sep 2014 | A1 |
| 20140273477 | Niskanen | Sep 2014 | A1 |
| 20140273510 | Chen et al. | Sep 2014 | A1 |
| 20140273528 | Niskanen | Sep 2014 | A1 |
| 20140273530 | Nguyen | Sep 2014 | A1 |
| 20140273531 | Niskanen | Sep 2014 | A1 |
| 20140283747 | Kasai et al. | Sep 2014 | A1 |
| 20140346142 | Chapuis et al. | Nov 2014 | A1 |
| 20140346650 | Raisanen et al. | Nov 2014 | A1 |
| 20140349033 | Nonaka et al. | Nov 2014 | A1 |
| 20140363980 | Kawamata et al. | Dec 2014 | A1 |
| 20140363983 | Nakano et al. | Dec 2014 | A1 |
| 20140363985 | Jang et al. | Dec 2014 | A1 |
| 20140367043 | Bishara et al. | Dec 2014 | A1 |
| 20140367642 | Guo | Dec 2014 | A1 |
| 20140377960 | Koiwa | Dec 2014 | A1 |
| 20150004316 | Thompson et al. | Jan 2015 | A1 |
| 20150004317 | Dussarrat et al. | Jan 2015 | A1 |
| 20150007770 | Chandrasekharan et al. | Jan 2015 | A1 |
| 20150010381 | Cai | Jan 2015 | A1 |
| 20150014632 | Kim et al. | Jan 2015 | A1 |
| 20150014823 | Mallikarjunan et al. | Jan 2015 | A1 |
| 20150017794 | Takamure | Jan 2015 | A1 |
| 20150021599 | Ridgeway | Jan 2015 | A1 |
| 20150024609 | Milligan et al. | Jan 2015 | A1 |
| 20150041431 | Zafiropoulo et al. | Feb 2015 | A1 |
| 20150048485 | Tolle | Feb 2015 | A1 |
| 20150056815 | Fernandez | Feb 2015 | A1 |
| 20150072509 | Chi et al. | Mar 2015 | A1 |
| 20150078874 | Sansoni | Mar 2015 | A1 |
| 20150079311 | Nakano | Mar 2015 | A1 |
| 20150086316 | Greenberg | Mar 2015 | A1 |
| 20150087154 | Guha et al. | Mar 2015 | A1 |
| 20150091057 | Xie et al. | Apr 2015 | A1 |
| 20150096973 | Dunn et al. | Apr 2015 | A1 |
| 20150099065 | Canizares et al. | Apr 2015 | A1 |
| 20150099072 | Takamure et al. | Apr 2015 | A1 |
| 20150099342 | Tsai | Apr 2015 | A1 |
| 20150102466 | Colinge | Apr 2015 | A1 |
| 20150111374 | Bao | Apr 2015 | A1 |
| 20150111395 | Hashimoto et al. | Apr 2015 | A1 |
| 20150122180 | Chang et al. | May 2015 | A1 |
| 20150132212 | Winkler et al. | May 2015 | A1 |
| 20150140210 | Jung et al. | May 2015 | A1 |
| 20150147483 | Fukazawa | May 2015 | A1 |
| 20150147488 | Choi et al. | May 2015 | A1 |
| 20150147877 | Jung | May 2015 | A1 |
| 20150162168 | Oehrlien | Jun 2015 | A1 |
| 20150162185 | Pore | Jun 2015 | A1 |
| 20150162214 | Thompson | Jun 2015 | A1 |
| 20150167159 | Halpin et al. | Jun 2015 | A1 |
| 20150170914 | Haukka et al. | Jun 2015 | A1 |
| 20150170947 | Bluck | Jun 2015 | A1 |
| 20150170954 | Agarwal | Jun 2015 | A1 |
| 20150171177 | Cheng et al. | Jun 2015 | A1 |
| 20150174768 | Rodnick | Jun 2015 | A1 |
| 20150179501 | Jhaveri et al. | Jun 2015 | A1 |
| 20150179564 | Lee et al. | Jun 2015 | A1 |
| 20150184291 | Alokozai et al. | Jul 2015 | A1 |
| 20150187559 | Sano | Jul 2015 | A1 |
| 20150187568 | Pettinger et al. | Jul 2015 | A1 |
| 20150217330 | Haukka | Aug 2015 | A1 |
| 20150217456 | Tsuji et al. | Aug 2015 | A1 |
| 20150218695 | Odedra | Aug 2015 | A1 |
| 20150225850 | Arora et al. | Aug 2015 | A1 |
| 20150228572 | Yang et al. | Aug 2015 | A1 |
| 20150240359 | Jdira et al. | Aug 2015 | A1 |
| 20150243542 | Yoshihara et al. | Aug 2015 | A1 |
| 20150243545 | Tang | Aug 2015 | A1 |
| 20150243658 | Joshi et al. | Aug 2015 | A1 |
| 20150255385 | Lee et al. | Sep 2015 | A1 |
| 20150259790 | Newman | Sep 2015 | A1 |
| 20150263033 | Aoyama | Sep 2015 | A1 |
| 20150267295 | Hill et al. | Sep 2015 | A1 |
| 20150267297 | Shiba | Sep 2015 | A1 |
| 20150267298 | Saitou et al. | Sep 2015 | A1 |
| 20150267299 | Hawkins | Sep 2015 | A1 |
| 20150267301 | Hill et al. | Sep 2015 | A1 |
| 20150270146 | Yoshihara et al. | Sep 2015 | A1 |
| 20150279681 | Knoops | Oct 2015 | A1 |
| 20150279708 | Kobayashi et al. | Oct 2015 | A1 |
| 20150284848 | Nakano et al. | Oct 2015 | A1 |
| 20150287626 | Arai | Oct 2015 | A1 |
| 20150287710 | Yun et al. | Oct 2015 | A1 |
| 20150292088 | Canizares | Oct 2015 | A1 |
| 20150299848 | Haukka | Oct 2015 | A1 |
| 20150308586 | Shugrue et al. | Oct 2015 | A1 |
| 20150303056 | Varadarajan et al. | Nov 2015 | A1 |
| 20150315704 | Nakano et al. | Nov 2015 | A1 |
| 20150340247 | Balakrishnan et al. | Nov 2015 | A1 |
| 20150340500 | Brunco | Nov 2015 | A1 |
| 20150343741 | Shibata et al. | Dec 2015 | A1 |
| 20150348755 | Han et al. | Dec 2015 | A1 |
| 20150361553 | Murakawa | Dec 2015 | A1 |
| 20150364371 | Yen | Dec 2015 | A1 |
| 20150367253 | Kanyal et al. | Dec 2015 | A1 |
| 20150376211 | Girard | Dec 2015 | A1 |
| 20150376785 | Knaapen et al. | Dec 2015 | A1 |
| 20150380296 | Antonelli et al. | Dec 2015 | A1 |
| 20160013022 | Ayoub | Jan 2016 | A1 |
| 20160013024 | Milligan et al. | Jan 2016 | A1 |
| 20160020092 | Kang et al. | Jan 2016 | A1 |
| 20160024656 | White et al. | Jan 2016 | A1 |
| 20160035566 | LaVoie | Feb 2016 | A1 |
| 20160051964 | Tolle et al. | Feb 2016 | A1 |
| 20160056074 | Na | Feb 2016 | A1 |
| 20160079054 | Chen et al. | Mar 2016 | A1 |
| 20160097123 | Shugrue et al. | Apr 2016 | A1 |
| 20160099150 | Tsai | Apr 2016 | A1 |
| 20160102214 | Dietz et al. | Apr 2016 | A1 |
| 20160111272 | Girard | Apr 2016 | A1 |
| 20160111438 | Tsutsumi et al. | Apr 2016 | A1 |
| 20160115590 | Haukka et al. | Apr 2016 | A1 |
| 20160133307 | Lee et al. | May 2016 | A1 |
| 20160133628 | Xie | May 2016 | A1 |
| 20160141172 | Kang | May 2016 | A1 |
| 20160145738 | Liu et al. | May 2016 | A1 |
| 20160148811 | Nakatani et al. | May 2016 | A1 |
| 20160148821 | Singh | May 2016 | A1 |
| 20160155629 | Hawryluk et al. | Jun 2016 | A1 |
| 20160163556 | Briggs et al. | Jun 2016 | A1 |
| 20160163561 | Hudson et al. | Jun 2016 | A1 |
| 20160168699 | Fukazawa et al. | Jun 2016 | A1 |
| 20160181128 | Mori | Jun 2016 | A1 |
| 20160181368 | Weeks | Jun 2016 | A1 |
| 20160190137 | Tsai et al. | Jun 2016 | A1 |
| 20160211135 | Noda et al. | Jul 2016 | A1 |
| 20160211147 | Fukazawa | Jul 2016 | A1 |
| 20160217857 | Paudel | Jul 2016 | A1 |
| 20160225607 | Yamamoto et al. | Aug 2016 | A1 |
| 20160245704 | Osaka et al. | Aug 2016 | A1 |
| 20160256187 | Shelton et al. | Sep 2016 | A1 |
| 20160268102 | White | Sep 2016 | A1 |
| 20160268107 | White | Sep 2016 | A1 |
| 20160276148 | Qian et al. | Sep 2016 | A1 |
| 20160284542 | Noda et al. | Sep 2016 | A1 |
| 20160289828 | Shero et al. | Oct 2016 | A1 |
| 20160293398 | Danek et al. | Oct 2016 | A1 |
| 20160307766 | Jongbloed et al. | Oct 2016 | A1 |
| 20160312360 | Rasheed et al. | Oct 2016 | A1 |
| 20160314964 | Tang et al. | Oct 2016 | A1 |
| 20160334709 | Huli et al. | Nov 2016 | A1 |
| 20160358772 | Xie | Dec 2016 | A1 |
| 20160362813 | Bao et al. | Dec 2016 | A1 |
| 20160365280 | Brink et al. | Dec 2016 | A1 |
| 20160372365 | Tang et al. | Dec 2016 | A1 |
| 20160372744 | Essaki et al. | Dec 2016 | A1 |
| 20160376700 | Haukka | Dec 2016 | A1 |
| 20160376704 | Raisanen | Dec 2016 | A1 |
| 20160379851 | Swaminathan et al. | Dec 2016 | A1 |
| 20160381732 | Moench et al. | Dec 2016 | A1 |
| 20170011889 | Winkler et al. | Jan 2017 | A1 |
| 20170011950 | Schmotzer | Jan 2017 | A1 |
| 20170018477 | Kato | Jan 2017 | A1 |
| 20170025280 | Milligan | Jan 2017 | A1 |
| 20170029945 | Kamakura | Feb 2017 | A1 |
| 20170033004 | Siew et al. | Feb 2017 | A1 |
| 20170037513 | Haukka | Feb 2017 | A1 |
| 20170040164 | Wang et al. | Feb 2017 | A1 |
| 20170040206 | Schmotzer et al. | Feb 2017 | A1 |
| 20170047446 | Margetis et al. | Feb 2017 | A1 |
| 20170051408 | Kosuke et al. | Feb 2017 | A1 |
| 20170062204 | Suzuki et al. | Mar 2017 | A1 |
| 20170062209 | Shiba | Mar 2017 | A1 |
| 20170062258 | Bluck | Mar 2017 | A1 |
| 20170091320 | Psota et al. | Mar 2017 | A1 |
| 20170092469 | Kurita et al. | Mar 2017 | A1 |
| 20170092531 | Coomer | Mar 2017 | A1 |
| 20170092847 | Kim et al. | Mar 2017 | A1 |
| 20170100742 | Pore et al. | Apr 2017 | A1 |
| 20170103907 | Chu et al. | Apr 2017 | A1 |
| 20170107621 | Suemori | Apr 2017 | A1 |
| 20170110313 | Tang et al. | Apr 2017 | A1 |
| 20170114464 | Iriuda et al. | Apr 2017 | A1 |
| 20170117141 | Zhu et al. | Apr 2017 | A1 |
| 20170117202 | Tang et al. | Apr 2017 | A1 |
| 20170117203 | Tang et al. | Apr 2017 | A1 |
| 20170117222 | Kim et al. | Apr 2017 | A1 |
| 20170130332 | Stumpf | May 2017 | A1 |
| 20170136578 | Yoshimura | May 2017 | A1 |
| 20170154757 | Winkler et al. | Jun 2017 | A1 |
| 20170173696 | Sheinman | Jun 2017 | A1 |
| 20170186754 | Blomberg et al. | Jun 2017 | A1 |
| 20170191164 | Alokozai et al. | Jul 2017 | A1 |
| 20170196562 | Shelton | Jul 2017 | A1 |
| 20170216762 | Shugrue et al. | Aug 2017 | A1 |
| 20170232457 | Toshiki et al. | Aug 2017 | A1 |
| 20170243734 | Ishikawa et al. | Aug 2017 | A1 |
| 20170250068 | Ishikawa | Aug 2017 | A1 |
| 20170250075 | Caymax et al. | Aug 2017 | A1 |
| 20170256429 | Lawson et al. | Sep 2017 | A1 |
| 20170260649 | Coomer | Sep 2017 | A1 |
| 20170263437 | Li et al. | Sep 2017 | A1 |
| 20170267527 | Kim et al. | Sep 2017 | A1 |
| 20170267531 | Huakka | Sep 2017 | A1 |
| 20170271256 | Inatsuka | Sep 2017 | A1 |
| 20170278707 | Margetis et al. | Sep 2017 | A1 |
| 20170287681 | Nitadori et al. | Oct 2017 | A1 |
| 20170294318 | Yoshida et al. | Oct 2017 | A1 |
| 20170306478 | Raisanen et al. | Oct 2017 | A1 |
| 20170306479 | Raisanen et al. | Oct 2017 | A1 |
| 20170306480 | Zhu et al. | Oct 2017 | A1 |
| 20170316933 | Xie et al. | Nov 2017 | A1 |
| 20170316940 | Ishikawa et al. | Nov 2017 | A1 |
| 20170317194 | Tang et al. | Nov 2017 | A1 |
| 20170338192 | Lee et al. | Nov 2017 | A1 |
| 20170342559 | Fukazawa et al. | Nov 2017 | A1 |
| 20170343896 | Darling et al. | Nov 2017 | A1 |
| 20170372884 | Margetis et al. | Dec 2017 | A1 |
| 20180010247 | Niskanen | Jan 2018 | A1 |
| 20180025890 | Choi | Jan 2018 | A1 |
| 20180025939 | Kovalgin et al. | Jan 2018 | A1 |
| 20180033616 | Masaru | Feb 2018 | A1 |
| 20180033625 | Yoo | Feb 2018 | A1 |
| 20180033645 | Saido et al. | Feb 2018 | A1 |
| 20180033674 | Jeong | Feb 2018 | A1 |
| 20180033679 | Pore | Feb 2018 | A1 |
| 20180040746 | Johnson et al. | Feb 2018 | A1 |
| 20180047749 | Kim | Feb 2018 | A1 |
| 20180057937 | Lee et al. | Mar 2018 | A1 |
| 20180061851 | Ootsuka | Mar 2018 | A1 |
| 20180069019 | Kim et al. | Mar 2018 | A1 |
| 20180076021 | Fukushima et al. | Mar 2018 | A1 |
| 20180087152 | Yoshida | Mar 2018 | A1 |
| 20180087154 | Pore et al. | Mar 2018 | A1 |
| 20180087156 | Kohei et al. | Mar 2018 | A1 |
| 20180102276 | Zhu et al. | Apr 2018 | A1 |
| 20180105930 | Kang et al. | Apr 2018 | A1 |
| 20180108587 | Jiang | Apr 2018 | A1 |
| 20180114680 | Kim et al. | Apr 2018 | A1 |
| 20180119283 | Fukazawa | May 2018 | A1 |
| 20180122642 | Raisanen | May 2018 | A1 |
| 20180122709 | Xie | May 2018 | A1 |
| 20180122959 | Calka et al. | May 2018 | A1 |
| 20180127876 | Tolle | May 2018 | A1 |
| 20180130652 | Pettinger et al. | May 2018 | A1 |
| 20180130701 | Chun | May 2018 | A1 |
| 20180135173 | Kim et al. | May 2018 | A1 |
| 20180135179 | Toshiyuki et al. | May 2018 | A1 |
| 20180142353 | Tetsuya et al. | May 2018 | A1 |
| 20180142357 | Yoshikazu | May 2018 | A1 |
| 20180151346 | Blanquart | May 2018 | A1 |
| 20180151358 | Margetis et al. | May 2018 | A1 |
| 20180158688 | Chen | Jun 2018 | A1 |
| 20180166258 | Kim et al. | Jun 2018 | A1 |
| 20180166315 | Coomer | Jun 2018 | A1 |
| 20180171475 | Maes et al. | Jun 2018 | A1 |
| 20180171477 | Kim et al. | Jun 2018 | A1 |
| 20180174826 | Raaijmakers et al. | Jun 2018 | A1 |
| 20180182613 | Blanquart et al. | Jun 2018 | A1 |
| 20180182618 | Blanquart et al. | Jun 2018 | A1 |
| 20180189923 | Zhong et al. | Jul 2018 | A1 |
| 20180195174 | Kim et al. | Jul 2018 | A1 |
| 20180223429 | Fukazawa et al. | Aug 2018 | A1 |
| 20180233372 | Vayrynen et al. | Aug 2018 | A1 |
| Number | Date | Country |
|---|---|---|
| 2588350 | Nov 2003 | CN |
| 1563483 | Jan 2005 | CN |
| 1664987 | Sep 2005 | CN |
| 101681873 | Mar 2010 | CN |
| 102383106 | Mar 2012 | CN |
| 102008052750 | Jun 2009 | DE |
| 0887632 | Dec 1998 | EP |
| 1889817 | Feb 2008 | EP |
| 2036600 | Mar 2009 | EP |
| 2426233 | Jul 2012 | EP |
| 1408266 | Aug 1965 | FR |
| 2233614 | Jan 1975 | FR |
| 752-277 | Jul 1956 | GB |
| 58-19462 | Apr 1983 | JP |
| 59-211779 | Nov 1984 | JP |
| 61038863 | Feb 1986 | JP |
| H02185038 | Jul 1990 | JP |
| H03-044472 | Feb 1991 | JP |
| H04-115531 | Apr 1992 | JP |
| H05-23079 | Mar 1993 | JP |
| H05-118928 | May 1993 | JP |
| H05-171446 | Jul 1993 | JP |
| H06-053210 | Feb 1994 | JP |
| H07297271 | Jan 1995 | JP |
| H07-109576 | Apr 1995 | JP |
| H07-034936 | Aug 1995 | JP |
| 7-272694 | Oct 1995 | JP |
| H07-283149 | Oct 1995 | JP |
| H07-209093 | Nov 1995 | JP |
| H08181135 | Jul 1996 | JP |
| H07-335558 | Dec 1996 | JP |
| 9-89676 | Apr 1997 | JP |
| H10-064696 | Mar 1998 | JP |
| H10-153494 | Jun 1998 | JP |
| H10-227703 | Aug 1998 | JP |
| H10-0261620 | Sep 1998 | JP |
| H11-097163 | Apr 1999 | JP |
| H11-118615 | Apr 1999 | JP |
| H11-183264 | Jul 1999 | JP |
| H11-183265 | Jul 1999 | JP |
| H11-287715 | Oct 1999 | JP |
| 2001015698 | Jan 2001 | JP |
| 2003035574 | Feb 2003 | JP |
| 2003153706 | May 2003 | JP |
| 2004014952 | Jan 2004 | JP |
| 2004023043 | Jan 2004 | JP |
| 2004091848 | Mar 2004 | JP |
| 2004113270 | Apr 2004 | JP |
| 2004128019 | Apr 2004 | JP |
| 2004134553 | Apr 2004 | JP |
| 2004294638 | Oct 2004 | JP |
| 2004310019 | Nov 2004 | JP |
| 2005033221 | Feb 2005 | JP |
| 2005507030 | Mar 2005 | JP |
| 2005172489 | Jun 2005 | JP |
| 2006059931 | Mar 2006 | JP |
| 2006090762 | Apr 2006 | JP |
| 2006153706 | Jun 2006 | JP |
| 2006186271 | Jul 2006 | JP |
| 2007027777 | Feb 2007 | JP |
| 3140111 | Mar 2008 | JP |
| 2008060304 | Mar 2008 | JP |
| 2008202107 | Sep 2008 | JP |
| 2009016815 | Jan 2009 | JP |
| 2009088421 | Apr 2009 | JP |
| 2009099938 | May 2009 | JP |
| 2009194248 | Aug 2009 | JP |
| 2009251216 | Oct 2009 | JP |
| 2010067940 | Mar 2010 | JP |
| 2010097834 | Apr 2010 | JP |
| 2010205967 | Sep 2010 | JP |
| 2010251444 | Oct 2010 | JP |
| 2011049592 | Mar 2011 | JP |
| 2011162830 | Aug 2011 | JP |
| 2012146939 | Aug 2012 | JP |
| 2013235912 | Nov 2013 | JP |
| 2016174158 | Sep 2016 | JP |
| 10-2000-0031098 | Jun 2000 | KR |
| 10-2000-0045257 | Jul 2000 | KR |
| 10-0295043 | Apr 2001 | KR |
| 10-2002-0064028 | Aug 2002 | KR |
| 2002-0086763 | Nov 2002 | KR |
| 10-0377095 | Mar 2003 | KR |
| 2003-0092305 | Dec 2003 | KR |
| 10-2005-0054122 | Jun 2005 | KR |
| 10-0547248 | Jan 2006 | KR |
| 10-0593960 | Jun 2006 | KR |
| 10-0688484 | Feb 2007 | KR |
| 10-2007-0084683 | Aug 2007 | KR |
| 10-2009-005543 | Jun 2009 | KR |
| 10-2010-0020834 | Feb 2010 | KR |
| 10-2010-0032812 | Mar 2010 | KR |
| 10-1114219 | Mar 2012 | KR |
| 538327 | Jun 2003 | TW |
| M292692 | Jun 2006 | TW |
| 200731357 | Aug 2007 | TW |
| 201247690 | Dec 2012 | TW |
| 1996017107 | Jun 1996 | WO |
| 1997003223 | Jan 1997 | WO |
| 1998032893 | Jul 1998 | WO |
| 1999023690 | May 1999 | WO |
| DM048579 | Jul 1999 | WO |
| 2004008491 | Jul 2002 | WO |
| 2004008827 | Jan 2004 | WO |
| 2004010467 | Jan 2004 | WO |
| 2005112082 | Nov 2005 | WO |
| 2006054854 | May 2006 | WO |
| 2006056091 | Jun 2006 | WO |
| 2006078666 | Jul 2006 | WO |
| 2006080782 | Aug 2006 | WO |
| 2006101857 | Sep 2006 | WO |
| 2006114781 | Nov 2006 | WO |
| 2007027165 | Mar 2007 | WO |
| 2007117718 | Oct 2007 | WO |
| 2007140376 | Dec 2007 | WO |
| 2008045972 | Apr 2008 | WO |
| 2008091900 | Jul 2008 | WO |
| 2008121463 | Oct 2008 | WO |
| 2008147731 | Dec 2008 | WO |
| 2009028619 | Mar 2009 | WO |
| 2009029532 | Mar 2009 | WO |
| 2009099776 | Aug 2009 | WO |
| 2009154889 | Dec 2009 | WO |
| 2009154896 | Apr 2010 | WO |
| 2010118051 | Jul 2010 | WO |
| 2010039363 | Sep 2010 | WO |
| 2010100702 | Oct 2010 | WO |
| 2010077533 | Nov 2010 | WO |
| 2010129428 | Nov 2010 | WO |
| 2010129430 | Nov 2010 | WO |
| 2010129431 | Nov 2010 | WO |
| 2011019950 | Feb 2011 | WO |
| 2011149640 | Dec 2011 | WO |
| 2012077590 | Jun 2012 | WO |
| 2013078065 | May 2013 | WO |
| 2013078066 | May 2013 | WO |
| 2014107290 | Jul 2014 | WO |
| 2015107009 | Jul 2015 | WO |
| 2018109553 | Jun 2016 | WO |
| 2018109554 | Jun 2016 | WO |
| 2017108713 | Jun 2017 | WO |
| 2017108714 | Jun 2017 | WO |
| 2017212546 | Dec 2017 | WO |
| 2018008088 | Jan 2018 | WO |
| 2018020316 | Feb 2018 | WO |
| 2018020318 | Feb 2018 | WO |
| 2018020320 | Feb 2018 | WO |
| 2018020327 | Feb 2018 | WO |
| 2008045972 | Apr 2018 | WO |
| 20181095C51 | Jun 2018 | WO |
| 2018109552 | Jun 2018 | WO |
| Entry |
|---|
| USPTO; Notice of Allowance dated Jul. 26, 2005 in U.S. Appl. No. 10/033,058. |
| USPTO; Non-Final Office Action dated Aug. 25, 2005 in U.S. Appl. No. 10/191,635. |
| USPTO; Final Office Action dated Apr. 25, 2006 in U.S. Appl. No. 10/191,635. |
| USPTO; Non-Final Office Action dated Nov. 20, 2006 in U.S. Appl. No. 10/191,635. |
| USPTO; Notice of Allowance dated May 21, 2007 in U.S. Appl. No. 10/191,635. |
| USPTO; Notice of Allowance dated Feb. 20, 2008 in U.S. Appl. No. 10/191,635. |
| USPTO; Non-Final Office Action dated May 13, 2003 in U.S. Appl. No. 10/222,229. |
| USPTO; Non-Final Office Action dated Oct. 22, 2003 in U.S. Appl. No. 10/222,229. |
| USPTO; Final Office Action dated Mar. 22, 2004 in U.S. Appl. No. 10/222,229. |
| USPTO; Advisory Action dated Oct. 7, 2004 in U.S. Appl. No. 10/222,229. |
| USPTO; Non-Final Office Action dated Dec. 22, 2004 in U.S. Appl. No. 10/222,229. |
| USPTO; Final Office Action dated Jun. 20, 2005 in U.S. Appl. No. 10/222,229. |
| USPTO; Advisory Action dated Nov. 16, 2005 in U.S. Appl. No. 10/222,229. |
| USPTO; Notice of Allowance dated Mar. 8, 2006 in U.S. Appl. No. 10/222,229. |
| USPTO; Non-Final Office Action dated Jan. 26, 2005 in U.S. Appl. No. 10/838,510. |
| USPTO; Notice of Allowance dated Jul. 12, 2005 in U.S. Appl. No. 10/838,510. |
| USPTO; Office Action dated Aug. 27, 2010 in U.S. Appl. No. 12/118,596. |
| USPTO; Office Action dated Feb. 15, 2011 in U.S. Appl. No. 12/118,596. |
| USPTO; Notice of Allowance dated Aug. 4, 2011 in U.S. Appl. No. 12/118,596. |
| USPTO; Non-Final Office Action dated Mar. 28, 2010 in U.S. Appl. No. 12/121,085. |
| USPTO; Notice of Allowance dated Jul. 26, 2010 in U.S. Appl. No. 12/121,085. |
| USPTO; Notice of Allowance dated Oct. 4, 2010 in U.S. Appl. No. 12/121,085. |
| USPTO; Non-Final Office Action dated Sep. 13, 2010 in U.S. Appl. No. 12/140,809. |
| USPTO; Final Office Action dated Dec. 28, 2010 in U.S. Appl. No. 12/140,809. |
| USPTO; Notice of Allowance dated Mar. 17, 2011 in U.S. Appl. No. 12/140,809. |
| USPTO; Non-Final Office Action dated Mar. 15, 2011 in U.S. Appl. No. 12/193,924. |
| USPTO; Foma; Office Action dated Sep. 30, 2011 in U.S. Appl. No. 12/193,924. |
| USPTO; Non-Final Office Action dated Oct. 24, 2012 in U.S. Appl. No. 12/193,924. |
| USPTO; Final Office Action dated Apr. 17, 2013 in U.S. Appl. No. 12/193,924. |
| USPTO; Advisory Action dated Jul. 9, 2013 in U.S. Appl. No. 12/193,924. |
| USPTO; Non-Final Office Action dated Jul. 28, 2011 in U.S. Appl. No. 12/330,096. |
| USPTO; Final Office Action dated Jan. 13, 2012 in U.S. Appl. No. 12/330,096. |
| USPTO; Notice of Allowance dated Mar. 6, 2012 in U.S. Appl. No. 12/330,096. |
| USPTO; Non-Final Office Action dated Mar. 20, 2012 in U.S. Appl. No. 12/330,096. |
| USPTO; Notice of Allowance dated Jun. 7, 2012 in U.S. Appl. No. 12/330,096. |
| USPTO; Non-Final Office Action dated Apr. 1, 2010 in U.S. Appl. No. 12/357,174. |
| USPTO; Final Office Action dated Sep. 1, 2010 in U.S. Appl. No. 12/357,174. |
| USPTO; Notice of Allowance dated Dec. 13, 2010 in U.S. Appl. No. 12/357,174. |
| USPTO; Non-Final Office Action dated Dec. 29, 2010 in U.S. Appl. No. 12/362,023. |
| USPTO; Non-Final Office Action dated Jul. 26, 2011 in U.S. Appl. No. 12/416,809. |
| USPTO; Final Office Action dated Dec. 6, 2011 in U.S. Appl. No. 12/416,809. |
| USPTO; Notice of Allowance dated Apr. 2, 2012 in U.S. Appl. No. 12/416,809. |
| USPTO; Advisory Action dated Feb. 3, 2012 in U.S. Appl. No. 12/416,809. |
| USPTO; Notice of Allowance dated Jun. 16, 2011 in U.S. Appl. No. 12/430,751. |
| USPTO; Notice of Allowance dated Jul. 27, 2011 in U.S. Appl. No. 12/430,751. |
| USPTO; Non-Final Office Action dated Aug. 3, 2011 in U.S. Appl. No. 12/436,300. |
| USPTO; Final Office Action dated Jan. 23, 2012 in U.S. Appl. No. 12/436,300. |
| USPTO; Advisory Action dated Mar. 6, 2012 in U.S. Appl. No. 12/436,300. |
| USPTO; Non-Final Office Action dated May 22, 2012 in U.S. Appl. No. 12/436,300. |
| USPTO; Notice of Allowance dated Nov. 28, 2012 in U.S. Appl. No. 12/436,300. |
| USPTO; Restriction Requirement dated Dec. 20, 2011 in U.S. Appl. No. 12/436,306. |
| USPTO; Non-Final Office Action dated Apr. 11, 2012 in U.S. Appl. No. 12/436,306. |
| USPTO; Final Office Action dated Sep. 26, 2012 in U.S. Appl. No. 12/436,306. |
| USPTO; Non-Final Office Action dated May 31, 2013 in U.S. Appl. No. 12/436,306. |
| USPTO; Final Office Action dated Oct. 17, 2013 in U.S. Appl. No. 12/436,306. |
| USPTO; Advisory Action dated Oct. 1, 2014 in U.S. Appl. No. 12/436,306. |
| USPTO; Non-Final Office Action dated Feb. 4, 2014 in U.S. Appl. No. 12/436,306. |
| USPTO; Final Office Action dated Jun. 23, 2014 in U.S. Appl. No. 12/436,306. |
| USPTO; Non-Final Office Action dated Feb. 3, 2015 in U.S. Appl. No. 12/436,306. |
| USPTO; Final Office Action dated May 13, 2015 in U.S. Appl. No. 12/436,306. |
| USPTO; Non-Final Office Action dated Oct. 14, 2015 in U.S. Appl. No. 12/436,306. |
| USPTO; Final Office Action dated Dec. 31, 2015 in U.S. Appl. No. 12/436,306. |
| USPTO; Notice of Allowance dated Feb. 3, 2016 in U.S. Appl. No. 12/436,306. |
| USPTO; Non-Final Office Action dated Aug. 3, 2011 in U.S. Appl. No. 12/436,315. |
| USPTO; Notice of Allowance dated Nov. 17, 2011 in U.S. Appl. No. 12/436,315. |
| USPTO; Notice of Allowance dated Oct. 1, 2010 in U.S. Appl. No. 12/467,017. |
| USPTO; Non-Final Office Action dated Mar. 18, 2010 in U.S. Appl. No. 12/489,252. |
| USPTO; Notice of Allowance dated Sep. 2, 2010 in U.S. Appl. No. 12/489,252. |
| USPTO; Non-Final Office Action dated Dec. 15, 2010 in U.S. Appl. No. 12/553,759. |
| USPTO; Final Office Action dated May 4, 2011 in U.S. Appl. No. 12/553,759. |
| USPTO; Advisory Action dated Jul. 13, 2011 in U.S. Appl. No. 12/553,759. |
| USPTO; Non-Final Office Action dated Sep. 6, 2011 in U.S. Appl. No. 12/553,759. |
| USPTO; Notice of Allowance dated Jan. 24, 2012 in U.S. Appl. No. 12/553,759. |
| USPTO; Non-Final Office Action dated Oct. 19, 2012 in U.S. Appl. No. 12/618,355. |
| USPTO; Final Office Action dated May 8, 2013 in U.S. Appl. No. 12/618,355. |
| USPTO; Advisory Action dated Jul. 23, 2013 in U.S. Appl. No. 12/618,355. |
| USPTO; Non-Final Office Action dated Apr. 8, 2015 in U.S. Appl. No. 12/618,355. |
| USPTO; Final Office Action dated Oct. 22, 2015 in U.S. Appl. No. 12/618,355. |
| USPTO; Advisory Action dated Mar. 4, 2016 in U.S. Appl. No. 12/618,355. |
| USPTO; Non-Final Office Action dated Jun. 30, 2016 in U.S. Appl. No. 12/618,355. |
| USPTO; Final Office Action dated Feb. 10, 2017 in U.S. Appl. No. 12/618,355. |
| USPTO; Advisory Action dated May 16, 2017 in U.S. Appl. No. 12/618,355. |
| USPTO; Non-Final Office Action dated Nov. 29, 2017 in U.S. Appl. No. 12/618,355. |
| USPTO; Final Office Action dated Aug. 10, 2018 in U.S. Appl. No. 12/618,355. |
| USPTO; Non-Final Office Action dated Feb. 16, 2012 in Application No. 12/618,419. |
| USPTO; Final Office Action dated Jun. 22, 2012 in U.S. Appl. No. 12/618,419. |
| USPTO; Non-Final Office Action dated Nov. 27, 2012 in U.S. Appl. No. 12/618,419. |
| USPTO; Advisory Action dated Aug. 9, 2012 in U.S. Appl. No. 12/618,419. |
| USPTO; Notice of Allowance dated Apr. 12, 2013 in U.S. Appl. No. 12/618,419. |
| USPTO; Notice of Allowance dated Oct. 9, 2013 in U.S. Appl. No. 12/618,419. |
| USPTO; Requirement for Restriction dated Sep. 12, 2011 in U.S. Appl. No. 12/718,731. |
| USPTO; Non-Final Office Action dated Dec. 6, 2011 in U.S. Appl. No. 12/718,731. |
| USPTO; Notice of Allowance dated Mar. 16, 2012 in U.S. Appl. No. 12/718,731. |
| USPTO; Restriction Requirement dated Jan. 15, 2013 in U.S. Appl. No. 12/754,223. |
| USPTO; Office Action dated Feb. 26, 2013 in U.S. Appl. No. 12/754,223. |
| USPTO; Final Office Action dated Jun. 28, 2013 in U.S. Appl. No. 12/754,223. |
| USPTO; Office Action dated Feb. 25, 2014 in U.S. Appl. No. 12/754,223. |
| USPTO; Final Office Action dated Jul. 14, 2014 in U.S. Appl. No. 12/754,223. |
| USPTO; Non-Final Office Action dated Mar. 25, 2015 in U.S. Appl. No. 12/754,223. |
| USPTO; Final Office Action dated Aug. 12, 2015 in U.S. Appl. No. 12/754,223. |
| USPTO; Notice of Allowance dated May 23, 2016 in U.S. Appl. No. 12/754,223. |
| USPTO; Office Action dated Apr. 23, 2013 in U.S. Appl. No. 12/763,037. |
| USPTO; Final Office Action dated Oct. 21, 2013 in U.S. Appl. No. 12/763,037. |
| USPTO; Office Action dated Oct. 8, 2014 in U.S. Appl. No. 12/763,037. |
| USPTO; Notice of Allowance dated Jan. 27, 2015 in U.S. Appl. No. 12/763,037. |
| USPTO; Non-Final Office Action dated Jan. 24, 2011 in U.S. Appl. No. 12/778,808. |
| USPTO; Notice of Allowance dated May 9, 2011 in U.S. Appl. No. 12/778,808. |
| USPTO; Notice of Allowance dated Oct. 12, 2012 in U.S. Appl. No. 12/832,739. |
| USPTO; Non-Final Office Action dated Oct. 16, 2012 in U.S. Appl. No. 12/847,848. |
| USPTO; Final Office Action dated Apr. 22, 2013 in U.S. Appl. No. 12/847,848. |
| USPTO; Advisory Action dated Jul. 1, 2013 in U.S. Appl. No. 12/847,848. |
| USPTO; Notice of Allowance dated Jan. 16, 2014 in U.S. Appl. No. 12/847,848. |
| USPTO; Restriction Requirement dated Sep. 25, 2012 in U.S. Appl. No. 12/854,818. |
| USPTO; Office Action dated Dec. 6, 2012 in U.S. Appl. No. 12/854,818. |
| USPTO; Final Office Action dated Mar. 13, 2013 in U.S. Appl. No. 12/854,818. |
| USPTO; Office Action dated Aug. 30, 2013 in U.S. Appl. No. 12/854,818. |
| USPTO; Final Office Action dated Mar. 26, 2014 in U.S. Appl. No. 12/854,818. |
| USPTO; Office Action dated Jun. 3, 2014 in U.S. Appl. No. 12/854,818. |
| USPTO; Non-Final Office Action dated Jul. 11, 2012 in U.S. Appl. No. 12/875,889. |
| USPTO; Notice of Allowance dated Jan. 4, 2013 in U.S. Appl. No. 12/875,889. |
| USPTO; Notice of Allowance dated Jan. 9, 2012 in U.S. Appl. No. 12/901,323. |
| USPTO; Requirement for Restriction dated Jul. 22, 2013 in U.S. Appl. No. 12/910,607. |
| USPTO; Non-Final Office Action dated Nov. 20, 2013 in U.S. Appl. No. 12/910,607. |
| USPTO; Final Office Action dated Apr. 28, 2014 in U.S. Appl. No. 12/910,607. |
| USPTO; Advisory Action dated Jul. 9, 2014 in U.S. Appl. No. 12/910,607. |
| USPTO; Notice of Allowance dated Aug. 15, 2014 in U.S. Appl. No. 12/910,607. |
| USPTO; Non-Final Office Action dated Oct. 24, 2012 in U.S. Appl. No. 12/940,906. |
| USPTO; Final Office Action dated Feb. 13, 2013 in U.S. Appl. No. 12/940,906. |
| USPTO; Notice of Allowance dated Apr. 23, 2013 in U.S. Appl. No. 12/940,906. |
| USPTO; Non-Final Office Action dated Dec. 7, 2012 in U.S. Appl. No. 12/953,870. |
| USPTO; Final Office Action dated Apr. 22, 2013 in U.S. Appl. No. 12/953,870. |
| USPTO; Advisory Action dated Jul. 8, 2013 in U.S. Appl. No. 12/953,870. |
| USPTO; Non-Final Office Action dated Aug. 28, 2013 in U.S. Appl. No. 12/953,870. |
| USPTO; Final Office Action dated Apr. 17, 2014 in U.S. Appl. No. 12/953,870. |
| USPTO; Requirement for Restriction dated Sep. 10, 2010 in U.S. Appl. No. 12/148,956. |
| USPTO; Non-Final Office Action dated Sep. 19, 2012 in U.S. Appl. No. 13/016,735. |
| USPTO; Final Office Action dated Feb. 11, 2013 in U.S. Appl. No. 13/016,735. |
| USPTO; Notice of Allowance dated Apr. 24, 2013 in U.S. Appl. No. 13/016,735. |
| USPTO; Non-Final Office Action dated Apr. 4, 2012 in U.S. Appl. No. 13/030,438. |
| USPTO; Final Office Action dated Aug. 22, 2012 in U.S. Appl. No. 13/030,438. |
| USPTO; Notice of Allowance dated Oct. 24, 2012 in U.S. Appl. No. 13/030,438. |
| USPTO; Non-Final Office Action dated Dec. 3, 2012 in U.S. Appl. No. 13/040,013. |
| USPTO; Notice of Allowance dated May 3, 2013 in U.S. Appl. No. 13/040,013. |
| USPTO; Notice of Allowance dated Sep. 13, 2012 in U.S. Appl. No. 13/085,698. |
| USPTO; Non-Final Office Action dated Mar. 29, 2013 in U.S. Appl. No. 13/094,402. |
| USPTO; Final Office Action dated Jul. 17, 2013 in U.S. Appl. No. 13/094,402. |
| USPTO; Notice of Allowance dated Sep. 30, 2013 in U.S. Appl. No. 13/094,402. |
| USPTO; Restriction Requirement dated May 8, 2013 in U.S. Appl. No. 13/102,980. |
| USPTO; Office Action dated Oct. 7, 2013 in U.S. Appl. No. 13/102,980. |
| USPTO; Final Office Action dated Mar. 25, 2014 in U.S. Appl. No. 13/102,980. |
| USPTO; Advisory Action dated Jun. 12, 2014 in U.S. Appl. No. 13/102,980. |
| USPTO; Notice of Allowance dated Jul. 3, 2014 in U.S. Appl. No. 13/102,980. |
| USPTO; Notice of Allowance dated Sep. 17, 2014 in U.S. Appl. No. 13/102,980. |
| USPTO; Requirement for Restriction dated Jun. 5, 2014 in U.S. Appl. No. 13/154,271. |
| USPTO; Non-Final Office Action dated Jul. 17, 2014 in U.S. Appl. No. 13/154,271. |
| USPTO; Final Office Action dated Jan. 2, 2015 in U.S. Appl. No. 13/154,271. |
| USPTO; Non-Final Office Action dated May 27, 2015 in U.S. Appl. No. 13/154,271. |
| USPTO; Final Office Action dated Nov. 23, 2015 in U.S. Appl. No. 13/154,271. |
| USPTO; Notice of Allowance dated Feb. 10, 2016 in U.S. Appl. No. 13/154,271. |
| USPTO; Requirement for Restriction dated Apr. 6, 2016 in U.S. Appl. No. 13/166,367. |
| USPTO; Non-Final Office Action dated Jun. 27, 2016 in U.S. Appl. No. 13/166,367. |
| USPTO; Final Office Action dated Dec. 30, 2016 in U.S. Appl. No. 13/166,367. |
| USPTO; Advisory Action dated Apr. 21, 2017 in U.S. Appl. No. 13/166,367. |
| USPTO; Requirement for Restriction dated Jun. 18, 2014 in U.S. Appl. No. 13/169,951. |
| USPTO; Non-Final Office Action dated Oct. 27, 2014 in U.S. Appl. No. 13/169,951. |
| USPTO; Final Office Action dated May 26, 2015 in U.S. Appl. No. 13/169,951. |
| USPTO; Non-Final Office Action dated Sep. 1, 2015 in U.S. Appl. No. 13/169,951. |
| USPTO; Final Office Action dated Mar. 3, 2016 in U.S. Appl. No. 13/169,951. |
| USPTO; Non-Final Office Action dated Jun. 9, 2016 in U.S. Appl. No. 13/169,951. |
| USPTO; Final Office Action dated Dec. 9, 2016 in U.S. Appl. No. 13/169,951. |
| USPTO; Advisory Action dated May 13, 2016 in U.S. Appl. No. 13/169,951. |
| USPTO; Advisory Action dated Feb. 15, 2017 in U.S. Appl. No. 13/169,951. |
| USPTO; Non-Final Office Action dated Apr. 26, 2017 in U.S. Appl. No. 13/169,951. |
| USPTO; Final Office Action dated Nov. 2, 2017 in U.S. Appl. No. 13/169,951. |
| USPTO; Advisory Action dated Feb. 8, 2018 in U.S. Appl. No. 13/169,951. |
| USPTO; Non-Final Office Action dated Apr. 6, 2018 in U.S. Appl. No. 13/169,951. |
| USPTO; Non-Final Office Action dated Jun. 24, 2014 in U.S. Appl. No. 13/181,407. |
| USPTO; Final Office Action dated Sep. 24, 2014 in U.S. Appl. No. 13/181,407. |
| USPTO; Advisory Action dated Dec. 17, 2014 in U.S. Appl. No. 13/181,407. |
| USPTO; Non-Final Office Action dated Jan. 2, 2015 in U.S. Appl. No. 13/181,407. |
| USPTO; Final Office Action dated Apr. 8, 2015 in U.S. Appl. No. 13/181,407. |
| USPTO; Requirement for Restriction Sep. 25, 2012 in U.S. Appl. No. 13/184,351. |
| USPTO; Non-Final Office Action dated Jan. 23, 2013 in U.S. Appl. No. 13/184,351. |
| USPTO; Final Office Action dated Jul. 29, 2013 in U.S. Appl. No. 13/184,351. |
| USPTO; Advisory Action dated Nov. 7, 2013 in U.S. Appl. No. 13/184,351. |
| USPTO; Non-Final Office Action dated Jul. 16, 2014 in U.S. Appl. No. 13/184,351. |
| USPTO; Final Office Action dated Feb. 17, 2015 in U.S. Appl. No. 13/184,351. |
| USPTO; Advisory Action dated May 18, 2015 in U.S. Appl. No. 13/184,351. |
| USPTO; Non-Final Office Action dated Aug. 10, 2015 in U.S. Appl. No. 13/184,351. |
| USPTO; Final Office Action dated Feb. 12, 2016 in Application No. 13/184,351. |
| USPTO; Non-Final Office Action dated Dec. 15, 2016 in U.S. Appl. No. 13/184,351. |
| USPTO; Final Office Action dated Jun. 15, 2017 in U.S. Appl. No. 13/184,351. |
| USPTO; Advisory Action dated Oct. 4, 2017 in U.S. Appl. No. 13/184,351. |
| USPTO; Non-Final Office Action dated Jul. 26, 2018 in U.S. Appl. No. 13/184,351. |
| USPTO; Restriction Requirement dated Aug. 21, 2014 in U.S. Appl. No. 13/187,300. |
| USPTO; Non-Final Office Action dated Sep. 17, 2014 in U.S. Appl. No. 13/187,300. |
| USPTO; Final Office Action dated Apr. 15, 2015 in U.S. Appl. No. 13/187,300. |
| USPTO; Non-Final Office Action dated Apr. 7, 2016 in U.S. Appl. No. 13/187,300. |
| USPTO; Final Office Acton dated Sep. 23, 2016 in U.S. Appl. No. 13/187,300. |
| USPTO; Non-Final Office Action dated Jan. 30, 2017 in U.S. Appl. No. 13/187,300. |
| USPTO; Final Office Action dated Aug. 9, 2017 in U.S. Appl. No. 13/187,300. |
| USPTO; Non-Final Office Action dated Oct. 1, 2012 in U.S. Appl. No. 13/191,762. |
| USPTO; Final Office Action dated Apr. 10, 2013 in U.S. Appl. No. 13/191,762. |
| USPTO; Notice of Allowance dated Aug. 15, 2013 in U.S. Appl. No. 13/191,762. |
| USPTO; Non-Final Office Action dated Oct. 22, 2012 in U.S. Appl. No. 13/238,960. |
| USPTO; Final Office Action dated May 3, 2013 in U.S. Appl. No. 13/238,960. |
| USPTO; Non-Final Office Action dated Apr. 26, 2013 in U.S. Appl. No. 13/250,721. |
| USPTO; Notice of Allowance dated Sep. 11, 2013 in U.S. Appl. No. 13/250,721. |
| USPTO; Non-Final Office Action dated Jul. 2, 2014 in U.S. Appl. No. 13/283,408. |
| USPTO; Final Office Action dated Jan. 29, 2015 in U.S. Appl. No. 13/283,408. |
| USPTO; Non-Final Office Action dated Jun. 17, 2015 in U.S. Appl. No. 13/283,408. |
| USPTO; Final Office Action dated Dec. 18, 2015 in U.S. Appl. No. 13/283,408. |
| USPTO; Advisory Action dated Mar. 28, 2016 in U.S. Appl. No. 13/283,408. |
| USPTO; Notice of Allowance dated Mar. 28, 2016 in U.S. Appl. No. 13/283,408. |
| USPTO; Restriction Requirement dated Dec. 16, 2013 in U.S. Appl. No. 13/284,642. |
| USPTO; Restriction Requirement dated Apr. 21, 2014 in U.S. Appl. No. 13/284,642. |
| USPTO; Office Action dated Jul. 30, 2014 in U.S. Appl. No. 13/284,642. |
| USPTO; Notice of Allowance dated Feb. 11, 2015 in U.S. Appl. No. 13/284,642. |
| USPTO; Restriction Requirement dated Oct. 2, 2013 in U.S. Appl. No. 13/312,591. |
| USPTO; Office Action dated Jan. 28, 2014 in U.S. Appl. No. 13/312,591. |
| USPTO; Final Office Action dated May 14, 2014 in U.S. Appl. No. 13/312,591. |
| USPTO; Advisory Action dated Aug. 26, 2014 in U.S. Appl. No. 13/312,591. |
| USPTO; Non-Final Office Action dated Nov. 26, 2014 in U.S. Appl. No. 13/312,591. |
| USPTO; Final Office Action dated Mar. 20, 2015 in U.S. Appl. No. 13/312,591. |
| USPTO; Notice of Allowance dated May 14, 2015 in U.S. Appl. No. 13/312,591. |
| USPTO; Notice of Allowance dated Jun. 11, 2015 in U.S. Appl. No. 13/312,591. |
| USPTO; Requirement for Restriction dated Nov. 26, 2013 in U.S. Appl. No. 13/333,420. |
| USPTO; Non-Final Office Action dated Apr. 9, 2014 in U.S. Appl. No. 13/333,420. |
| USPTO; Notice of Allowance dated Sep. 15, 2014 in U.S. Appl. No. 13/333,420. |
| USPTO; Requirement for Restriction dated Jan. 10, 2013 in U.S. Appl. No. 13/339,609. |
| USPTO; Office Action dated Feb. 11, 2013 in U.S. Appl. No. 13/339,609. |
| USPTO; Final Office Action dated May 17, 2013 in U.S. Appl. No. 13/339,609. |
| USPTO; Office Action dated Aug. 29, 2013 in U.S. Appl. No. 13/339,609. |
| USPTO; Final Office Action dated Dec. 18, 2013 in U.S. Appl. No. 13/339,609. |
| USPTO; Notice of Allowance dated Apr. 7, 2014 in U.S. Appl. No. 13/339,609. |
| USPTO; Non-Final Office Action dated Oct. 10, 2012 in U.S. Appl. No. 13/406,791. |
| USPTO; Final Office Action dated Jan. 31, 2013 in U.S. Appl. No. 13/406,791. |
| USPTO; Advisory Action dated Mar. 27, 2013 in U.S. Appl. No. 13/406,791. |
| USPTO; Non-Final Office Action dated Apr. 25, 2013 in U.S. Appl. No. 13/406,791. |
| USPTO; Final Office Action dated Aug. 23, 2013 in U.S. Appl. No. 13/406,791. |
| USPTO; Advisory Action dated Oct. 29, 2013 in U.S. Appl. No. 13/406,791. |
| USPTO; Non-Final Office Action dated Dec. 4, 2013 in U.S. Appl. No. 13/406,791. |
| USPTO; Final Office Action dated Apr. 21, 2014 in U.S. Appl. No. 13/406,791. |
| USPTO; Non-Final Office Action dated Jan. 14, 2013 in U.S. Appl. No. 13/410,970. |
| USPTO; Notice of Allowance dated Feb. 14, 2013 in U.S. Appl. No. 13/410,970. |
| USPTO; Non-Final Office Action dated Feb. 13, 2014 in U.S. Appl. No. 13/411,271. |
| USPTO; Non-Final Office Action dated Jul. 31, 2014 in U.S. Appl. No. 13/411,271. |
| USPTO; Advisory Action dated Apr. 22, 2015 in U.S. Appl. No. 13/411,271. |
| USPTO; Final Office Action dated Jan. 16, 2015 in U.S. Appl. No. 13/411,271. |
| USPTO; Notice of Allowance dated Oct. 6, 2015 in U.S. Appl. No. 13/411,271. |
| USPTO; Office Action dated Feb. 4, 2014 in U.S. Appl. No. 13/439,528. |
| USPTO; Final Office Action dated Jul. 8, 2014 in U.S. Appl. No. 13/439,528. |
| UPPTO; Notice of Allowance dated Oct. 21, 2014 in U.S. Appl. No. 13/439,528. |
| USPTO; Non-Final Office Action dated Apr. 11, 2013 in U.S. Appl. No. 13/450,368. |
| USPTO; Notice of Allowance dated Jul. 17, 2013 in U.S. Appl. No. 13/450,368. |
| USPTO; Office Action dated May 23, 2013 in U.S. Appl. No. 13/465,340. |
| USPTO; Final Office Action dated Oct. 30, 2013 in U.S. Appl. No. 13/465,340. |
| USPTO; Notice of Allowance dated Feb. 12, 2014 in U.S. Appl. No. 13/465,340. |
| USPTO; Non-Final Office Action dated Oct. 17, 2013 in U.S. Appl. No. 13/493,897. |
| USPTO; Notice of Allowance dated Mar. 20, 2014 in U.S. Appl. No. 13/493,897. |
| USPTO; Office Action dated Dec. 20, 2013 in U.S. Appl. No. 13/535,214. |
| USPTO; Final Office Action dated Jun. 18, 2014 in U.S. Appl. No. 13/535,214. |
| USPTO; Notice of Allowance dated Oct. 23, 2014 in U.S. Appl. No. 13/535,214. |
| USPTO; Non-Final Office Action dated Sep. 11, 2013 in U.S. Appl. No. 13/550,419. |
| USPTO; Final Office Action dated Jan. 27, 2014 in U.S. Appl. No. 13/550,419. |
| USPTO; Advisory Action dated Mar. 31, 2014 in U.S. Appl. No. 13/550,419. |
| USPTO; Notice of Allowance dated May 29, 2014 in U.S. Appl. No. 13/550,419. |
| USPTO; Non-Final Office Action dated Aug. 8, 2014 in U.S. Appl. No. 13/563,066. |
| USPTO; Final Office Action dated Feb. 12, 2015 in U.S. Appl. No. 13/563,066. |
| USPTO; Advisory Action dated Apr. 16, 2015 in U.S. Appl. No. 13/563,066. |
| USPTO; Notice of Allowance dated Jun. 12, 2015 in U.S. Appl. No. 13/563,066. |
| USPTO; Notice of Allowance dated Jul. 16, 2015 in U.S. Appl. No. 13/563,066. |
| USPTO; Non-Final Office Action dated May 28, 2013 in U.S. Appl. No. 13/563,274. |
| USPTO; Notice of Allowance dated Sep. 27, 2013 in U.S. Appl. No. 13/563,274. |
| USPTO; Non-Final Office Action dated Nov. 7, 2013 in U.S. Appl. No. 13/565,564. |
| USPTO; Final Office Action dated Feb. 28, 2014 in U.S. Appl. No. 13/565,564. |
| USPTO; Advisory Action dated May 5, 2014 in U.S. Appl. No. 13/565,564. |
| USPTO; Non-Final Office Action dated Jul. 2, 2014 in U.S. Appl. No. 13/565,564. |
| USPTO; Notice of Allowance dated Nov. 3, 2014 in U.S. Appl. No. 13/565,564. |
| USPTO; Notice of Allowance dated Sep. 13, 2013 in U.S. Appl. No. 13/566,069. |
| USPTO; Non-Final Office Action dated Aug. 30, 2013 in U.S. Appl. No. 13/570,067. |
| USPTO; Notice of Allowance dated Jan. 6, 2014 in U.S. Appl. No. 13/570,067. |
| USPTO; Non-Final Office Action dated Oct. 15, 2014 in U.S. Appl. No. 13/597,043. |
| USPTO; Final Office Action dated Mar. 13, 2015 in U.S. Appl. No. 13/597,043. |
| USPTO; Notice of Allowance dated Aug. 28, 2015 in U.S. Appl. No. 13/597,043. |
| USPTO; Non-Final Office Action dated Feb. 12, 2015 in U.S. Appl. No. 13/597,108. |
| USPTO; Final Office Action dated Jun. 1, 2015 in U.S. Appl. No. 13/597,108. |
| USPTO; Advisory Action dated Sep. 2, 2015 in U.S. Appl. No. 13/597,108. |
| USPTO; Non-Final Office Action dated Dec. 8, 2015 in U.S. Appl. No. 13/597,108. |
| USPTO; Final Office Action dated Jun. 2, 2016 in U.S. Appl. No. 13/597,108. |
| USPTO; Non-Final Office Action dated Sep. 15, 2016 in U.S. Appl. No. 13/597,108. |
| USPTO; Notice of Allowance dated Mar. 7, 2017 in U.S. Appl. No. 13/597,108. |
| USPTO; Notice of Allowance dated Mar. 27, 2014 in U.S. Appl. No. 13/604,498. |
| USPTO; Restriction Requirement dated Jul. 9, 2013 in U.S. Appl. No. 13/612,538. |
| USPTO; Office Action dated Nov. 15, 2013 in U.S. Appl. No. 13/612,538. |
| USPTO; Office Action dated Jul. 10, 2014 in U.S. Appl. No. 13/612,538. |
| USPTO; Notice of Allowance dated Feb. 25, 2015 in U.S. Appl. No. 13/612,538. |
| USPTO; Requirement for Restriction dated Feb. 4, 2015 in U.S. Appl. No. 13/646,403. |
| USPTO; Non-Final Office Action dated Apr. 15, 2015 in U.S. Appl. No. 13/646,403. |
| USPTO; Final Office Action dated Oct. 15, 2015 in U.S. Appl. No. 13/646,403. |
| USPTO; Notice of Allowance dated Feb. 2, 2016 in U.S. Appl. No. 13/646,403. |
| USPTO; Requirement for Restriction dated Apr. 11, 2014 in U.S. Appl. No. 13/646,471. |
| USPTO; Non-Final Office Action dated May 15, 2014 in U.S. Appl. No. 13/646,471. |
| USPTO; Final Office Action dated Aug. 18, 2014 in U.S. Appl. No. 13/646,471. |
| USPTO; Advisory Action dated Nov. 14, 2014 in U.S. Appl. No. 13/646,471. |
| USPTO; Non-Final Office Action dated Dec. 16, 2014 in U.S. Appl. No. 13/646,471. |
| USPTO; Final Office Action dated Apr. 21, 2015 in U.S. Appl. No. 13/646,471. |
| USPTO; Non-Final Office Action dated Aug. 19, 2015 in U.S. Appl. No. 13/646,471. |
| USPTO; Final Office Action dated Jan. 22, 2016 in U.S. Appl. No. 13/646,471. |
| USPTO; Advisory Action dated Apr. 15, 2016 in U.S. Appl. No. 13/646,471. |
| USPTO; Non-Final Office Action dated Jun. 2, 2016 in U.S. Appl. No. 13/646,471. |
| USPTO; Final Office Action dated Oct. 20, 2016 in U.S. Appl. No. 13/646,471. |
| USPTO; Restriction Requirement dated Mar. 4, 2015 in U.S. Appl. No. 13/651,144. |
| USPTO; Non-Final Office Action dated May 28, 2015 in U.S. Appl. No. 13/651,144. |
| USPTO; Final Office Action dated Dec. 14, 2017 in U.S. Appl. No. 13/651,144. |
| USPTO; Final Office Action dated Nov. 19, 2015 in U.S. Appl. No. 13/651,144. |
| USPTO; Non-Final Office Action dated May 10, 2016 in U.S. Appl. No. 13/651,144. |
| USPTO; Final Office Action dated Sep. 20, 2016 in U.S. Appl. No. 13/651,144. |
| USPTO; Non-Final Office Action dated May 17, 2017 in U.S. Appl. No. 13/651,144. |
| USPTO; Non-Final Office Action dated Dec. 14, 2017 in U.S. Appl. No. 13/651,144. |
| USPTO; Advisory Action dated Apr. 19, 2018 in U.S. Appl. No. 13/651,144. |
| USPTO; Non-Final Office Action dated Nov. 19, 2015 in U.S. Appl. No. 14/659,437. |
| USPTO; Final Office Action dated Mar. 17, 2016 in U.S. Appl. No. 14/659,437. |
| USPTO; Notice of Allowance dated May 31, 2016 in U.S. Appl. No. 14/659,437. |
| USPTO; Requirement for Restriction dated Dec. 24, 2014 in U.S. Appl. No. 13/665,366. |
| USPTO; Non-Final Office Action dated Jun. 18, 2015 in U.S. Appl. No. 13/665,366. |
| USPTO; Final Office Action dated Mar. 1, 2016 in U.S. Appl. No. 13/665,366. |
| USPTO; Advisory Action dated May 13, 2016 in U.S. Appl. No. 13/665,366. |
| USPTO; Non-Final Office Action dated Jun. 17, 2016 in U.S. Appl. No. 13/665,366. |
| USPTO; Final Office Action dated May 3, 2017 in U.S. Appl. No. 13/665,366. |
| USPTO; Non-Final Office Action dated Apr. 3, 2015 in U.S. Appl. No. 13/677,133. |
| USPTO; Notice of Allowance dated Aug. 4, 2015 in U.S. Appl. No. 13/677,133. |
| USPTO; Notice of Allowance dated Aug. 24, 2015 in U.S. Appl. No. 13/677,133. |
| USPTO; Office Action dated Jun. 2, 2014 in U.S. Appl. No. 13/677,151. |
| USPTO; Final Office Action dated Nov. 14, 2014 in U.S. Appl. No. 13/677,151. |
| USPTO; Notice of Allowance dated Feb. 26, 2015 in U.S. Appl. No. 13/677,151. |
| USPTO; Notice of Allowance dated Mar. 17, 2015 in U.S. Appl. No. 13/677,151. |
| USPTO; Non-Final Office Action dated Aug. 20, 2013 in U.S. Appl. No. 13/679,502. |
| USPTO; Final Office Action dated Feb. 25, 2014 in U.S. Appl. No. 13/679,502. |
| USPTO; Notice of Allowance dated May 2, 2014 in U.S. Appl. No. 13/679,502. |
| USPTO; Non-Final Office Action dated Jul. 21, 2015 in U.S. Appl. No. 13/727,324. |
| USPTO; Final Office Action dated Jan. 22, 2016 in U.S. Appl. No. 13/727,324. |
| USPTO; Advisory Action dated Apr. 6, 2016 in U.S. Appl. No. 13/727,324. |
| USPTO; Non-Final Office Action dated May 25, 206 in U.S. Appl. No. 13/727,324. |
| USPTO; Final Office Action dated Dec. 1, 2016 in U.S. Appl. No. 13/727,324. |
| USPTO; Notice of Allowance dated Mar. 1, 2017 in U.S. Appl. No. 13/727,324. |
| USPTO; Non-Final Office Action dated Oct. 24, 2013 in U.S. Appl. No. 13/749,878. |
| USPTO; Non-Final Office Action dated Jun. 18, 2014 in U.S. Appl. No. 13/749,878. |
| USPTO; Final Office Action dated Dec. 10, 2014 in U.S. Appl. No. 13/749,878. |
| USPTO; Notice of Allowance Mar. 13, 2015 dated in U.S. Appl. No. 13/749,878. |
| USPTO; Non-Final Office Action dated Sep. 16, 2013 in U.S. Appl. No. 13/760,160. |
| USPTO; Final Office Action dated Dec. 27, 2013 in U.S. Appl. No. 13/760,160. |
| USPTO; Non-Final Office Action dated Jun. 4, 2014 in U.S. Appl. No. 13/760,160. |
| USPTO; Final Office Action dated Sep. 25, 2014 in U.S. Appl. No. 13/760,160. |
| USPTO; Final Office Action dated Jan. 28, 2015 in U.S. Appl. No. 13/760,160. |
| USPTO; Final Office Action dated May 12, 2015 in U.S. Appl. No. 13/760,160. |
| USPTO; Notice of Allowance dated Oct. 21, 2015 in U.S. Appl. No. 13/760,160. |
| USPTO; Notice of Allowance dated Jan. 20, 2016 in U.S. Appl. No. 13/760,160. |
| USPTO; Office Action dated Apr. 23, 2014 in U.S. Appl. No. 13/784,362. |
| USPTO; Notice of Allowance dated Aug. 13, 2014 in U.S. Appl. No. 13/784,362. |
| USPTO; Non-Final Office Action dated Dec. 19, 2013 in U.S. Appl. No. 13/784,388. |
| USPTO; Notice of Allowance dated Jun. 4, 2014 in U.S. Appl. No. 13/784,388. |
| USPTO; Restriction Requirement dated May 8, 2014 in U.S. Appl. No. 13/791,246. |
| USPTO; Non-Final Office Action dated Sep. 19, 2014 in U.S. Appl. No. 13/791,246. |
| USPTO; Final Office Action dated Mar. 25, 2015 in U.S. Appl. No. 13/791,246. |
| USPTO; Non-Final Office Action dated Oct. 26, 2015 in U.S. Appl. No. 13/791,246. |
| USPTO; Final Office Action dated Apr. 20, 2016 in U.S. Appl. No. 13/791,246. |
| USPTO; Advisory Action dated Jul. 13, 2016 in U.S. Appl. No. 13/791,246. |
| USPTO; Non-Final Office Action dated Aug. 11, 2016 in U.S. Appl. No. 13/791,246. |
| USPTO; Notice of Allowance dated Oct. 19, 2016 in U.S. Appl. No. 13/791,246. |
| USPTO; Notice of Allowance dated Nov. 25, 2016 in U.S. Appl. No. 13/791,246. |
| USPTO; Non-Final Office Action dated Nov. 6, 2015 in U.S. Appl. No. 13/791,339. |
| USPTO; Final Office Action dated Apr. 12, 2016 in U.S. Appl. No. 13/791,339. |
| USPTO; Advisory Action dated Jul. 14, 2016 in U.S. Appl. No. 13/791,339. |
| USPTO; Notice of Allowance dated Aug. 24, 2016 in U.S. Appl. No. 13/791,339. |
| USPTO; Non-Final Office Action dated Mar. 21, 2014 in U.S. Appl. No. 13/799,708. |
| USPTO; Notice of Allowance dated Oct. 31, 2014 in U.S. Appl. No. 13/799,708. |
| USPTO; Non-Final Office Action dated Sep. 1, 2016 in U.S. Appl. No. 14/827,177. |
| USPTO; Restriction Requirement dated Jun. 26, 2014 in U.S. Appl. No. 13/874,708. |
| USPTO; Non-Final Office Action dated Oct. 9, 2014 in U.S. Appl. No. 13/874,708. |
| USPTO; Notice of Allowance dated Mar. 10, 2015 in U.S. Appl. No. 13/874,708. |
| USPTO; Notice of Allowance dated Apr. 10, 2014 in U.S. Appl. No. 13/901,341. |
| USPTO; Notice of Allowance dated Jun. 6, 2014 in U.S. Appl. No. 13/901,341. |
| USPTO; Non-Final Office Action dated Jan. 2, 2015 in U.S. Appl. No. 13/901,372. |
| USPTO; Final Office Action dated Apr. 16, 2015 in U.S. Appl. No. 13/901,372. |
| USPTO; Notice of Allowance dated Aug. 5, 2015 in U.S. Appl. No. 13/901,372. |
| USPTO; Advisory Action dated Jun. 29, 2015 in U.S. Appl. No. 13/901,372. |
| USPTO; Non-Final Office Action dated Jul. 8, 2015 in U.S. Appl. No. 13/901,400. |
| USPTO; Final Office Action dated Jan. 14, 2016 in U.S. Appl. No. 13/901,400. |
| USPTO; Notice of Allowance dated Apr. 12, 2016 in U.S. Appl. No. 13/901,400. |
| USPTO; Non-Final Office Action dated Apr. 24, 2014 in U.S. Appl. No. 13/912,666. |
| USPTO; Final Office Action dated Sep. 25, 2014 in U.S. Appl. No. 13/912,666. |
| USPTO; Advisory Action dated Dec. 11, 2014 in U.S. Appl. No. 13/912,666. |
| USPTO; Non-Final Office Action dated Jan. 26, 2015 in U.S. Appl. No. 13/912,666. |
| USPTO; Notice of Allowance dated Jun. 25, 2015 in U.S. Appl. No. 13/912,666. |
| USPTO; Requirement for Restriction dated Sep. 4, 2014 in U.S. Appl. No. 13/915,732. |
| USPTO; Non-Final Office Action dated Dec. 16, 2014 in U.S. Appl. No. 13/915,732. |
| USPTO; Final Office Action dated Apr. 10, 2015 in U.S. Appl. No. 13/915,732. |
| USPTO; Notice of Allowance dated Jun. 19, 2015 in U.S. Appl. No. 13/915,732. |
| USPTO; Notice of Allowance dated Mar. 17, 2015 in U.S. Appl. No. 13/923,197. |
| USPTO; Non-Final Office Action dated Sep. 12, 2014 in U.S. Appl. No. 13/941,134. |
| USPTO; Notice of Allowance dated Jan. 20, 2015 in U.S. Appl. No. 13/941,134. |
| USPTO; Restriction Requirement dated Apr. 30, 2015 in U.S. Appl. No. 13/941,216. |
| USPTO; Non-Final Office Action dated Jul. 30, 2015 in U.S. Appl. No. 13/941,216. |
| USPTO; Final Office Action dated Mar. 1, 2016 in U.S. Appl. No. 13/941,216. |
| USPTO; Non-Final Office Action dated Jun. 15, 2016 in U.S. Appl. No. 13/941,216. |
| USPTO; Notice of Allowance dated Sep. 13, 2016 in U.S. Appl. No. 13/941,216. |
| USPTO; Notice of Allowance dated Nov. 14, 2016 in U.S. Appl. No. 13/941,216. |
| USPTO; Non-Final Office Action dated Jan. 14, 2014 in U.S. Appl. No. 13/941,226. |
| USPTO; Non-Final Office Action dated Jul. 8, 2014 in U.S. Appl. No. 13/941,226. |
| USPTO; Non-Final Office Action dated Feb. 3, 2015 in U.S. Appl. No. 13/941,226. |
| USPTO; Final Office Action dated Feb. 12, 2016 in U.S. Appl. No. 13/941,226. |
| USPTO; Advisory Action dated Jul. 29, 2016 in U.S. Appl. No. 13/941,226. |
| USPTO; Non-Final Office Action dated Aug. 8, 2017 in U.S. Appl. No. 13/941,226. |
| USPTO; Restriction Requirement dated Sep. 16, 2014 in U.S. Appl. No. 13/948,055. |
| USPTO; Non-Final Office Action dated Oct. 30, 2014 in U.S. Appl. No. 13/948,055. |
| USPTO; Notice of Allowance dated Feb. 27, 2015 in U.S. Appl. No. 13/948,055. |
| USPTO; Notice of Allowance dated Mar. 31, 2015 in U.S. Appl. No. 13/948,055. |
| USPTO; Non-Final Office Action dated Jun. 29, 2015 in U.S. Appl. No. 13/966,782. |
| USPTO; Final Office Action dated Jan. 4, 2016 in U.S. Appl. No. 13/966,782. |
| USPTO; Notice of Allowance dated Mar. 21, 2016 in U.S. Appl. No. 13/966,782. |
| USPTO; Notice of Allowance dated Oct. 7, 2015 in U.S. Appl. No. 13/973,777. |
| USPTO; Non-Final Office Action dated Feb. 20, 2015 in U.S. Appl. No. 14/018,231. |
| USPTO; Notice of Allowance dated Jul. 20, 2015 in U.S. Appl. No. 14/018,231. |
| USPTO; Restriction Requirement Action dated Jan. 28, 2015 in U.S. Appl. No. 14/018,345. |
| USPTO; Non-Final Office Action dated Apr. 7, 2015 in U.S. Appl. No. 14/018,345. |
| USPTO; Final Office Action dated Sep. 14, 2015 in U.S. Appl. No. 14/018,345. |
| USPTO; Notice of Allowance dated Jan. 14, 2016 in U.S. Appl. No. 14/018,345. |
| USPTO; Notice of Allowance dated Mar. 17, 2016 in U.S. Appl. No. 14/018,345. |
| USPTO; Non-Final Office Action dated Mar. 26, 2015 in U.S. Appl. No. 14/031,982. |
| USPTO; Final Office Action dated Aug. 28, 2015 in U.S. Appl. No. 14/031,982. |
| USPTO; Notice of Allowance dated Nov. 17, 2015 in U.S. Appl. No. 14/031,982. |
| USPTO; Non-Final Office Action Restriction dated Jan. 2, 2015 in U.S. Appl. No. 14/040,196. |
| USPTO; Non-Final Office Action dated Apr. 28, 2015 in U.S. Appl. No. 14/040,196. |
| USPTO; Notice of Allowance dated Sep. 11, 2015 in U.S. Appl. No. 14/040,196. |
| USPTO; Non-Final Action dated Dec. 3, 2015 in U.S. Appl. No. 14/050,150. |
| USPTO; Final Office Action dated Jun. 15, 2016 in U.S. Appl. No. 14/050,150. |
| USPTO; Final Office Action dated Jul. 8, 2016 in U.S. Appl. No. 14/050,150. |
| USPTO; Notice of Allowance dated Oct. 20, 2016 in U.S. Appl. No. 14/050,150. |
| USPTO; Non-Final Office Action dated Dec. 15, 2014 in U.S. Appl. No. 14/065,114. |
| USPTO; Final Office Action dated Jun. 19, 2015 in U.S. Appl. No. 14/065,114. |
| USPTO; Advisory Action dated Aug. 24, 2015 in U.S. Appl. No. 14/065,114. |
| USPTO; Non-Final Office Action dated Oct. 7, 2015 in U.S. Appl. No. 14/065,114. |
| USPTO; Notice of Allowance dated Feb. 22, 2016 in U.S. Appl. No. 14/065,114. |
| USPTO; Non-Final Office Action dated Nov. 14, 2014 in U.S. Appl. No. 14/069,244. |
| USPTO; Notice of Allowance dated Mar. 25, 2015 in U.S. Appl. No. 14/069,244. |
| USPTO; Non-Final Office Action dated Mar. 19, 2015 in U.S. Appl. No. 14/079,302. |
| USPTO; Final Office Action dated Sep. 1, 2015 in U.S. Appl. No. 14/079,302. |
| USPTO; Non-Final Office Action dated Dec. 23, 2015 in U.S. Appl. No. 14/079,302. |
| USPTO; Non-Final Office Action dated Apr. 27, 2016 in U.S. Appl. No. 14/079,302. |
| USPTO; Final Office Action dated Aug. 22, 2016 in U.S. Appl. No. 14/079,302. |
| USPTO; Notice of Allowance dated Dec. 14, 2016 in U.S. Appl. No. 14/079,302. |
| USPTO; Requirement for Restriction dated Aug. 11, 2015 in U.S. Appl. No. 14/090,750. |
| USPTO; Non-Final Office Action dated Sep. 9, 2015 in U.S. Appl. No. 14/090,750. |
| USPTO; Final Office Action dated Feb. 11, 2016 in U.S. Appl. No. 14/090,750. |
| USPTO; Advisory Action dated May 5, 2016 in U.S. Appl. No. 14/090,750. |
| USPTO; Non-Final Office Action dated Jun. 14, 2016 in U.S. Appl. No. 14/090,750. |
| USPTO; Advisory Action dated Dec. 21, 2016 in U.S. Appl. No. 14/090,750. |
| USPTO; Advisory Action dated Jan. 30, 2018 in U.S. Appl. No. 14/090,750. |
| USPTO; Final Office Action dated Sep. 28, 2016 in U.S. Appl. No. 14/090,750. |
| USPTO; Non Final Office Action dated Jun. 23, 2017 in U.S. Appl. No. 14/090,750. |
| USPTO; Final Office Action dated Nov. 17, 2017 in U.S. Appl. No. 14/090,750. |
| USPTO; Non-Final Office Action dated Mar. 12, 2018 in U.S. Appl. No. 14/090,750. |
| USPTO; Non-Final Office Action dated Mar. 19, 2015 in U.S. Appl. No. 14/166,462. |
| USPTO; Notice of Allowance dated Sep. 3, 2015 in U.S. Appl. No. 14/166,462. |
| USPTO; Non-Final Office Action dated Nov. 17, 2015 in U.S. Appl. No. 14/172,220. |
| USPTO; Office Action dated May 29, 2014 in U.S. Appl. No. 14/183,187. |
| USPTO; Final Office Action dated Nov. 7, 2014 in U.S. Appl. No. 14/183,187. |
| USPTO; Advisory Action dated Feb. 20, 2015 in U.S. Appl. No. 14/183,187. |
| USPTO; Non-Final Office Action dated Mar. 16, 2015 in U.S. Appl. No. 14/183,187. |
| USPTO; Final Office Action dated Jul. 10, 2015 in U.S. Appl. No. 14/183,187. |
| USPTO; Notice of Allowance dated Aug. 31, 2015 in U.S. Appl. No. 14/183,187. |
| USPTO; Requirement for Restriction dated Sep. 24, 2015 in U.S. Appl. No. 14/188,760. |
| USPTO; Non-Final Office Action dated Jan. 11, 2016 in U.S. Appl. No. 14/188,760. |
| USPTO; Final Office Action dated Aug. 25, 2016 in U.S. Appl. No. 14/188,760. |
| USPTO; Advisory Action dated Jan. 12, 2017 in U.S. Appl. No. 14/188,760. |
| USPTO; Non-Final Office Action dated Mar. 23, 2017 in U.S. Appl. No. 14/188,760. |
| USPTO; Final Office Action dated Oct. 5, 2017 in U.S. Appl. No. 14/188,760. |
| USPTO; Advisory Action dated Jan. 3, 2018 in U.S. Appl. No. 14/188,760. |
| USPTO; Non-Final Office Action dated Apr. 18, 2018 in U.S. Appl. No. 14/188,760. |
| USPTO; Non-Final Office Action dated Oct. 8, 2015 in U.S. Appl. No. 14/218,374. |
| USPTO; Final Office Action dated Feb. 23, 2016 in U.S. Appl. No. 14/218,374. |
| USPTO; Advisory Action dated Apr. 29, 2016 in U.S. Appl. No. 14/218,374. |
| USPTO; Notice of Allowance dated Aug. 5, 2016 in U.S. Appl. No. 14/218,374. |
| USPTO; Restriction Requirement dated May 20, 2016 in U.S. Appl. No. 14/218,690. |
| USPTO; Non-Final Office Action dated Jul. 15, 2016 in U.S. Appl. No. 14/218,690. |
| USPTO; Final Office Action dated Nov. 14, 2016 in U.S. Appl. No. 14/218,690. |
| USPTO; Non-Final Office Action dated Apr. 6, 2017 in U.S. Appl. No. 14/218,690. |
| USPTO; Final Office Action dated Jul. 20, 2017 in U.S. Appl. No. 14/218,690. |
| USPTO; Non-Final Office Action dated Jan. 11, 2018 in U.S. Appl. No. 14/218,690. |
| USPTO; Final Office Action dated May 24, 2018 in U.S. Appl. No. 14/218,690. |
| USPTO; Non-Final Office Action dated Sep. 22, 2015 in U.S. Appl. No. 14/219,839. |
| USPTO; Final Office Action dated Mar. 25, 2016 in U.S. Appl. No. 14/219,839. |
| USPTO; Non-Final Office Action dated Dec. 22, 2016 in U.S. Appl. No. 14/219,839. |
| USPTO; Advisory Action dated Jun. 30, 2016 in U.S. Appl. No. 14/219,839. |
| USPTO; Final Office Action dated Jul. 6, 2017 in U.S. Appl. No. 14/219,839. |
| USPTO; Non-Final Office Action dated Mar. 27, 2018 in U.S. Appl. No. 14/219,839. |
| USPTO; Non-Final Office Action dated Nov. 25, 2015 in U.S. Appl. No. 14/219,879. |
| USPTO; Final Office action dated May 19, 2016 in U.S. Appl. No. 14/219,879. |
| USPTO; Advisory Action dated Aug. 22, 2016 in U.S. Appl. No. 14/219,879. |
| USPTO; Non-Final Office Action dated Dec. 23, 2016 in U.S. Appl. No. 14/219,879. |
| USPTO; Final Office action dated Jul. 6, 2017 in U.S. Appl. No. 14/219,879. |
| USPTO; Advisory Action dated Oct. 5, 2017 in U.S. Appl. No. 14/219,879. |
| USPTO; Non-Final Office Action dated Apr. 6, 2018 in U.S. Appl. No. 14/219,879. |
| USPTO; Non-Final Office Action dated Sep. 18, 2015 in U.S. Appl. No. 14/244,689. |
| USPTO; Notice of Allowance dated Feb. 11, 2016 in U.S. Appl. No. 14/244,689. |
| USPTO; Non-Final Office Action dated Oct. 7, 2015 in U.S. Appl. No. 14/246,969. |
| USPTO; Final Office Action dated May 4, 2016 in U.S. Appl. No. 14/246,969. |
| USPTO; Advisory Action dated Aug. 2, 2016 in U.S. Appl. No. 14/246,969. |
| USPTO; Non Final Office Action dated Aug. 12, 2016 in U.S. Appl. No. 14/246,969. |
| USPTO; Notice of Allowance dated Feb. 27, 2017 in U.S. Appl. No. 14/246,969. |
| USPTO; Non-Final Office Action dated Nov. 20, 2015 in U.S. Appl. No. 14/260,701. |
| USPTO; Notice of Allowance dated Jun. 2, 2016 in U.S. Appl. No. 14/260,701. |
| USPTO; Notice of Allowance dated Feb. 23, 2016 in U.S. Appl. No. 14/327,134. |
| USPTO; Requirement for Restriction dated Jun. 15, 2015 in U.S. Appl. No. 14/268,348. |
| USPTO; Non-Final Office Action dated Aug. 19, 2015 in U.S. Appl. No. 14/268,348. |
| USPTO; Non-Final Office Action dated Jan. 6, 2016 in U.S. Appl. No. 14/268,348. |
| USPTO; Final Office Action dated Apr. 29, 2016 in U.S. Appl. No. 14/268,348. |
| USPTO; Notice of Allowance dated Aug. 30, 2016 in U.S. Appl. No. 14/268,348. |
| USPTO; Requirement for Restriction dated May 21, 2015 in U.S. Appl. No. 14/281,477. |
| USPTO; Non-Final Office Action dated Oct. 20, 2015 in U.S. Appl. No. 14/281,477. |
| USPTO; Advisory Action dated Mar. 28, 2016 in U.S. Appl. No. 14/281,477. |
| USPTO; Non-Final Office Action dated Jan. 13, 2017 in U.S. Appl. No. 14/444,744. |
| USPTO; Final Office Action dated Jul. 10, 2017 in U.S. Appl. No. 14/444,744. |
| USPTO; Non-Final Office Action dated Nov. 29, 2017 in U.S. Appl. No. 14/444,744. |
| USPTO; Final Office Action dated Mar. 28, 2018 in U.S. Appl. No. 14/444,744. |
| USPTO; Non-Final Office Action dated Jul. 27, 2018 in U.S. Appl. No. 14/444,744. |
| USPTO; Non-Final Office Action dated May 18, 2016 in U.S. Appl. No. 14/449,838. |
| USPTO; Notice of Allowance dated Nov. 28, 2016 in U.S. Appl. No. 14/449,838. |
| USPTO; Non-Final Office Action dated Feb. 12, 2015 in U.S. Appl. No. 14/457,058. |
| USPTO; Final Office Action dated Jul. 14, 2015 in U.S. Appl. No. 14/457,058. |
| USPTO; Non-Final Office Action dated Nov. 6, 2015 in U.S. Appl. No. 14/457,058. |
| USPTO; Final Office Acton dated Jun. 17, 2016 in U.S. Appl. No. 14/457,058. |
| USPTO; Advisory Action dated Sep. 21, 2016 in U.S. Appl. No. 14/457,058. |
| USPTO; Non-Final Office Action dated Oct. 6, 2016 in U.S. Appl. No. 14/457,058. |
| USPTO; Final Office Acton dated May 4, 2017 in U.S. Appl. No. 14/457,058. |
| USPTO; Non-Final Office Action dated Oct. 19, 2017 in U.S. Appl. No. 14/457,058. |
| USPTO; Final Office Action dated Jun. 14, 2018 in U.S. Appl. No. 14/457,058. |
| USPTO; Non-Final Office Action dated Sep. 16, 2016 in U.S. Appl. No. 14/465,252. |
| USPTO; Final Office Action dated Nov. 1, 2016 in U.S. Appl. No. 14/465,252. |
| USPTO; Non-Final Office Action dated Mar. 6, 2017 in U.S. Appl. No. 14/465,252. |
| USPTO; Final Office Action dated Jun. 9, 2017 in U.S. Appl. No. 14/465,252. |
| USPTO; Notice of Allowance dated Oct. 3, 2017 in U.S. Appl. No. 14/465,252. |
| USPTO; Non-Final Office Action dated May 31, 2018 in U.S. Appl. No. 15/491,726. |
| USPTO; Requirement for Restriction dated Sep. 3, 2015 in U.S. Appl. No. 14/498,036. |
| USPTO; Non-Final Office Action dated Nov. 24, 2015 in U.S. Appl. No. 14/498,036. |
| USPTO; Final Office Action dated Apr. 5, 2016 in U.S. Appl. No. 14/498,036. |
| USPTO; Advisory Action dated Jun. 16, 2016 in U.S. Appl. No. 14/498,036. |
| USPTO; Notice of Allowance dated Aug. 17, 2016 in U.S. Appl. No. 14/498,036. |
| USPTO; Requirement for Restriction dated Mar. 20, 2015 in U.S. Appl. No. 14/505,290. |
| USPTO; Non-Final Office Action dated Apr. 10, 2015 in U.S. Appl. No. 14/505,290. |
| USPTO; Notice of Allowance dated Aug. 21, 2015 in U.S. Appl. No. 14/505,290. |
| USPTO; Non-Final Office Action dated Dec. 17, 2015 in U.S. Appl. No. 14/508,296. |
| USPTO; Final Office Action dated May 26, 2016 in U.S. Appl. No. 14/508,296. |
| USPTO; Advisory Action dated Aug. 17, 2016 in U.S. Appl. No. 14/508,296. |
| USPTO; Non-Final Office Action dated Sep. 8, 2016 in U.S. Appl. No. 14/508,296. |
| USPTO; Final Office Action dated Dec. 7, 2016 in U.S. Appl. No. 14/508,296. |
| USPTO; Notice of Allowance dated Jan. 27, 2017 in U.S. Appl. No. 14/508,296. |
| USPTO; Restriction for Requirement dated Dec. 30, 2016 in U.S. Appl. No. 14/508,489. |
| USPTO; Non-Final Office Action dated Apr. 6, 2017 in U.S. Appl. No. 14/508,489. |
| USPTO; Final Office Action dated Oct. 4, 2017 in U.S. Appl. No. 14/508,489. |
| USPTO; Non-Final Office Action dated May 15, 2018 in U.S. Appl. No. 14/508,489. |
| USPTO; Non-Final Office Action dated Jan. 16, 2015 in U.S. Appl. No. 14/563,044. |
| USPTO; Final Office Action dated Jul. 16, 2015 in U.S. Appl. No. 14/563,044. |
| USPTO; Notice of Allowance dated Oct. 15, 2015 in U.S. Appl. No. 14/563,044. |
| USPTO; Notice of Allowance dated Dec. 2, 2015 in U.S. Appl. No. 14/563,044. |
| USPTO; Non-Final Office Action dated May 4, 2016 in U.S. Appl. No. 14/568,647. |
| USPTO; Final Office Action dated Sep. 29, 2016 in U.S. Appl. No. 14/568,647. |
| USPTO; Advisory Action dated Dec. 21, 2016 in U.S. Appl. No. 14/568,647. |
| USPTO; Non-Final Office Action dated Feb. 2, 2017 in U.S. Appl. No. 14/568,647. |
| USPTO; Final Office Action dated May 19, 2017 in U.S. Appl. No. 14/568,647. |
| USPTO; Non-Final Office Action dated Sep. 14, 2017 in U.S. Appl. No. 14/568,647. |
| USPTO; Final Office Action dated Jan. 23, 2018 in U.S. Appl. No. 14/568,647. |
| USPTO; Advisory Action dated Apr. 12, 2018 in U.S. Appl. No. 14/568,647. |
| USPTO; Non-Final Office Action dated May 25, 2018 in U.S. Appl. No. 14/568,647. |
| USPTO; Non-Final Office Action dated Oct. 1, 2015 in U.S. Appl. No. 14/571,126. |
| USPTO; Final Office Action dated Feb. 22, 2016 in U.S. Appl. No. 14/571,126. |
| USPTO; Notice of Allowance dated May 18, 2016 in U.S. Appl. No. 14/571,126. |
| USPTO; Notice of Allowance dated Jun. 2, 2016 in U.S. Appl. No. 14/571,126. |
| USPTO; Non-Final Office Action dated Nov. 25, 2015 in U.S. Appl. No. 14/598,532. |
| USPTO; Notice of Allowance dated May 16, 2016 in U.S. Appl. No. 14/598,532. |
| USPTO; Non-Final Office Action dated Jan. 15, 2016 in U.S. Appl. No. 14/606,364. |
| USPTO; Restriction Requirement dated Mar. 7, 2016 in U.S. Appl. No. 14/606,364. |
| USPTO; Final Office Action dated Jun. 14, 2016 in U.S. Appl. No. 14/606,364. |
| USPTO; Advisory Action dated Aug. 25, 2016 in U.S. Appl. No. 14/606,364. |
| USPTO; Non-Final Office Action dated Sep. 27, 2016 in U.S. Appl. No. 14/606,354. |
| USPTO; Final Office Action dated Jan. 12, 2017 in U.S. Appl. No. 14/606,364. |
| USPTO; Non-Final Office Action dated May 10, 2017 in U.S. Appl. No. 14/606,364. |
| USPTO; Non-Final Office Action dated Mar. 3, 2016 in U.S. Appl. No. 14/622,603. |
| USPTO; Notice of Allowance dated Aug. 2, 2016 in U.S. Appl. No. 14/622,603. |
| USPTO; Notice of Allowance dated Feb. 16, 2016 in U.S. Appl. No. 14/634,342. |
| USPTO; Non-Final Office Action dated Oct. 19, 2017 in U.S. Appl. No. 14/645,234. |
| USPTO; Non-Final Office Action dated May 16, 2018 in U.S. Appl. No. 14/645,234. |
| USPTO; Final Office Action dated Aug. 10, 2018 in U.S. Appl. No. 14/645,234. |
| USPTO; Non-Final Office Action dated Jun. 7, 2017 in U.S. Appl. No. 14/656,588. |
| USPTO; Final Office Action dated Dec. 26, 2017 in U.S. Appl. No. 14/656,588. |
| USPTO; Non-Final Office Action dated Apr. 6, 2018 in U.S. Appl. No. 14/656,588. |
| USPTO; Requirement for Restriction dated Oct. 26, 2015 in U.S. Appl. No. 14/659,152. |
| USPTO; Non-Final Office Action dated Mar. 21, 2016 in U.S. Appl. No. 14/659,152. |
| USPTO; Final Office Action dated Jul. 29, 2016 in U.S. Appl. No. 14/659,152. |
| USPTO; Notice of Allowance dated Nov. 22, 2016 in U.S. Appl. No. 14/659,152. |
| USPTO; Non-Final Office Action dated Sep. 7, 2017 in U.S. Appl. No. 14/660,755. |
| USPTO; Restriction Requirement dated Sep. 11, 2017 in U.S. Appl. No. 14/660,755. |
| USPTO; Notice of Allowance dated Oct. 2, 2017 in U.S. Appl. No. 14/660,755. |
| USPTO; Notice of Allowance dated Mar. 25, 2016 in U.S. Appl. No. 14/693,138. |
| USPTO; Requirement for Restriction dated Jul. 5, 2017 in U.S. Appl. No. 14/752,712. |
| USPTO; Non-Final Office Action dated Aug. 3, 2017 in U.S. Appl. No. 14/752,712. |
| USPTO; Final Office Action dated Nov. 29, 2017 in U.S. Appl. No. 14/752,712. |
| USPTO; Advisory Action dated Feb. 15, 2018 in U.S. Appl. No. 14/752,712. |
| USPTO; Non-Final Office Action dated Mar. 21, 2018 in U.S. Appl. No. 14/752,712. |
| USPTO; Non-Final Office Action dated Nov. 29, 2017 in U.S. Appl. No. 14/793,323. |
| USPTO; Final Office Action dated Mar. 29, 2018 in U.S. Appl. No. 14/793,323. |
| USPTO; Non-Final Office Action dated Aug. 10, 2018 in U.S. Appl. No. 14/793,323. |
| USPTO; Non-Final Office Action dated Jun. 16, 2017 in U.S. Appl. No. 14/798,136. |
| USPTO; Notice of Allowance dated Oct. 5, 2017 in U.S. Appl. No. 14/798,136. |
| USPTO; Non-Final Office Action dated Mar. 30, 2016 in U.S. Appl. No. 14/808,979. |
| USPTO; Final Office Acton dated Sep. 30, 2016 in U.S. Appl. No. 14/808,979. |
| USPTO; Non-Final Office Action dated Dec. 20, 2016 in U.S. Appl. No. 14/808,979. |
| USPTO; Final Office Action dated Jun. 8, 2017 in U.S. Appl. No. 14/808,979. |
| USPTO; Non-Final Office Action dated Sep. 21, 2017 in U.S. Appl. No. 14/808,979. |
| USPTO; Final Office Action dated Mar. 14, 2018 in U.S. Appl. No. 14/808,979. |
| USPTO; Notice of Allowance dated Jun. 27, 2018 in U.S. Appl. No. 14/808,979. |
| USPTO; Non-Final Office Action dated Feb. 23, 2018 in U.S. Appl. No. 14/817,953. |
| USPTO; Notice of Allowance dated Jul. 11, 2018 in U.S. Appl. No. 14/817,953. |
| USPTO; Requirement for Restriction dated Mar. 17, 2016 in U.S. Appl. No. 14/827,177. |
| USPTO; Notice of Allowance dated Jan. 27, 2017 in U.S. Appl. No. 14/827,177. |
| USPTO; Requirement for Restriction dated Aug. 8, 2016 in U.S. Appl. No. 14/829,565. |
| USPTO; Non-Final Office Action dated Sep. 9, 2016 in U.S. Appl. No. 14/829,565. |
| USPTO; Final Office Action dated Feb. 9, 2017 in U.S. Appl. No. 14/829,565. |
| USPTO; Advisory Action dated Apr. 20, 2017 in U.S. Appl. No. 14/829,565. |
| USPTO; Non-Final Office Action dated Sep. 19, 2017 in U.S. Appl. No. 14/829,565. |
| USPTO; Final Office Action dated Mar. 5, 2018 in U.S. Appl. No. 14/829,565. |
| USPTO; Non-Final Office Action dated Apr. 29, 2016 in U.S. Appl. No. 14/835,637. |
| USPTO; Final Office Action dated Nov. 25, 2016 in U.S. Appl. No. 14/835,637. |
| USPTO; Advisory Action dated Feb. 14, 2017 in U.S. Appl. No. 14/835,637. |
| USPTO; Notice of Allowance dated Apr. 25, 2017 in U.S. Appl. No. 14/835,637. |
| USPTO; Non-Final Office Action dated Jul. 29, 2016 in U.S. Appl. No. 14/884,695. |
| USPTO; Final Office Action dated Feb. 9, 2017 in U.S. Appl. No. 14/884,695. |
| USPTO; Advisory Action dated Apr. 20, 2017 in U.S. Appl. No. 14/884,695. |
| USPTO; Non-Final Office Action dated May 18, 2017 in U.S. Appl. No. 14/884,695. |
| USPTO; Requirement for Restriction dated Dec. 1, 2016 in U.S. Appl. No. 14/886,571. |
| USPTO; Non-Final Office Action dated May 18, 2017 in U.S. Appl. No. 14/886,571. |
| USPTO; Final Office Action dated Sep. 21, 2017 in U.S. Appl. No. 14/886,571. |
| USPTO; Notice of Allowance dated Dec. 6, 2017 in U.S. Appl. No. 14/886,571. |
| USPTO; Requirement for Restriction dated Sep. 20, 2016 in U.S. Appl. No. 14/919,536. |
| USPTO; Non-Final Office Action dated Dec. 1, 2016 in U.S. Appl. No. 14/919,536. |
| USPTO; Final Office Action dated Mar. 28, 2017 in U.S. Appl. No. 14/919,536. |
| USPTO; Non-Final Office Action dated Aug. 29, 2017 in U.S. Appl. No. 14/919,536. |
| USPTO; Final Office Action dated May 11, 2018 in U.S. Appl. No. 14/919,536. |
| USPTO; Non-Final Office Action dated May 3, 2016 in U.S. Appl. No. 14/937,053. |
| USPTO; Notice of Allowance dated Jul. 26, 2016 in U.S. Appl. No. 14/937,053. |
| USPTO; Requirement for Restriction dated Sep. 15, 2016 in U.S. Appl. No. 14/938,180. |
| USPTO; Non-Final Office Action dated Dec. 15, 2016 in U.S. Appl. No. 14/938,180. |
| USPTO; Notice of Allowance dated Nov. 9, 2017 in U.S. Appl. No. 14/938,180. |
| USPTO; Non-Final Office Action dated Apr. 14, 2017 in U.S. Appl. No. 14/956,115. |
| USPTO; Final Office Action dated Jul. 21, 2017 in U.S. Appl. No. 14/956,115. |
| USPTO; Notice of Allowance dated Dec. 14, 2017 in U.S. Appl. No. 14/956,115. |
| USPTO; Notice of Allowance dated Feb. 3, 2017 in U.S. Appl. No. 14/977,291. |
| USPTO; Non-Final Office Action dated Aug. 12, 2016 in U.S. Appl. No. 14/981,434. |
| USPTO; Notice of Allowance dated Nov. 21, 2016 in U.S. Appl. No. 14/981,434. |
| USPTO; Non-Final Office Action dated Jan. 12, 2017 in U.S. Appl. No. 14/981,468. |
| USPTO; Notice of Allowance dated Jun. 7, 2017 in U.S. Appl. No. 14/981,468. |
| USPTO; Non-Final Office Action dated Mar. 22, 2016 in U.S. Appl. No. 14/987,420. |
| USPTO; Non-Final Office Action dated Dec. 14, 2016 in U.S. Appl. No. 14/997,683. |
| USPTO; Final Office Action dated Apr. 14, 2017 in U.S. Appl. No. 14/997,683. |
| USPTO; Non-Final Office Action dated Sep. 1, 2017 in U.S. Appl. No. 14/997,683. |
| USPTO; Final Office Action dated Feb. 6, 2018 in U.S. Appl. No. 14/997,683. |
| USPTO; Advisory Action dated May 2, 2018 in U.S. Appl. No. 14/997,683. |
| USPTO; Non-Final Office Action dated Jun. 20, 2018 in U.S. Appl. No. 14/997,683. |
| USPTO; Non-Final Office Action dated Sep. 23, 2016 in U.S. Appl. No. 15/048,422. |
| USPTO; Notice of Allowance dated May 4, 2017 in U.S. Appl. No. 15/048,422. |
| USPTO; Requirement for Restriction dated Apr. 19, 2017 in U.S. Appl. No. 15/050,159. |
| USPTO; Non-Final Office Action dated Aug. 4, 2017 in U.S. Appl. No. 15/050,159. |
| USPTO; Notice of Allowance dated Feb. 7, 2018 in U.S. Appl. No. 15/050,159. |
| USPTO; Non-Final Office Action dated Apr. 22, 2016 in U.S. Appl. No. 15/055,122. |
| USPTO; Notice of Allowance dated Sep. 15, 2016 in U.S. Appl. No. 15/055,122. |
| USPTO; Non-Final Office Action dated Feb. 20, 2018 in U.S. Appl. No. 15/060,412. |
| USPTO; Requirement for Restriction dated Jun. 4, 2018 in U.S. Appl. No. 15/067,028. |
| USPTO; Requirement for Restriction dated Jun. 28, 2018 in U.S. Appl. No. 15/074,813. |
| USPTO; Non-Final Office Action dated Jan. 9, 2018 in U.S. Appl. No. 15/135,224. |
| USPTO; Notice of Allowance dated Jun. 29, 2018 in U.S. Appl. No. 15/135,224. |
| USPTO; Non-Final Office Action dated Jan. 9, 2018 in U.S. Appl. No. 15/135,258. |
| USPTO; Final Office Action dated Jul. 6, 2018 in U.S. Appl. No. 15/135,258. |
| USPTO; Non-Final Office Action dated Jan. 9, 2018 in U.S. Appl. No. 15/135,333. |
| USPTO; Non Final Office Action dated Nov. 21, 2016 in U.S. Appl. No. 15/144,481. |
| USPTO; Final Office Action dated May 26, 2017 in U.S. Appl. No. 15/144,481. |
| USPTO; Non-Final Office Action dated Sep. 21, 2017 in U.S. Appl. No. 15/144,481. |
| USPTO; Notice of Allowance dated Apr. 11, 2018 in U.S. Appl. No. 15/144,481. |
| USPTO; Non-Final Office Action dated Apr. 13, 2017 in U.S. Appl. No. 15/144,506. |
| USPTO; Final Office Action dated Oct. 10, 2017 in U.S. Appl. No. 15/144,506. |
| USPTO; Final Office Action dated Jul. 26, 2018 in U.S. Appl. No. 15/144,506. |
| USPTO; Requirement for Restriction dated Jun. 22, 2018 in U.S. Appl. No. 15/182,504. |
| USPTO; Non-Final Office Action dated Nov. 28, 2016 in U.S. Appl. No. 15/203,632. |
| USPTO; Final Office Action dated Jun. 7, 2017 in U.S. Appl. No. 15/203,632. |
| USPTO; Advisory Action dated Aug. 23, 2017 in U.S. Appl. No. 15/203,632. |
| USPTO; Notice of Allowance dated Sep. 20, 2017 in U.S. Appl. No. 15/203,632. |
| USPTO; Non-Final Office Action dated Nov. 29, 2016 in U.S. Appl. No. 15/203,642. |
| USPTO; Final Office Action dated Apr. 13, 2017 in U.S. Appl. No. 15/203,642. |
| USPTO; Advisory Action dated Jun. 22, 2017 in U.S. Appl. No. 15/203,642. |
| USPTO; Notice of Allowance dated Aug. 7, 2017 in U.S. Appl. No. 15/203,642. |
| USPTO; Non-Final Office Action dated Jun. 1, 2017 in U.S. Appl. No. 15/205,827. |
| USPTO; Final Office Action dated Oct. 16, 2017 in U.S. Appl. No. 15/205,827. |
| USPTO; Non-Final Office Action dated May 14, 2018 in U.S. Appl. No. 15/205,827. |
| USPTO; Requirement for Restriction dated Jan. 26, 2017 in U.S. Appl. No. 15/205,890. |
| USPTO; Non-Final Office Action dated Mar. 31, 2017 in U.S. Appl. No. 15/205,890. |
| USPTO; Notice of Allowance dated Oct. 16, 2017 in U.S. Appl. No. 15/205,890. |
| USPTO; Non-Final Office Action dated Jan. 20, 2017 in U.S. Appl. No. 15/210,256. |
| USPTO; Notice of Allowance dated May 18, 2017 in U.S. Appl. No. 15/210,256. |
| USPTO; Notice of Allowance dated Jul. 24, 2017 in U.S. Appl. No. 15/210,256. |
| USPTO; Requirement for Restriction dated Apr. 3, 2017 in U.S. Appl. No. 15/222,715. |
| USPTO; Non Final Office Action dated Apr. 21, 2017 in U.S. Appl. No. 15/222,715. |
| USPTO; Notice of Allowance dated Jul. 14, 2017 in U.S. Appl. No. 15/222,715. |
| USPTO; Notice of Allowance dated Sep. 27, 2017 in U.S. Appl. No. 15/222,715. |
| USPTO; Non-Final Office Action dated Feb. 3, 2017 in U.S. Appl. No. 15/222,738. |
| USPTO; Notice of Allowance dated Feb. 3, 2017 in U.S. Appl. No. 15/222,738. |
| USPTO; Notice of Allowance dated Aug. 23, 2017 in U.S. Appl. No. 15/222,738. |
| USPTO; Non-Final Office Action dated Jan. 17, 2017 in U.S. Appl. No. 15/222,749. |
| USPTO; Final Office Action dated May 5, 2017 in U.S. Appl. No. 15/222,749. |
| USPTO; Non-Final Office Action dated Sep. 7, 2017 in U.S. Appl. No. 15/222,749. |
| USPTO: Final Office Action dated Jun. 4, 2018 in U.S. Appl. No. 15/222,749. |
| USPTO; Non-Final Office Action dated Jan. 3, 2017 in U.S. Appl. No. 15/222,780. |
| USPTO; Final Office Action dated May 5, 2017 in U.S. Appl. No. 15/222,780. |
| USPTO; Non-Final Office Action dated Sep. 7, 2017 in U.S. Appl. No. 15/222,780. |
| USPTO; Final Office Action dated May 17, 2018 in U.S. Appl. No. 15/222,780. |
| USPTO; Requirement for Restriction dated Dec. 5, 2017 in U.S. Appl. No. 15/254,605. |
| USPTO; Notice of Allowance dated Jul. 12, 2018 in U.S. Appl. No. 15/254,605. |
| USPTO; Non-Final Office Action dated Aug. 28, 2017 in U.S. Appl. No. 15/254,724. |
| USPTO; Notice of Allowance dated Jan. 17, 2018 in U.S. Appl. No. 15/254,724. |
| USPTO; Notice of Allowance dated Apr. 2, 2018 in U.S. Appl. No. 15/254,724. |
| USPTO; Non-Final Office Action dated May 22, 2018 in U.S. Appl. No. 15/262,990. |
| USPTO; Non-Final Office Action dated Aug. 3, 2018 in U.S. Appl. No. 15/273,488. |
| USPTO; Non-Final Office Action dated Jul. 2, 2018 in U.S. Appl. No. 15/286,503. |
| USPTO; Requirement for Restriction dated Sep. 12, 2017 in U.S. Appl. No. 15/377,439. |
| USPTO; Non-Final Office Action dated Oct. 23, 2017 in U.S. Appl. No. 15/377,439. |
| USPTO; Final Office Action dated Apr. 16, 2018 in U.S. Appl. No. 15/377,439. |
| USPTO; Advisory Action dated Aug. 8, 2018 in U.S. Appl. No. 15/377,439. |
| USPTO; Notice of Allowance dated Aug. 8, 2017 in U.S. Appl. No. 15/380,895. |
| USPTO; Notice of Allowance dated Oct. 11, 2017 in U.S. Appl. No. 15/380,895. |
| USPTO; Non-Final Office Action dated Jan. 4, 2018 in U.S. Appl. No. 15/380,921. |
| USPTO; Requirement for Restriction dated Sep. 21, 2017 in U.S. Appl. No. 15/380,921. |
| USPTO; Final Office Action dated Jun. 28, 2018 in U.S. Appl. No. 15/380,921. |
| USPTO; Final Office Action dated May 15, 2018 in U.S. Appl. No. 15/388,410. |
| USPTO; Non-Final Office Action dated Aug. 11, 2017 in U.S. Appl. No. 15/397,237. |
| USPTO; Notice of Allowance dated Dec. 22, 2017 in U.S. Appl. No. 15/397,237. |
| USPTO; Non-Final Office Action dated Apr. 12, 2017 in U.S. Appl. No. 15/397,319. |
| USPTO; Final Office Action dated Jul. 12, 2017 in U.S. Appl. No. 15/397,319. |
| USPTO; Notice of Allowance dated Dec. 15, 2017 in U.S. Appl. No. 15/397,319. |
| USPTO; Non-Final Office Action dated Aug. 7, 2018 in U.S. Appl. No. 15/428,808. |
| USPTO; Non-Final Office Action dated Apr. 6, 2018 in U.S. Appl. No. 15/434,051. |
| USPTO; Notice of Allowance dated Oct. 6, 2017 in U.S. Appl. No. 15/450,199. |
| USPTO; Non-Final Office Action dated Dec. 15, 2017 in U.S. Appl. No. 15/466,149. |
| USPTO; Notice of Allowance dated Apr. 20, 2018 in U.S. Appl. No. 15/466,149. |
| USPTO; Non-Final Office Action dated Oct. 4, 2017 in U.S. Appl. No. 15/489,453. |
| USPTO; Final Office Action dated Apr. 19, 2018 in U.S. Appl. No. 15/489,453. |
| USPTO; Notice of Allowance dated Dec. 19, 2017 in U.S. Appl. No. 15/489,660. |
| USPTO; Non-Final Office Action dated Apr. 6, 2018 in U.S. Appl. No. 15/472,750. |
| USPTO; Non-Final Office Action dated Dec. 6, 2017 in U.S. Appl. No. 15/476,035. |
| USPTO; Notice of Allowance dated Mar. 21, 2018 in U.S. Appl. No. 15/476,035. |
| USPTO; Notice of Allowance dated Aug. 14, 2018 in U.S. Appl. No. 15/476,035. |
| USPTO; Non-Final Office Action dated Jan. 16, 2018 in U.S. Appl. No. 15/499,647. |
| USPTO; Notice of Allowance dated May 23, 2018 in U.S. Appl. No. 15/499,647. |
| USPTO; Non-Final Office Action dated Jun. 21, 2018 in U.S. Appl. No. 15/499,647. |
| USPTO; Office Action dated May 3, 2018 in U.S. Appl. No. 15/589,861. |
| USPTO; Requirement of Restriction dated Mar. 30, 2018 in U.S. Appl. No. 15/589,849. |
| USPTO; Office Action dated Aug. 30, 2018 in U.S. Appl. No. 15/589,849. |
| USPTO; Non-Final Office Action dated Apr. 4, 2018 in U.S. Appl. No. 15/592,730. |
| USPTO; Requirement for Restriction dated Aug. 1, 2018 in U.S. Appl. No. 15/627,189. |
| USPTO; Non-Final Office Action dated Jun. 5, 2018 in U.S. Appl. No. 15/650,686. |
| USPTO; Requirement for Restriction dated Apr. 6, 2018 in U.S. Appl. No. 15/659,631. |
| USPTO; Non-Final Office Action dated Aug. 9, 2018 in U.S. Appl. No. 15/660,805. |
| USPTO; Non-Final Office Action dated Jul. 27, 2018 in U.S. Appl. No. 15/673,110. |
| USPTO; Non-Final Office Action dated Apr. 25, 2018 in U.S. Appl. No. 15/673,278. |
| USPTO; Non-Final Office Action dated Jan. 18, 2018 in U.S. Appl. No. 15/683,701. |
| USPTO; Final Office Action dated Aug. 24, 2018 in U.S. Appl. No. 15/683,701. |
| USPTO; Non-Final Office Action dated Aug. 9, 2018 in U.S. Appl. No. 15/691,241. |
| USPTO; Requirement for Restriction dated Jul. 11, 2018 in U.S. Appl. No. 15/707,786. |
| USPTO; Requirement for Restriction dated May 11, 2018 in U.S. Appl. No. 15/711,989. |
| USPTO; Non-Final Office Action dated Jun. 14, 2018 in U.S. Appl. No. 15/711,989. |
| USPTO; Non-Final Office Action dated May 29, 2018 in U.S. Appl. No. 15/719,208. |
| USPTO; Non-Final Office Action dated Apr. 19, 2018 in U.S. Appl. No. 15/726,959. |
| USPTO; Non-Final Office Action dated May 17, 2018 in U.S. Appl. No. 15/729,485. |
| USPTO; Non-Final Office Action dated Jun. 26, 2018 in U.S. Appl. No. 15/796,593. |
| USPTO; Non-Final Office Action dated Dec. 26, 2017 in U.S. Appl. No. 15/798,120. |
| USPTO; Notice of Allowance dated Jun. 13, 2018 in U.S. Appl. No. 15/798,120. |
| USPTO; Requirement for Restriction dated Apr. 6, 2018 in U.S. Appl. No. 15/798,201. |
| USPTO; Non-Final Office Action dated Aug. 9, 2018 in U.S. Appl. No. 15/798,201. |
| USPTO; Non-Final Office Action dated Jul. 2, 2018 in U.S. Appl. No. 15/815,483. |
| USPTO; Requirement for Restriction dated Mar. 21, 2018 in U.S. Appl. No. 15/863,340. |
| USPTO; Non-Final Office Action dated Jul. 23, 2018 in U.S. Appl. No. 15/863,340. |
| USPTO; Notice of Allowance dated May 14, 2012 in U.S. Appl. No. 29/411,637. |
| USPTO; Notice of Allowance dated Oct. 2, 2013 in U.S. Appl. No. 29/412,887. |
| USPTO; Non-Final Office Action dated Mar. 16, 2015 in U.S. Appl. No. 29/447,298. |
| USPTO; Notice of Allowance dated Jul. 6, 2015 in U.S. Appl. No. 29/447,298. |
| USPTO; Notice of Allowance dated Dec. 19, 2013 in U.S. Appl. No. 29/448,094. |
| USPTO; Notice of Allowance dated Nov. 26, 2014 in U.S. Appl. No. 29/481,301. |
| USPTO; Notice of Allowance dated Feb. 17, 2015 in U.S. Appl. No. 29/481,308. |
| USPTO; Requirement for Restriction dated Dec. 1, 2014 in U.S. Appl. No. 29/481,312. |
| USPTO; Notice of Allowance dated Jan. 12, 2015 in U.S. Appl. No. 29/481,312. |
| USPTO; Requirement for Restriction dated Dec. 4, 2014 in U.S. Appl. No. 29/481,315. |
| USPTO; Notice of Allowance dated Apr. 30, 2015 in U.S. Appl. No. 29/481,315. |
| USPTO; Notice of Allowance dated May 11, 2015 in U.S. Appl. No. 29/511,011. |
| USPTO; Notice of Allowance dated May 11, 2015 in U.S. Appl. No. 29/514,153. |
| USPTO; Notice of Allowance dated Dec. 14, 2015 in U.S. Appl. No. 29/514,264. |
| USPTO; Notice of Allowance dated Jun. 16, 2017 in U.S. Appl. No. 29/570,711. |
| USPTO; Notice of Allowance dated Jun. 26, 2018 in U.S. Appl. No. 29/604,288. |
| PCT; International Preliminary Report on Patentability dated Nov. 24, 2009 and International Search Report dated Jul. 31, 2008 in Application No. PCT/US2008/063919. |
| PCT; International Preliminary Report on Patentability dated Feb. 24, 2010 in Application No. PCT/US2008/074063. |
| PCT; International Preliminary Report on Patentability dated Nov. 26, 2009 in Application No. PCT/US2009/043454. |
| PCT; International Preliminary Report on Patentability dated Jun. 14, 2011 in Application No. PCT/US2009/066377. |
| PCT; International Search report and Written Opinion dated Nov. 12, 2010 in Application No. PCT/US2010/030126. |
| PCT; International Preliminary Report on Patentability dated Oct. 11, 2011 Application No. PCT/US2010/030126. |
| PCT; International Preliminary Report on Patentability dated Nov. 9, 2011 in Application No. PCT/US2010/033244. |
| PCT; International Preliminary Report on Patentability dated Nov. 9, 2011 in Application No. PCT/US2010/033248. |
| PCT; International Preliminary Report on Patentability dated Nov. 9, 2011 in Application No. PCT/US2010/033252. |
| PCT; International Search report and Written Opinion dated Jan. 20, 2011 in Application No. PCT/US2010/045368. |
| PCT; International Search report and Written Opinion dated Feb. 6, 2013 in Application No. PCT/US2012/065343. |
| PCT; International Search report and Written Opinion dated Feb. 13, 2013 in Application No. PCT/US2012/065347. |
| PCT; International Search Report and Written Opinion dated Nov. 16, 2017 in Application No. PCT/IB2017/001015. |
| PCT; International Search Report and Written Opinion dated Nov. 13, 2017 in Application No. PCT/IB2017/001050. |
| PCT; International Search Report and Written Opinion dated Nov. 30, 2017 in Application No. PCT/IB2017/001070. |
| PCT; International Search Report and Written Opinion dated Jan. 25, 2018 in Application No. PCT/IB2017/001262. |
| PCT: International Search Report and Written Opinion dated Jun. 1, 2018 in Application No. PCT/IB2017/001644. |
| PCT: International Search Report and Written Opinion dated Jun. 1, 2018 in Application No. PCT/IB2017/001656. |
| Chinese Patent Office; Office Action dated Jan. 10, 2013 in Application No. 201080015699.9. |
| Chinese Patent Office; Office Action dated Aug. 1, 2013 in Application No. 201080015699.9. |
| Chinese Patent Office; Office Action dated Jan. 21, 2014 in Application No. 201080015699.9. |
| Chinese Patent Office; Office Action dated Jul. 24, 2014 in Application No. 201080015699.9. |
| Chinese Patent Office; Office Action dated Jan. 12, 2015 in Application No. 201080015699.9. |
| Chinese Patent Office; Office Action dated Dec. 10, 2013 in Application No. 201080020267.7. |
| Chinese Patent Office; Office Action dated Jan. 21, 2013 in Application No. 201080020268.1. |
| Chinese Patent Office; Office Action dated Sep. 26, 2013 in Application No. 201080020268.1. |
| Chinese Patent Office; Office Action dated Apr. 3, 2014 in Application No. 201080020268.1. |
| Chinese Patent Office; Office Action dated Sep. 23, 2014 in Application No. 201080020268.1. |
| Chinese Patent Office; Office Action dated Apr. 7, 2015 in Application No. 201080020268.1. |
| Chinese Patent Office; Office Action dated May 24, 2013 in Application No. 201080036764.6. |
| Chinese Patent Office; Office Action dated Jan. 2, 2014 in Application No. 201080036764.6. |
| Chinese Patent Office; Office Action dated Jul. 1, 2014 in Application No. 201080036764.6. |
| Chinese Patent Office; Office Action dated Feb. 8, 2014 in Application No. 201110155056. |
| Chinese Patent Office; Office Action dated Sep. 16, 2014 in Application No. 201110155056. |
| Chinese Patent Office; Office Action dated Feb. 9, 2015 in Application No. 201110155056. |
| Chinese Patent Office; Office Action dated Dec. 4, 2015 in Application No. 201210201995.9. |
| Chinese Patent Office; Office Action dated Jul. 14, 2016 in Application No. 201210201995.9. |
| Chinese Patent Office; Office Action dated Jan. 20, 2017 in Application No. 201210201995.9. |
| Chinese Patent Office; Office Action dated Dec. 24, 2015 in Application No. 201280057466.4. |
| Chinese Patent Office; Office Action dated Dec. 4, 2015 in Application No. 201280057542.1. |
| Chinese Patent Office; Office Action dated May 16, 2016 in Application No. 201280057542.1. |
| Chinese Patent Office; Office Action dated Sep. 9, 2016 in Application No. 201280057542.1. |
| Chinese Patent Office; Office Action dated Dec. 5, 2016 in Application No. 201310412808.6. |
| Chinese Patent Office; Office Action dated Feb. 5, 2018 in Application No. 201410331047.6. |
| European Patent Office; Supplementary European Search Report and Opinion dated Nov. 9, 2012 in Application No. 08798519.8. |
| European Patent Office; Office Action dated Jul. 18, 2016 in Application No. 08798519.8. |
| European Patent Office; Extended European Search Report dated Dec. 9, 2016 in Application No. 9767208.3. |
| European Patent Office; Supplementary European Search Report and Opinion dated Jan. 5, 2017 in Application No. 09836647.9. |
| European Patent Office; Office Action dated Feb. 28, 2018 in Application No. 09836647.9. |
| Japanese Patent Office; Office Action dated Dec. 20, 2011 in Application No. 2010-522075. |
| Japanese Patent Office; Office Action dated Apr. 11, 2012 in Application No. 2010-522075. |
| Japanese Patent Office; Office Action dated May 31, 2012 in Application No. 2011-514650. |
| Japanese Patent Office; Office Action dated Sep. 11, 2012 in Application No. 2011-514650. |
| Japanese Patent Office; Office Action dated Dec. 25, 2013 in Application No. 2012-504786. |
| Japanese Patent Office; Office Action dated Jan. 25, 2014 in Application No. 2012-504786. |
| Japanese Patent Office; Office Action dated Dec. 1, 2014 in Application No. 2012-504786. |
| Japanese Patent Office; Office Action dated Mar. 11, 2013 in Application No. 2012-509857. |
| Korean Patent Office; Office Action dated Dec. 10, 2015 in Application No. 10-2010-0028336. |
| Korean Patent Office; Final Office Action dated Jun. 29, 2016 in Application No. 10-2010-0028336. |
| Korean Patent Office; Office Action dated Mar. 3, 2016 in Application No. 10-2010-0067768. |
| Korean Patent Office; Office Action dated Aug. 1, 2016 in Application No. 10-2010-0067768. |
| Korean Patent Office; Office Action dated May 2, 2016 in Application No. 10-2010-0082446. |
| Korean Patent Office; Office Action dated Sep. 19, 2016 in Application No. 10-2010-0082446. |
| Korean Patent Office; Office Action dated Nov. 24, 2017 in Application No. 10-20110036449. |
| Korean Patent Office; Office Action dated May 23, 2017 in Application No. 10-20110036449. |
| Korean Patent Office; Office Action dated Sep. 4, 2017 in Application No. 10-2011-0087600. |
| Korean Patent Office; Office Action dated Oct. 23, 2017 in Application No. 10-2011-0142924. |
| Korean Patent Office; Office Action dated Dec. 11, 2015 in Application No. 10-20117023416. |
| Korean Patent Office; Office Action dated Mar. 13, 2016 in Application No. 10-20117023416. |
| Korean Patent Office; Office Action dated Oct. 30, 2017 in Application No. 10-2012-0041878. |
| Korean Patent Office; Office Action dated Mar. 21, 2018 in Application No. 20120042518. |
| Korean Patent Office; Office Action dated Mar. 21, 2018 in Application No. 10-2012-0064526. |
| Korean Patent Office; Office Action dated Mar. 30, 2018 in Application No. 10-2012-0076564. |
| Korean Patent Office; Office Action dated Apr. 30, 2018 in Application No. 10-2012-0103114. |
| Korean Patent Office; Office Action dated Oct. 24, 2016 in Application No. 10-20127004062. |
| Korean Patent Office; Office Action dated Jul. 24, 2017 in Application No. 10-20127004062. |
| Korean Patent Office; Office Action dated Sep. 28, 2017 in Application No. 10-20147017112. |
| Korean Patent Office; Office Action dated Nov. 9, 2016 in Application No. 10-20167023913. |
| Korean Patent Office; Office Action dated Sep. 15, 2017 in Application No. 30-2017-0001320. |
| Korean Patent Office; Office Action dated Jul. 11, 2018 in Application No. 30/2018-006016. |
| Taiwanese Patent Office; Office Action dated Aug. 30, 2013 in Application No. 97132391. |
| Taiwanese Patent Office; Office Action dated Dec. 20, 2013 in Application No. 98117513. |
| Taiwan Patent Office; Office Action dated Jul. 4, 2014 in Application No. 099110511. |
| Taiwanese Patent Office; Office Action dated Aug. 27, 2014 in Application No. 99114329. |
| Taiwanese Patent Office; Office Action dated Dec. 26, 2014 in Application No. 99114330. |
| Taiwanese Patent Office; Office Action dated Aug. 14, 2014 in Application No. 99114331. |
| Taiwan Patent Office; Office Action dated Dec. 19, 2014 in Taiwan Application No. 099127063. |
| Taiwanese Patent Office; Office Action received in Application No. 100113130. |
| Taiwan Patent Office; Office Action dated May 13, 2016 in Taiwan Application No. 101142582. |
| Taiwanese Patent Office; Office Action dated Aug. 1, 2016 in Application No. 101124745. |
| Taiwanese Patent Office; Office Action received in Application No. 102113028. |
| Taiwanese Patent Office; Office Action received in Application No. 102115605. |
| Taiwanese Patent Office; Office Action dated Feb. 24, 2017 in Application No. 102115605. |
| Taiwanese Patent Office; Office Action received in Application No. 102125191. |
| Taiwanese Patent Office; Office Action dated Dec. 6, 2016 in Application No. 102126071. |
| Taiwanese Patent Office; Office Action dated May 17, 2018 in Application No. 102126071. |
| Taiwanese Patent Office; Office Action dated Feb. 10, 2017 in Application No. 102127065. |
| Taiwanese Patent Office; Office Action dated Mar. 11, 2016 in Application No. 102129262. |
| Taiwanese Patent Office; Office Action dated Dec. 29, 2016 in Application No. 102129397. |
| Taiwanese Patent Office; Office Action dated Nov. 4, 2016 in Application No. 102131839. |
| Taiwanese Patent Office; Office Action dated Dec. 2, 2016 in Application No. 102136496. |
| Taiwanese Patent Office; Office Action dated Jan. 10, 2018 in Application No. 102136496. |
| Taiwanese Patent Office; Office Action dated Nov. 11, 2016 in Application No. 102132952. |
| Taiwanese Patent Office; Office Action dated Jul. 17, 2017 in Application No. 103101400. |
| Taiwanese Patent Office; Office Action dated Feb. 23, 2017 in Application No. 103102563. |
| Taiwanese Patent Office; Office Action dated Mar. 3, 2017 in Application No. 103105251. |
| Taiwanese Patent Office; Office Action received in Application No. 103106021. |
| Taiwanese Patent Office; Office Action dated Oct. 31, 2017 in Application No. 103106022. |
| Taiwanese Patent Office; Office Action dated Jul. 5, 2017 in Application No. 103117477. |
| Taiwanese Patent Office; Office Action dated Nov. 22, 2017 in Application No. 103117478. |
| Taiwanese Patent Office; Office Action dated May 19, 2017 in Application No. 103120478. |
| Taiwanese Patent Office; Office Action dated Nov. 8, 2017 in Application No. 103124509. |
| Taiwanese Patent Office; Office Action dated Nov. 20, 2017 in Application No. 103127588. |
| Taiwanese Patent Office; Office Action dated Sep. 19, 2017 in Application No. 103127734. |
| Taiwanese Patent Office; Office Action dated Nov. 22, 2017 in Application No. 103134537. |
| Taiwanese Patent Office; Office Action dated Aug. 24, 2017 in Application No. 103136251. |
| Taiwanese Patent Office; Office Action dated Feb. 26, 2018 in Application No. 103138510. |
| Taiwanese Patent Office; Office Action dated May 21, 2018 in Application No. 103139014. |
| Taiwanese Patent Office; Office Action dated Jun. 22, 2018 in Application No. 104105533. |
| Taiwanese Patent Office; Office Action dated Jun. 13, 2018 in Application No. 104111910. |
| Taiwanese Patent Office; Office Action received in Application No. 106117181. |
| Bearzotti, et al., “Fast Humidity Response of a Metal Halide-Doped Novel Polymer,” Sensors and Actuators B, 7, pp. 451-454, (1992). |
| Becker et al., “Atomic Layer Deposition of Insulating Hafnium and Zirconium Nitrides,” Chem. Mater., 16, 3497-3501 (2004). |
| Bhatnagar et al., “Copper Interconnect Advances to Meet Moore's Law Milestones,” Solid State Technology, 52, 10 (2009). |
| Buriak, “Organometallic Chemistry on Silicon and Germanium Surfaces,” Chemical Reviews, 102, 5 (2002). |
| Cant et al., “Chemisorption Sites on Porous Silica Glass and on Mixed-Oxide Catalysis,” Can. J. Chem. 46, 1373 (1968). |
| Chang et al. “Small-Subthreshold-Swing and Low-Voltage Flexible Organic Thin-Film Transistors Which Use HfLaO as the Gate Dielectric,” IEEE Electron Device Letters, Feb. 2009, pp. 133-135; vol. 30, No. 2; IEEE Electron Device Society. |
| Chatterjee et al., “Sub-100nm Gate Length Metal Gate NMOS Transistors Fabricated by a Replacement by a Replacement Gate Process,” IEEE Semiconductor Process and Device Center, 821-824 (1997). |
| Chen et al., “A Self-Aligned Airgap Interconnect Scheme,” IEEE International Interconnect Technology Conference, vol. 1-3, 146-148 (2009). |
| Choi et al., “Improvement of Silicon Direct Bonding using Surfaces Activated by Hydrogen Plasma Treatment,” Journal of the Korean Physical Society, 37, 6, 878-881 (2000). |
| Choi et al., “Low Temperature Formation of Silicon Oxide Thin Films by Atomic Layer Deposition Using NH3/O2 Plasma,” ECS Solid State Letters, 2(12) p. 114-116 (2013). |
| Coates, “Process Analytical Technology: Spectroscopic Tools and Implementation Strategies for the Chemical and Pharmaceutical Industries.” Blackwell Publishing Ltd, 91-132, (2005). |
| Crowell, “Chemical methods of thin film deposition: Chemical vapor deposition, atomic layer deposition, and related technologies,” Journal of Vacuum Science & Technology A 21.5, (2003): S88-S95. |
| Cui et al., “Impact of Reductive N2/H2 Plasma on Porous Low-Dielectric Constant SiCOH Thin Films,” Journal of Applied Physics 97, 113302, 1-8 (2005). |
| Dingemans et al., “Comparison Between Aluminum Oxide Surface Passivation Films Deposited with Thermal Aid,” Plasma Aid and Pecvd, 35th IEEE PVCS, Jun. 2010. |
| Drummond et al., “Hydrophobic Radiofrequency Plasma-Deposited Polymer Films: Dielectric Properties and Surface Forces,” Colloids and Surfaces A, 129-130, 117-129 (2006). |
| Easley et al., “Thermal Isolation of Microchip Reaction Chambers for Rapid Non-Contact DNA Amplification,” J. Micromech. Microeng. 17, 1758-1766 (2007). |
| Elam et al., “New Insights into Sequential Infiltration Synthesis”, ECS Transactions, vol. 69, pp. 147-157 (2015). |
| Ge et al., “Carbon Nanotube-Based Synthetic Gecko Tapes,” Department of Polymer Science, PNAS, 10792-10795 (2007). |
| George et al., “Atomic Layer Deposition: An Overview,” Chem. Rev. 110, 111-131 (2010). |
| Grill et al., “The Effect of Plasma Chemistry on the Damage Induced Porous SiCOH Dielectrics,” IBM Research Division, RC23683 (W0508-008), Materials Science, 1-19 (2005). |
| Guan et al., “Voltage gated ion and molecule transport in engineered nanochannels: theory, fabrication and applications,” Nanotechnology 25 (2014) 122001. |
| Gupta et al., “Conversion of Metal Carbides to Carbide Derived Carbon by Reactive Ion Etching in Halogen Gas,” Proceedings of SPIE—The International Society for Optical Engineering and Nanotechnologies for Space Applications, ISSN: 0277-786X (2006). |
| Harrison et al., “Poly-gate Replacement Through Contact Hole (PRETCH): A New Method for High-K/ Metal Gate and Multi-Oxide Implementation on Chip,” IEEE (2004). |
| Heo et al., “Structural Characterization of Nanoporous Low-Dielectric Constant SiCOH Films Using Organosilane Precursors,” NSTI-Nanotech, vol. 4, 122-123 (2007). |
| Henke et al.., “X-Ray Interactions: Photo absorption, Scattering, Transmission, and Reflection at E = 50-30,000 eV, Z = 1-92,” Atomic Data and Nuclear Data Tables, 54, 181-342 (1993). |
| H.J. Yun et al., “Comparison of Atomic Scale Etching of Poly-Si in Inductively Coupled Ar and He Plasmas”, Korean Journal of Chemical Engineering, vol. 24, 670-673 (2007). |
| Hubert et al., “A Stacked SONOS Technology, up to 4 Levels and 6nm Crystalline Nanowires, With Gate-All-Around or Independent Gates (-Flash), Suitable for Full 3D Integration,” Minatec, IEDM09-637-640 (2009). |
| Hudis, “Surface Crosslinking of Polyethylene Using a Hydrogen Glow Discharge,” J. Appl. Polym. Sci., 16 (1972) 2397. |
| Jones et al., “Growth of Aluminum Films by Low Pressure Chemical Vapour Deposition Using Tritertiarybutylaluminium,” Journal of Crystal Growth 135, pp. 285-289, Elsevier Science B.V. (1994). |
| Jones et al., “Recent Developments in Metalorganic Precursors for Metalorganic Chemical Vapour Deposition,” Journal of Crystal Growth 146, pp. 503-510, Elsevier Science B.V. (1995). |
| Jung et al., “Double Patterning of Contact Array with Carbon Polymer,” Proc. of SPIE, 6924, 69240C, 1-10 (2008). |
| Katamreddy et al., “ALD and Characterization of Aluminum Oxide Deposited on Si(100) using Tris(diethylamino) Aluminum and Water Vapor,” Journal of the Electrochemical Society, 153 (10) C701-C706 (2006). |
| Kim et al., “Passivation Effect on Low-k S/OC Dielectrics by H2 Plasma Treatment,” Journal of the Korean Physical Society, 40, 1, 94-98 (2002). |
| Kim et al., “Characteristics of Low Temperature High Quality Silicon Oxide by Plasma Enhanced Atomic Layer Deposition with In-Situ Plasma Densification Process,” The Electrochemical Society, ECS Transactions, College of Information and Communication Engineering, Sungkyunkwan University, 53(1), 321-329 (2013) . . . |
| King, Plasma Enhanced Atomic Layer Deposition of SiNx: H and SiO2, J. Vac. Sci. Technol., A29(4) (2011). |
| Klug et al., “Atomic Layer Deposition of Amorphous Niobium Carbide-Based Thin Film Superconductors,” The Journal of Physical Chemistry C, vol. 115, pp. 25063-25071, (2011). |
| Kobayshi, et al., “Temperature Dependence of SiO2 Film Growth with Plasma-Enhanced Atomic Layer Deposition,” regarding Thin Solid Films, published by Elsevier in the International Journal on the Science and Technology of Condensed Matter, in vol. 520, No. 11, 3994-3998 (2012). |
| Koo et al., “Characteristics of Al2O3 Thin Films Deposited Using Dimethylaluminum Isopropoxide and Trimethylaluminum Precursors by the Plasma-Enhanced Atomic-Layer Deposition Method,” Journal of Physical Society, 48, 1, 131-136 (2006). |
| Koutsokeras et al. “Texture and Microstructure Evolution in Single-Phase TixTa1-xN Alloys of Rocksalt Structure,” Journal of Applied Physics, 110, pp. 043535-1-043535-6, (2011). |
| Knoops et al., “Atomic Layer Deposition of Silicon Nitride from Bis(tert-butyloamino) silane and N2 Plasma,” Applied Materials & Interfaces, American Chemical Society, A-E (2015). |
| Krenek et al. “IR Laser CVD of Nanodisperse Ge—Si—Sn Alloys Obtained by Dielectric Breakdown of GeH4/SiH4/SnH4 Mixtures”, NanoCon 2014, Nov. 5-7, Brno, Czech Republic, EU. |
| Kurosawa et al., “Synthesis and Characterization of Plasma-Polymerized Hexamethyldisiloxane Films,” Thin Solid Films, 506-507, 176-179 (2006). |
| Lanford et al., “The Hydrogen Content of Plasmadeposited Silicon Nitride,” J. Appl. Phys., 49, 2473 (1978). |
| Lee et al., “Layer Selection by Multi-Level Permutation in 3-D Stacked NAND Flash Memory,” IEEE Electron Devices Letters, vol. 37, No. 7, 866-869 (2016). |
| Lieberman, et al., “Principles of Plasma Discharges and Materials Processing,” Second Edition, 368-381. |
| Lim et al., “Low-Temperature Growth of SiO2 Films by Plasma-Enhanced Atomic Layer Deposition,” ETRI Journal, 27 (1), 118-121 (2005). |
| Liu et al., “Research, Design, and Experiment of End Effector for Wafer Transfer Robot,” Industrial Robot: An International Journal, 79-91 (2012). |
| Longrie et al., “Plasma-Enhanced ALD of Platinum with O2, N2 and NH3 Plasmas”, ECS Journal of Solid State Science and Technology, vol. 1, pp. Q123-Q129 (2012). |
| Mackus et al., “Optical Emission Spectroscopy as a Tool for Studying Optimizing and Monitoring Plasma-Assisted Atomic Layer Deposition Processes,” Journal of Vacuum Science and Technology, 77-87 (2010). |
| Maeno, “Gecko Tape Using Carbon Nanotubes,” Nitto Denko Gihou, 47, 48-51. |
| Maeng et al. Electrical properties of atomic layer disposition Hf02 and Hf0xNy on Si substrates with various crystal orientations, Journal of the Electrochemical Society, Apr. 2008, p. H267-H271, vol. 155, No. 4, Department of Materials Science and Engineering, Pohang University of Science and Technology, Pohang, Korea. |
| Marsik et al., “Effect of Ultraviolet Curing Wavelength on Low-k Dielectric Material Properties and Plasma Damage Resistance,” Sciencedirect.com, 519, 11, 3619-3626 (2011). |
| Mason et al., “Hydrolysis of Tri-tert-butylaluminum: The First Structural Characterization of Alkylalumoxanes [(R2A1)2O]n and (RAIO)n,” J. American Chemical Society, vol. 115, No. 12, pp. 4971-4984 (1993). |
| Massachusetts Institute of Technology Lincoln Laboratory, “Solid State Research,” Quarterly Technical Report (1995). |
| Maydannik et al., “Spatial atomic layer deposition: Performance of low temperature H2O and 03oxidant chemistry for flexible electronics encapsulation”, Journal of Vacuum Science and Technology: Part A AVS/AIP, vol. 33 (1901). |
| Meng et al., “Atomic Layer of Deposition of Silicon Nitride Thin Films: A Review of Recent Progress, Challenges, and Outlooks,” Materials, 9, 1007 (2016). |
| Mix et al., “Characterization of plasma-polymerized allyl alcohol polymers and copolymers with styrene,” Adhes. Sci. Technol., 21 (2007), S. 487-507. |
| Moeen, “Design, Modelling and Characterization of Si/SiGe Structures for IR Bolometer Applications,” KTH Royal Institute of Technology. Information and Communication Technology, Department of Integrated Devices and Circuits, Stockholm Sweden (2015). |
| Morishige et al., “Thermal Desorption and Infrared Studies of Ammonia Amines and Pyridines Chemisorbed on Chromic Oxide,” J. Chem. Soc., Faraday Trans. 1, 78, 2947-2957 (1982). |
| Mosleh et al., “Enhancement of Material Quality of (Si)GeSn Films Grown by SnC14 Precursor,” ECS Transactions, 69 (5), 279-285 (2015). |
| Mukai et al., “A Study of CD Budget in Spacer Patterning Technology,” Proc. of SPIE, 6924, 1-8 (2008). |
| Nigamananda et al., “Low-Temperature (<200oC) Plasma Enhanced Atomic Deposition of Dense Titanium Nitride Thin Films.” |
| Nogueira et al., “Production of Highly Hydrophobic Films Using Low Frequency and High Density Plasma,” Revista Brasileira de Aplicacoes de Vacuo, 25(1), 45-53 (2006). |
| Novaro et al. Theoretical Study on a Reaction Pathway of Ziegler-Natta-Type Catalysis, J. Chem. Phys. 68(5), Mar. 1, 1978 p. 2337-2351. |
| S. Okamoto et al., “Luminescent Properties of Pr3+-sensitized LaPO4: Gd3+ Ultraviolet-B Phosphor Under Vacuum-Ultraviolet Light Excitation,” J. App. Phys. 106, 013522 (2009). |
| Park “Substituted Aluminum Metal Gate on High-K Dielectric for Low Work-Function and Fermi-Level Pinning Free,” 4 pages, IEEE 0-7803-8684-1/04 (2004). |
| Portet et al., “Impact of Synthesis Conditions on Surface Chemistry and Structure of Carbide-Derived Carbons,” Thermochimica Acta, 497, 137-142 (2010). |
| Potts et al., “Low Temperature Plasma-Enhanced Atomic Layer Deposition of metal Oxide Thin Films,” Journal of the Electrochemical Society, 157, 66-74 (2010). |
| Potts et al., “Room-Temperature ALD of Metal Oxide Thin Films by Energy-Enhanced ALD”, Chemical Vapor Deposition, vol. 19, pp. 125-133 (2013). |
| Presser, et al., “Effect of Pore Size on Carbon Dioxide Sorption by Carbide Derived Carbon,” Energy & Environmental Science 4.8, 3059-3066 (2011). |
| Provine et al., “Correlation of Film Density and Wet Etch Rate in Hydrofluoric Acid of Plasma Enhanced Atomic Layer Deposited Silicon Nitride,” AIP Advances, 6 (2016). |
| Radamson et al. “Growth of Sn-alloyed Group IV Materials for Photonic and Electronic Applications”, Chapter 5 pp. 129-144, Manufacturing Nano Structures. |
| Sakuma et al., “Highly Scalable Horizontal Channel 3-D NAND Memory Excellent in Compatibility with Conventional Fabrication Technology,” IEEE Electron Deivice Letters, vol. 34, No. 9, 1142-1144 (2013). |
| Salim, “In-situ Fourier Transform Infrared Spectroscopy of Chemistry and Growth in Chemical Vapor Deposition,” Massachusetts Institute of Technology, 187 pages (1995). |
| Salim et al., “In Situ Concentration Monitoring in a Vertical OMVPE Reactor by Fiber-Optics-Based Fourier Transform Infrared Spectroscopy,” Journal of Crystal Growth 169, pp. 443-449, Elsevier Science B.V. (1996). |
| Schmatz et al., “Unusual Isomerization Reactions in 1.3-Diaza-2-Silcyclopentanes,” Organometallics, 23, 1180-1182 (2004). |
| Scientific and Technical Information Center EIC 2800 Search Report dated Feb. 16, 2012. |
| Selvaraj et al., “Selective Atomic Layer Deposition of Zirconia on Copper Patterned Silicon Substrates Using Ethanol as Oxygen Source as Well as Copper Reductant,” J. Vac. Sci. Technol. A32(1), (2014). |
| Selvaraj et al., “Surface Selective Atomic Layer Deposition of Hafnium Oxide for Copper Diffusion Barrier Application Using Tetrakis (diethylamino) Hafnium and Ethanol,” 225th ECS Meeting, Meeting Abstract, (May 12, 2014). |
| S.D. Athavale and D.J. Economou, “Realization of Atomic Layer Etching of Silicon”, Journal of Vacuum Science and Technology B, vol. 14, year 1996, pp. 3702-3705. |
| Shamma et al., “PDL Oxide Enabled Doubling,” Proc. of SPIE, 6924, 69240D, 1-10 (2008). |
| Tseng et al., “Etch Properties of Resists Modified by Sequential Infiltration Synthesis,” American Vacuum Society (2011). |
| Tseng et al., “Enhanced Block Copolymer Lithography Using Sequntial Infiltration Synthesis,” Journal of Physical Chemistry, vol. 5, 17725-17729 (2011). |
| Varma, et al., “Effect of Metal Halides on Thermal, Mechanical, and Electrical Properties of Polypyromelitimide Films,” Journal of Applied Polymer Science, vol. 32, pp. 3987-4000, (1986). |
| Voltaix, “Meterial Safety Data Sheet for: Trisilylamine”, pp. 1-8, (2014). |
| Wang et al., “Tritertiarybutylaluminum as an Organometallic Source for Epitaxial Growth of AlGaSb,” Appl. Phys. Lett. 67 (10), Sep. 4, pp. 1384-1386, American Institute of Physics (1995). |
| Wirths, et al, “SiGeSn Growth tudies Using Reduced Pressure Chemical Vapor Deposition Towards Optoeleconic Applications,” This Soid Films, 557, 183-187 (2014). |
| Yoshida, et al., Threshold Voltage Tuning for 10NM and Beyond CMOS Integration, Solid State Technology, 57(7): 23-25 (2014). |
| Yu et al., “Modulation of the Ni FUSI Workfunction by Yb Doping: from Midgap to N-Type Band-Edge,” 4 pages, IEEE 0-7803-9269-8/05 (2005). |
| Yun et al., “Behavior of Various Organosilicon Molecules in PECVD Processes for Hydrocarbon-Doped Silicon Oxide Films,” Solid State Phenomena, vol. 124-126, 347-350 (2007). |
| Yun et al., “Single-Crystalline Si Stacked Array (STAR) NAND Flash Memory,” IEEE Transactions on Electron Devices, vol. 58, No. 4, 1006-1014 (2011). |
| Yun et al., “Effect of Plasma on Characteristics of Zirconium Oxide Films Deposited by Plasma-Enhanced Atomic Layer Deposition,” Electrochemical and Solid State Letters, 8(11) F47-F50 (2005). |
| Yushin et al., “Carbon-Derived Carbon,” Department of Materials Science and Engineering, Taylor & Francis Group, LLC (2006). |
| Chemistry Stack Exchange, “Why is CF4 Non-Polar and CHF Polar,” https://chemistry.stackexchange.com/questions/31604/why-is-cf4-non-polar-and-chf3-polar, (2015). |
| USPTO; Notice of Allowance dated Jun. 28, 2017 in U.S. Appl. No. 13/166,367. |
| USPTO; Non-Final Office Action dated Sep. 20, 2018 in U.S. Appl. No. 13/651,144. |
| USPTO; Notice of Allowance dated Aug. 13, 2018 in U.S. Appl. No. 13/941,226. |
| USPTO; Notice of Allowance dated Oct. 3, 2018 in U.S. Appl. No. 13/941,226. |
| USPTO; Notice of Allowance dated Aug. 29, 2018 in U.S. Appl. No. 14/090,750. |
| USPTO; Notice of Allowance dated Sep. 24, 2018 in U.S. Appl. No. 14/218,690. |
| USPTO; Final Office Action dated Sep. 5, 2018 in U.S. Appl. No. 14/752,712. |
| USPTO; Advisory Action dated Aug. 10, 2018 in U.S. Appl. No. 14/829,565. |
| USPTO; Non-Final Office Action dated Sep. 6, 2018 in U.S. Appl. No. 14/829,565. |
| USPTO; Notice of Allowance dated Oct. 20, 2017 in U.S. Appl. No. 14/884,695. |
| USPTO; Notice of Allowance dated Oct. 4, 2018 in U.S. Appl. No. 14/919,536. |
| USPTO; Non-Final Office Action dated Aug. 27, 2018 in U.S. Appl. No. 15/067,028. |
| USPTO; Notice of Allowance dated Oct. 14, 2018 in U.S. Appl. No. 15/135,333. |
| USPTO; Notice of Allowance dated May 22, 2017 in U.S. Appl. No. 15/222,738. |
| USPTO; Notice of Allowance dated Sep. 10, 2018 in U.S. Appl. No. 15/222,749. |
| USPTO; Non-Final Office Action dated Oct. 1, 2018 in U.S. Appl. No. 15/222,780. |
| USPTO; Non-Final Office Action dated Sep. 13, 2018 in U.S. Appl. No. 15/262,990. |
| USPTO; Non-Final Office Action dated Oct. 3, 2017 in U.S. Appl. No. 15/388,410. |
| USPTO; Non-Final Office Action dated Sep. 20, 2018 in U.S. Appl. No. 15/410,503. |
| USPTO; Final Office Action dated Aug. 29, 2018 in U.S. Appl. No. 15/434,051. |
| USPTO; Non-Final Office Action dated Sep. 10, 2018 in U.S. Appl. No. 15/489,453. |
| USPTO; Notice of Allowance dated Jul. 18, 2018 in U.S. Appl. No. 15/640,239. |
| USPTO; Notice of Allowance dated Aug. 30, 2018 in U.S. Appl. No. 15/640,239. |
| USPTO; Non-Final Office Action dated Sep. 21, 2017 in U.S. Appl. No. 15/659,631. |
| USPTO; Non-Final Office Action dated Aug. 27, 2018 in U.S. Appl. No. 15/662,107. |
| USPTO; Requirement for Restriction dated Sep. 11, 2018 in U.S. Appl. No. 15/672,063. |
| USPTO; Requirement for Restriction dated Aug. 14, 2018 in U.S. Appl. No. 15/705,955. |
| USPTO; Non-Final Office Action dated Oct. 4, 2018 in U.S. Appl. No. 15/726,222. |
| USPTO; Restriction Requirement dated Aug. 31, 2018 in U.S. Appl. No. 15/795,056. |
| USPTO; Non-Final Office Action dated Jun. 26, 2018 in U.S. Appl. No. 15/796,693. |
| USPTO; Non-Final Office Action dated Sep. 10, 2018 in U.S. Appl. No. 15/836,547. |
| European Patent Office; Office Action dated Aug. 10, 2018 in Application No. 09767208.3. |
| Korean Patent Office; Office Action dated Apr. 2, 2018 in Application No. 10-2011-0036449. |
| Korean Patent Office; Office Action dated Sep. 18, 2018 in Application No. 10-2012-0064526. |
| Korean Patent Office; Office Action dated Sep. 27, 2018 in Application No. 10-2012-0076564. |
| Korean Patent Office; Office Action dated Sep. 28, 2017 in Application No. 10-2017-7023740. |
| Taiwanese Patent Office; Office Action dated Sep. 26, 2018 in Application No. 103132230. |
| Taiwanese Patent Office; Office Action dated May 21, 2018 Application No. 103139014. |
| Taiwanese Patent Office; Office Action dated Jul. 9, 2018 in Application No. 104107876. |
| Taiwanese Patent Office; Office Action dated Aug. 7, 2018 Application No. 104107888. |
| Taiwanese Patent Office; Office Action dated Jul. 9, 2018 in Application No. 104110326. |
| Taiwanese Patent Office; Office Action dated Jul. 11, 2018 in Application No. 104124377. |
| Taiwanese Patent Office; Office Action dated Jun. 25, 2018 in Application No. 106138800. |
| Taiwanese Patent Office; Office Action dated Aug. 31, 2018 in Application No. 10720809210. |
| WIPO; International Search Report and Written Opinion dated Jul. 9, 2018 in Application No. PCT/IB2018/000419. |
| WIPO; International Search Report and Written Opinion dated Sep. 14, 2018 in Application No. PCT/IB2017/001640. |
| Crystal IS “Application Note: Using UV Reflective Materials to Maximize Disinfection”; AN011; Jun. 16, 2016. |
| Kukli et al., “Properties of hafnium oxide films grown by atomic layer deposition from hafnium tetraiodide and oxygen”. Journal of Applied Physics, vol. 92, No. 10, Nov. 15, 2002, pp. 5698-5703. |
| Liang et al. “Conversion of Metal Carbides to Carbide Derived Carbon by Reactive Ion Etching in Halogen Gas” Micro (MEMS) and Nanotechnologies for Space Applications, Thomas George et al. vol. 6223, 2006 p. 62230J-I to 62230J-11 lines 3-14 in the “Abstract” section and lines 7-9 in the “Introduction” section of p. 1, lines 3-4 in the “Introduction” section and lines 3-4 in the “Experimental Procedure” section of p. 2. |
| Sellers, Making Your Own Timber Dogs, Paul Sellers blog, Published on Nov. 18, 2014, [online], [site visited Jun. 10, 2017]. Available from Internet, <URL. |
| “Polyurethane HF”; webpage; no date. Cited in Notice of References Cited by Examiner dated May 18, 2017 in U.S. Appl. No. 14/884,695. |
| Xu et al., “14NM Metal Gate Film Stack Development and Challenges,” SMIC et al. (2016). |
| Number | Date | Country | |
|---|---|---|---|
| 20180182618 A1 | Jun 2018 | US |
